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Summary
Characterization of calpain activation in response to excitotoxic 
events in primary neurons
Excitotoxicity resulting from excessive Ca2+ influx through glutamate receptors 
contributes to neuronal injury after stroke, trauma, and seizures. Increased 
cytosolic Ca2+ levels activate a family of calcium-dependent proteases with 
papain-like activity, the calpains. Here we investigated the role of calpain 
activation during NMDA-induced excitotoxic injury in embryonic (E l6 -E l8 ) 
murine cortical neurons that underwent either: (i) excitotoxic necrosis,
9+characterized by immediate deregulation of Ca homeostasis, a persistent 
depolarization of mitochondrial membrane potential (Ay/m), and insensitivity to 
bax-gene deletion; (ii) excitotoxic apoptosis, characterized by recovery of 
NMDA-induced cytosolic Ca2+ increases, sensitivity to bax gene deletion, and 
delayed Ai//m depolarization and Ca2+ deregulation; or (iii) that were tolerant to 
excitotoxic injury. Interestingly, treatment with the calpain inhibitor calpeptin, 
overexpression of the endogenous calpain inhibitor calpastatin, or gene silencing 
of calpain protected neurons against excitotoxic apoptosis, but did not influence 
excitotoxic nccrosis. Calpeptin failed to exert a protective effect in ôax-deficient 
neurons, but protected bid- and è/'m-deficient neurons similarly to wild-type 
cells. To identify when calpains became activated during excitotoxic apoptosis, 
we monitored calpain activation dynamics by time-lapse fluorescence 
microscopy, using a calpain-sensitive Forster resonance energy transfer probe. 
We observed a delayed calpain activation that occurred downstream of
mitochondrial engagement and directly preceded neuronal death. In contrast, we 
could not detect significant calpain activity during excitotoxic necrosis or in 
neurons that were tolerant to excitotoxic injuiy. Oxygen/glucose deprivation- 
induced injury in organotypic hippocampal slice cultures confirmed that calpains 
were specifically activated during ¿ax-dependent apoptosis and in this setting 
function as downstream cell death executioners. Lastly, box gene deletion 
prevented NMDA-induced alterations to Ay/m, hyperpolarisation and 
depolarisation were notably diminished, and affected neuronal calcium handling, 
resulting in increased neuronal survival.
xiv
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CHAPTER I
General Introduction
1
1.1 Historical perspective
From a historical standpoint, no other cell type has attracted as much attention or 
caused as much controversy as the nerve cell.
Morphological observations of the nucleolated cell body (soma), several nervous 
branched fibres (dendrites) and a single unbranched nerve prolongation (axon) 
were first made by Karl Deiters in 1865. On the basis of these studies, the 
German Heinrich Waldeyer, coined the term “neuron” in 1891. Later, using light 
microscopy and a silver impregnation staining technique, Santiago Ramon y 
Cajal and his contemporary Camillo Golgi described in much greater detail the 
so-called “neuron theory”, contributing to the foundations of modem 
neuroscience (Mazzarello, 1999). Definitive physiological evidence of the 
neuron theory was obtained with the introduction of the electron microscopy, 
which allowed the identification of synaptic transmission between neurons 
(Foster and Sherrington, 1897).
1.2 Neurons and brain functions
Cajal and Golgi’s successors observed that the nervous system consists of 
neurons and their supporting cells (glia), providing protection, facilitating 
neurotransmission and mediating trophic support of the neurons.
Classically, neurons are classified in three types according to the number of 
processes that protrude from the soma: (i) unipolar, commonly found in the 
invertebrate system; (ii) bipolar, such as retinal ganglion neurons, commonly 
known as sensory neurons; (iii) and multipolar, which are the most common type
in vertebrates and they possess various functions (intemeurons, pyramidal 
neurons, motoneurons). Transmission of an electrical signal between neurons 
(synaptic transmission) is allowed by neurotransmitters, chemicals which can be 
either excitatory or inhibitory (acetylcholine, serotonin, dopamine, GABA). 
Neurotransmitters molecules are released from vesicles by the pre-synaptic 
terminal into the synaptic cleft, finally activating receptors on the post-synaptic 
neuron. The receptors elicit cellular responses such as opening voltage dependent 
ions channels which create a new electric signal and transferring of information 
from one neuron to the next (Siegel et al., 1999).
The human brain contains about 100 billion neurons and each of them is 
connected to other neurons through about 1 0 0  trillion synapses, forming a 
network of information through which the brain can create memories, emotions, 
perception and feeling. The brain is not homogeneous and is composed of the 
brain stem, which includes the pons, midbrain and medulla oblongata, the 
cerebellum to the rear of the brain and the cerebral cortcx to the fore (Fig. 1.1). 
Each of these can be hierarchically subdivided into many regions, and areas 
within each region, either according to the anatomical structure of the neural 
networks within it, or according to the function performed by it. The brain stem 
controls the primary autonomic functions such as breathing, heartbeat and blood 
pressure. The cerebellum has two hemispheres and controls primary physical 
functions such as co-ordination of movement, posture and balance. The cerebral 
cortex is nearly symmetrical and divided in two hemispheres which are 
conventionally divided into four lobes: the frontal lobe, parietal lobe, occipital 
lobe and temporal lobe. The cortex is associated with the highest brain functions, 
including self-control, planning, decision-making, vision, memory and emotion.
Cerebral 
hemisphere
Thalamus 
Hypothalamus
Pituitary 
Pons
Midbrain
Figure 1.1: Schematic diagram of the brain. Basic anatomical structure of the 
brain as seen from the middle of the brain. The brain is composed of the cerebral 
cortex, the cerebellum and the brain stem which is continuous with the spinal 
cord and includes the medulla oblongata, pons, and midbrain. The thalamus 
serves as a central relay point for incoming nervous messages (Purves et al., 
1992).
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1.3 Stroke
Brain cell function requires a constant delivery of oxygen and glucose from the 
bloodstream. Stroke, or cerebrovascular accident (CVA), results from a transient 
or permanent reduction of blood flow in the brain, inducing neurological damage 
and cell death. The severity of stroke depends on the duration of the cerebral 
blood flow reduction within the brain and region affected. Strokes can be 
classified in two main categories: ischemic stroke and hemorrhagic stroke. 
Ischemic stroke occurs when there is an interruption of a blood vessel that 
supplies blood to the brain (thrombosis or cerebral embolism) and hemorrhagic 
stroke occurs when there is a rupture of a blood vessel causing bleeding into the 
brain. Ischemia is the most common type of stroke which, in turn, it is divided 
into two forms: global ischemia which is characterised by a complete 
interruption of blood flow over a short period and affects the whole brain while 
focal cerebral ischemia is a more localised and slower event (Lipton, 1999). Risk 
factors for stroke include age, hypertension, previous stroke or transient ischemic 
attack (TIA), diabetes, high cholesterol and smoking (Sug Yoon et a l, 2001).
As an interruption in blood flow results in a rapid depletion of oxygen and 
glucose during ischemia, affected neurons promptly lose their ability to produce 
vital levels of ATP disturbing the correct functioning of the Na+/K+ and Ca2+ 
ATPases. The loss of ionic homeostasis results in an increase of cytoplasmic 
Ca2+ concentration accompanied by an increase of extracellular K concentration 
and a decrease of extracellular Na' concentration (Folbergrova et al., 1990, 
Silver and Erecinska, 1990). This leads to a depolarisation of the plasma 
membrane which produces synaptic release of glutamate from neurons causing
5
Ischemia produces various cellular events including glutamate mediated 
excitotoxicity and calcium overload, oxidative stress, stress signalling, 
neurovascular pathophysiology, inflammation, cell death and gene expression 
(Wong and Crack, 2008).
1.4 The concept of excitotoxicity
The neurotoxicity of sustained glutamate exposure was first observed in 1954 by 
T. Hayashi who noticed that direct application of this excitatory amino acid in 
the CNS could cause seizure activity. The toxic effect of monosodium glutamate 
on retinal neurons was subsequently reported in 1957 by D.R. Lucas and J.P. 
Newhouse and at around the same time the excitatory properties of glutamate 
were being characterised (Curtis et ah, 1959). Later, in 1969, the term 
“excitotoxicity” was introduced by J. Olney who described that glutamate 
toxicity was not restricted to retinal neurons but occurred throughout the brain 
(Olney, 1969, Olney etal., 1972).
High concentrations of glutamate overactivates different types of receptors 
(ionotropic and metabotropic) causing a significant disruption of cellular ion 
homeostasis. In 1987, Choi demonstrated that Ca2+ entry was a key mediator of 
glutamate excitotoxicity and the NMDA receptors was a predominant source of 
this toxic influx (Choi, 1987). Shortly afterwards, several papers implicated 
glutamate excitotoxicity in ischemic, traumatic and seizure-induced brain injury 
(Choi, 1994) and in several chronic neurodegenerative disorders (Rothstein et al., 
1990, Lipton, 2007, Mattson, 2007).
an overactivation of glutamate receptors.
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Glutamate is the major excitatory neurotransmitter in the mammalian central 
nervous system where it plays a crucial role for several physiological functions, 
including neurotransmission and synaptic plasticity, learning and memory, 
central pain transduction and neuronal injury following ischemia or trauma. 
Glutamate can activate either ionotropic (iGluRs) and metabotropic receptors 
(mGluRs). The latter indirectly activates ion-channels on the plasma membrane 
requiring a secondary signal which involves G proteins. mGluRs are subdivided 
into three main families and can be coupled to phospholipase C (Group I) or to 
adenylyl cyclase (Group II and III). The ionotropic glutamate receptors are 
ligand-gated ion channel which form the ion channel pore that become activated 
as a consequence of the glutamate-receptor binding. mGluRs are more 
distributed throughout the cell, whereas iGluRs are more localised. Ionotropic 
receptors are divided into three defined groups which were originally named 
after selective agonists-N-methyl-D-aspartate (NMDA), a-amino-3-hydroxy-5- 
methyl-4-isoxazolepropionic acid (AMPA) and kainate acid (Collingridge, 
1994).
Most of ionotropic glutamate receptors are permeable to cations and largely 
exclude anions from the pore. Although iGluRs are thought to be nearly equally 
permeable to sodium and potassium ions, Ca2+ permeation is different between 
them: NMDARs possess high conductance of calcium, while only AMPA 
receptors lacking GluR2 subunit are Ca2+ permeable (Premkumar and Auerbach,
1996, Dingledine et al., 1999).
1.4.1 Glutamate receptors
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NMDA receptors are among the most tightly regulated neurotransmitter 
receptors and they are distinctive in their simultaneous requirement of two 
different agonists for the receptor activation: short-chain dicarboxylic amino 
acids, such as glutamate, aspartate and NMDA, and a co-agonist like glycine or 
D-serine (Mothet et a l,  2000). Under physiological conditions, the high 
conductance of ions through NMDARs is inhibited by Mg2+. This binding 
blockade is voltage dependent and is relieved by a depolarisation of the plasma 
membrane (Ascher and Nowak, 1986).
The NMDA receptors form heterotetramer between the NR1 subunit and any of 
the four NR2 subunits (NR2A, B, C, D). There are also NR3A and B modulatory 
subunits, which are distantly related to the other NMDA subunits and have a 
neuroprotective effect on the receptor activity (Nakanishi et al., 2009). The high 
permeability of NMDA receptor channels for Ca2+ ions has many physiological 
implications. Overactivation of NMDA receptors causes an increase of Ca2f entry 
in the cytosol, which may lead to the transient activation of a variety of Ca2+- 
activated enzymes such as proteases, phospholipases, endonucleases, damaging 
cell structures and often promoting neuronal cell death (Choi, 1987, Tymianski et 
a l, 1993, Stout et al., 1998).
Studies in excitotoxic-injury models have shown that increased Ca2 1 levels in the 
cytosol are able to activate a family of calcium-dependent proteases with papain­
like activity, the calpains. Calpains participate in proteolytic cleavage events of 
specific regulatory targets in response to NMDA receptor activation and may 
contribute to cell demolition during excitotoxic injury (del Cerro et al., 1994, 
Bednarski et al., 1995).
1.4.2 NMDA receptors
1.4.3 Role of NMDA receptors in excitotoxicity
Although physiological activation of the NMDA receptors is necessary for cell 
survival, they are the major mediator of excitotoxicity and their overactivation is 
a signal of cell death (Hardingham and Bading, 2010). The physiological role of 
NMDARs is believed to be related to the acquisition of information and memory 
events, such as synaptic plasticity and the establishment of long-term 
potentiation (LTP) and long-term depression (LTD) between neurons 
(Dunwiddie and Lynch, 1979, Wang and Linden, 2000). Under normal 
conditions, Ca2+ entry through NMDA channels provides a transient signal 
necessary for the induction of LTP. The excessive Ca2+ influx that results from 
overactivation of NMDARs activates a variety of cellular components, like 
calpains, resulting in protein degradation. Moreover, second-messenger cascades 
involving Ca2+/calmodulin dependent kinase II (CaM-KII), protein kinase C 
(PKC) and adenyl cyclase are activated, which results in an activation of cAMP- 
dependent protein kinase (Michaelis, 1998). The catalytic subunit of this kinase 
translocates to the nucleus triggering the expression of transcription factors 
involved in trophic and structural long-lasting changes. In addition, an increased 
entry of Ca2+ causes enhanced metabolic stress on mitochondria and activation of 
phospholipase A2, that lead to the production of reactive oxygen species (ROS). 
Furthermore, a number of Ca2+-dependent endonucleases is activated causing 
DNA degradation and leading, finally, to neuronal cell death.
1.4.4 Excitotoxicity and neurological disease
The phenomenon of excitotoxicity induced by pathophysiological overactivation
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of glutamate receptors has been implicated in several pathologic states in the 
nervous system. The best characterised and established examples of neurological 
conditions are the pathophysiology of stroke and traumatic brain injury, in which 
decreases in ATP production evoke glutamate release through depolarisation of 
presynaptic terminals; and epileptic seizures where excitatory synapses become 
over active (Schanne et al., 1979, Choi, 1994, Zipfel et al., 1999).
Excitotoxicity may play a secondary role in mediating chronic neurodegenerative 
processes such as Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral 
sclerosis and Huntington’s disease (Rothstein et al., 1990, Bezprozvanny and 
Hayden, 2004, Lipton, 2007, Mattson, 2007).
In the last few years, due to the relevance of the neurodegenerative diseases and 
the lack of effective treatment, research to develop a therapy of these 
neurological conditions has been extremely active. Drugs that block 
glutamatergic neurotransmission, such as the AMPA and NMDA receptor 
antagonists acting at the glycine site, as well as compounds like glutamate- 
release inhibitors attenuate some of the pathological symptoms in experimental 
models of acutc and chronic neurodegenerative diseases (Doble, 1999).
1.5 The concept of calcium as a cellular signal
Calcium plays a central role as a ubiquitous signalling molecule in various 
cellular processes like energy production, cell proliferation, gene regulation, 
membrane excitability, synaptic transmission and cell death. In signal 
transduction pathways, calcium acts as a second messenger in neurotransmission 
events, muscle contraction, cell motility, and in biochemical pathways,
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regulating enzymes activity, ion pumps and cytoskeleton components.
Under resting conditions, the intracellular calcium ([Ca2+]j) is tightly controlled 
in the range of -75-200 nM by a number of buffering and sequestering 
mechanisms to prevent improper levels of [Ca2+]j that could damage the cell. 
These mechanisms are performed at different cell organelles, such as at 
mitochondria, the endoplasmic reticulum (ER), the cytoplasm through cytosolic 
proteins binding calcium and at a membrane level using ATP-dependent pumps 
or Na+/Ca2+ exchanger. Ca2+ signalling is dependent on a rapid and transient 
increase in intracellular Ca2+ level by influx through the glutamate receptors and 
it is dynamically mediated by using both internal and external sources of Ca2+ 
(Choi, 1987).
The [Ca2+]j is regulated at the plasma membrane level by two distinct 
mechanisms capable of rapidly extruding large amounts of Ca2+ from the 
cytoplasm to the extracellular space. The Ca2+-ATPase pump transports calcium 
out of all eukaryotic cells, involving its phosphorylation in an ATP-dependent 
manner whereas, the Na+/Ca2+ exchanger (NCX) is an antiporter protein that 
removes calcium, exporting one calcium ion from cell in exchange for three 
sodium ions imported. This occurs in excitable cells only, such as nerve and 
muscle cells, via an electrochemical gradient. However, due to the electrogenic 
nature of the NCX, in cases of depolarisation of the plasma membrane, such as 
during excitotoxicity, the exchanger’s direction can be reversed (Yu and Choi,
1997, Scotti et al., 1999). Furthermore, during excessive calcium influx, the 
NCX can be cleaved, preventing re-establishment of calcium homeostasis (Bano 
et al., 2005).
Internal calcium stores are associated with specialised intracellular organelles,
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such as mitochondria and the endoplasmic reticulum (Berridge et al., 2000).
1.5.1 Mitochondrial Ca2+buffering
Mitochondria are receiving increasing attention for their role in Ca2+ storage and 
signalling, and as key players in the processes leading to cell death, following 
Ca2+overload through glutamate receptors. Mitochondria accumulate Ca2+ by an 
energy-dependent process, using an electrogenic Ca2~t channel. The accumulation 
of Ca2+ across the inner membrane is driven by a uniporter. This utilises the 
substantial mitochondrial membrane potential generated by the proton gradient 
of the electron transport chain during the respiration coupling synthesis of ATP 
(Duchen, 1999). This key role in the activation of mitochondrial metabolism 
occurs via the stimulation of matrix Ca2+-dependent dehydrogenases, such as 
pyruvate, NAD+-isocitate and a-ketoglutarate dehydrogenases (Denton and 
McCormack, 1980, McCormack et al., 1990). These enzymes trigger the process 
of oxidative phosphorylation by providing nicotinamide adenine dinucleotide 
(NADH) as substrate. The process leads to energy production in the 
mitochondria and maintains ionic homeostasis essential for synaptic transmission 
(Parihar et al., 2008).
Following cytosolic Ca2+ increases, mitochondria establish a localised interaction 
with the ER capable of performing a rapid ion uptake (Duchen, 2000). To 
extrude Ca2+, mitochondria, like the plasma membrane, possess a Na+/Ca2+ 
exchanger, which under pathological conditions, can operate in reverse (as 
mentioned above). This mitochondrial buffering system may facilitate inhibiting 
acute neuronal injury during ischemia (Pivovarova et al., 2004).
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Apart from “classical” calcium stores, other organelles, such as the nuclear
• * 1 2 +envelope and neurotransmitter vesicles, may potentially act as functional Ca 
storage compartments (Fig. 1.2). An improved understanding of how Ca2+ is 
controlled within these intracellular compartments, and how these compartments 
interact, will be important for neuroprotective strategies.
1.5.2 Ca2+ and endoplasmic reticulum
The ER plays an important role in regulating cytosolic calcium levels through the 
Sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) pumps, which 
accumulate calcium in the ER lumen. The most ubiquitous of the intracellular 
Ca2+ release mechanisms is mediated via inositol 1,4,5-trisphosphate receptor 
(L1SP3R) and ryanodine receptor (RYR) (Clapham, 1995), in which the principal 
activator is Ca2+ itself through a process named as Ca2+-induced Ca2+ release. 
Release of Ca2+ from the ER is tightly controlled by chemical or electrical 
signals. The InsPsR releases Ca2+ from the ER upon IP3 binding, while in 
striated muscle, the RYR senses electrical signals and releases Ca2+ from the SR.
Altered InsP3R channel function induces aberrant neuronal Ca2+ signalling in a 
variety of neurodegenerative diseases, hence L1SP3R may be an important 
component of pathologic cascades. Of note, recently, Kopil et al. demonstrated 
that calpain-mediated proteolysis of InsPsRl, the predominant neuronal isoform 
of InsP3R, generates a dysregulated channel that disrupts cellular Ca2+ 
homeostasis (Kopil et al., 2011). These may be of value as potential targets for 
therapeutic intervention following brain ischemia or in other neurological 
disorders associated with Ca2+ dysregulation and protease activation.
AMPA-RNMDA-R
VGCC
Ca2*- binding 
proteins
nAChR
Mitochondrion
Uniporter
Nudeus
TRPC
Figure 1.2: Neuronal calcium signalling. The intracellular Ca2+ is regulated by 
Ca -binding proteins, such as calmodulin, and by Ca2+ transport across the 
plasma membrane and the membranes of organelles (mitochondria, ER and 
nucleus). Sources of calcium influx are calcium-permeable AMPA and NMDA 
receptors, voltage-gated calcium channels (VGCC), nicotinic acetylcholine 
receptors (nAChR), and transient receptor potential type C (TRPC) channels. 
Calcium is expelled from the cell by the plasma membrane calcium ATPase 
(PMCA), the Na+/Ca2+ exchanger (NCX). At the ER, Ca2+ enters the sarco- 
/endoplasmic reticulum calcium ATPase (SERCA), while it is released through 
inositol trisphosphate receptors (IP3R) and ryanodine receptors (RyR). IP3 can 
be generated by metabotropic glutamate receptors (mGluR). Also the 
mitochondria are important for neuronal calcium homeostasis: Ca2+ can enter 
mitochondria through the low-affinity electrophoretic uniporter and it exits 
through a Na+/Ca2+ exchanger. In addition, Ca2+ can be exchanged between the 
cytosol and the nucleus (Grienberger and Konnerth, 2012).
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Ca2+ signalling is believed to play an important role in the major and best 
recognised modes of cell death, necrosis and apoptosis. Recent studies have 
shown that necrosis and apoptosis are related processes: (i) Ca2+ overload can 
induce either modes of cell death (Gwag et a l, 1999); (ii) mitochondrial 
disruption is involved in both apoptosis and necrosis, sharing signalling and 
regulatory mechanisms (Nieminen, 2003); (iii) expression of the oncoprotein 
Bcl-2 can block both processes (Martinou et al., 1994); (iv) modulation of 
cellular ATP levels can switch the response from apoptosis to necrosis or vice 
versa in the same cells (Leist et al., 1997, Nicotera and Melino, 2004); (v) in the 
presence of caspase inhibitors, such as z-VAD, classical apoptosis inducers can 
cause necrosis (Hirsch et al., 1997) and finally, (vi) after apoptosis, the cells can 
undergo secondary necrosis (Thompson, 1995).
Both modes of neuronal death are observed in various neurological and 
neurodegenerative disorders, such as Huntington’s disease, Alzheimer’s disease, 
amyotrophic lateral sclerosis and AIDS-associated dementia (Kevin K.W, 2000).
1.6.1 Apoptosis versus necrosis
Although the similarities of apoptosis and necrosis indicate clearly the 
interrelation between them, the two processes differ significantly.
Whereas necrosis is considered an uncontrolled and passive biological process in 
which cell death occurs as a consequence of environment’s changes or adverse 
conditions, apoptosis is considered a physiological and pathological programmed 
cell death (PCD), which requires energy expenditure to activate a cascade of
1.6 Cell death
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biochemical reaction that lead to a “cell suicide” (Rosser and Gores, 1995). 
Morphologically, apoptosis is characterised by a tightly regulated sequence of 
events, such as nuclear fragmentation and condensation, formation of the 
apoptotic bodies, cell shrinkage with blebbing of the plasma membrane and 
cytoskeletal collapse (Taylor et al., 2008). Apoptosis is induced by physiological 
stimuli, including lack of growth factors and changes in hormonal environment. 
Apoptotic cell death plays a central role in maintaining cellular homeostasis, 
removing damaged and potentially dangerous cells, as well as in the development 
of the nervous system and endocrine-dependent tissue atrophy. In the case of 
dysregulation of the process, apoptosis can result in cancer, neurodegenerative 
disease, or autoimmunity (Thompson, 1995). In vivo, recognition and 
phagocytosis of the apoptotic bodies by adjacent epithelial cells, macrophages or 
microglia, prevents the eliciting of any inflammatory response (Wyllie et al., 
1980).
In contrast, necrosis begins with an impairment of the cell’s ability to maintain 
homeostasis, due to a massive ion influx, leads to an irreversible swelling of the 
cytoplasm and its organelles, including mitochondria. The process ends with a 
loss of plasma membrane integrity and cell lysis with leakage of cell content into 
the extracellular fluid evoking intense inflammation of the surrounding tissue 
(Orrenius et al., 2003).
Although apoptotic and necrotic cell death are well defined, other forms of PCD 
exist and the nomenclature of them is still controversial. Leist and Jaattela 
proposed a classification of different PCD forms according to both 
morphological and biochemical criteria. Three types of cell death have been 
suggested in addition to passive necrosis: (i) classical, caspase-dependent
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apoptosis associated with membrane blebbing, chromatin 
condensation/fragmentation, activation of executioner caspases and 
intemucleosomal DNA cleavage; (ii) apoptosis-like PCD characterised by less 
compact chromatin condensation and absence of executioner caspase activation; 
and (iii) necrosis-like PCD which occurs in the absence of both chromatin 
condensation and caspase activation (Leist and Jaattela, 2001).
In addition to this classification, there are more specialised forms of PCD not 
fitting into any of the three above models, such as paraptosis (Sperandio et al., 
2000, Turmaine et al., 2000) and autophagy-related cell death (Lee and 
Baehrecke, 2001).
1.6.2 Apoptosis and caspases
The term apoptosis, from the Greek words apo - from, ptosis -  falling, was 
coined by John Kerr, Andrew Wyllie and Alastair Currie in 1972 and means 
"dropping off', symbolising the falling of petals or leaves from plants or trees, 
and describing the process of natural cell death (Kerr et al., 1972).
One of the key events in apoptotic signalling is the activation of caspases. 
Caspases are a family of cytosolic cysteinyl aspartate proteases that have a 
cysteine at their pentapeptide active site ‘QACXG’ (X can be R, Q or D) and 
cleave their target proteins at specific aspartate residues. Fourteen caspases have 
been identified so far, and they exist within the cells as inactive zymogens 
(procaspases), which consist of a prodomain, a large (p20) and a small (plO) 
subunit. Caspases can be classified by alternative methods: depending on the 
length of their prodomain, which also correspond to the position in the apoptotic
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signalling cascade (initiator and effector caspases); on the basis of their major 
functions (pro-apoptotic and pro-inflammatory caspases) (Nicholson, 1999). Pro- 
apoptotic caspases subfamily, comprised of initiators and effectors, are mainly 
involved in mediating cell death signalling transduction, whereas pro- 
inflammatory caspases (caspase 1, 4, 5, 13, 14) activate and regulate pro- 
inflammatory cytokines (for example, ILip and IL18) (Lavrik et al., 2005). 
Initiator caspases (caspase 2, 8 , 9, 10) have a long prodomain and are more 
specific proteases able to auto-activate and activate other caspases downstream. 
The effector caspases (caspase 3, 6 , 7) possess the shortest prodomain and are 
predominantly processed and activated by upstream caspases with the function to 
cleave the majority of substrates during the demolition phase of apoptosis (Li and 
Yuan, 2008).
Caspases cleave many cytoskeletal and structural proteins, including actin 
microfilaments and actin-associated proteins, several microtubular and 
intermediate filament proteins and components of cell-cell adherens junctions. 
Caspases substrates also include apoptosis regulators, cell cycle controlling 
components, signal transduction and transcription-translation proteins, proteins 
involved in DNA-binding, synthesis and repair, in RNA synthesis and splicing, 
and others (Fischer et al., 2003).
Three major caspase-activating pathways have been identified in mammals: the 
extrinsic or death receptor pathway, where the caspase activation occurs after 
ligation of the death ligands to their receptors; the intrinsic or apoptosome 
pathway, where the release of pro-apoptotic factor from the mitochondria leads 
caspase activation; and the cytotoxic lymphocyte-initiated granzyme B pathway, 
which entails the intracellular delivery of granule-associated serine proteases
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(granzymes) from cytotoxic T lymphocytes (CTL) or natural killer (NK) cells, 
able to activate caspases (especially caspase-3 and -7) to initiate apoptosis 
(Cullen and Martin, 2009).
1.6.3 Extrinsic death receptor-induced apoptosis pathway
The extrinsic pathway is activated by the engagement of the transmembrane 
death receptors of the tumor necrosis factor (TNF) receptor family, such as 
TNFR-I, Fas and death receptor 5, by their extracellular corresponding ligand, 
including TNF-a, FasL and TRAIL. The binding ligand-receptor leads to the 
death receptors multimerisation and formation of the death-inducing signalling 
complex (DISC). In the DISC, multiple adaptor proteins, such as TNFR- 
associated death domain (TRADD) and Fas-associated death domain (FADD) 
are included to recruit procaspase 8  or 1 0 , enabling their autoactivation and 
initiating the caspase cascade (Juo et al., 1998, Varfolomeev et al., 1998).
1.6.4 Intrinsic mitochondrial apoptosis pathway
In this pathway, an intrinsic cellular stress, such as DNA damage, proteasomal or 
ER stress, can lead to mitochondrial outer membrane permeabilisation (MOMP) 
through the recruitment of Bcl-2-homology domain-3 (BH3)-only proteins, 
which activate the pro-apoptotic members Bax (Bcl-2-associated x protein) and 
Bak (Bcl-2-antagonist/killer-l). As a result, pro-apoptotic factors from the 
mitochondrial inter membrane space, such as cytochrome c (cyt-c) and small 
mitochondrial activator of caspases (Smac/DIABLO), are released to the cytosol,
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contributing to the progression of cell death. Release of cyt-c from mitochondria 
is a key regulatory step in the process, which is required for the assembly of the 
apoptotic protease activating factor-1 (Apaf-l)/caspase 9 apoptosome (Jiang and 
Wang, 2000). Apaf-1 and procaspase 9 both possess caspase recruitment 
domains (CARDs), which consent to the interaction between each other and the 
further activation of caspase 9. This complex leads to the activation of effector 
caspases, including caspase 3 and 7, which propagate a cascade of execution 
events resulting in apoptosis (Slee et al., 1999).
1.6.5 The Bcl-2 family
The name Bcl-2 derives from B-cell lymphoma-2, as the founder gene was first 
discovered in the chromosomal translocation breakpoint of t(14; 18) in B-cell 
follicular lymphomas. The bcl-2 gene has been intensively studied for many 
years and implicated in apoptosis, tumorigenesis, in the development of 
autoimmune disorders and cellular responses to anti-cancer therapy (Fisher, 
1994, Johnstone et al., 2002, Bidere et al., 2006, Tischner et al., 2010). Bcl-2 
family proteins play a crucial role in the regulation of apoptosis, deciding the 
cellular destiny, as they act upstream of the cell death execution and regulate the 
release of mitochondrial proteins. According to structural and functional 
characteristics, the Bcl-2 family is divided into two subfamilies, anti-apoptotic 
and pro-apoptotic proteins (Fig. 1.3). Both groups contain between one and four 
Bcl-2 homology (BH) domains, designed BH1, BH2, BH3 and BH4, which play 
an essential role in mediating heterodimeric interaction among the Bcl-2 family 
members (Adams and Cory, 1998, Danial and Korsmeyer, 2004). The anti-
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apoptotic family members are multidomain proteins, most of them containing all 
four BH domains and a transmembrane domain (TM), typical of proteins 
associated with membranes. The anti-apoptotic family includes Bcl-2, B c 1 -x l  
(Bel-extra long), A l, Bcl-w, Boo (Bcl-2 homolog of ovary) and Mcll (myeloid 
cell leukaemia-1). Anti-apoptotic members are integral membrane proteins, such 
as Bcl-2, or they become associated with the membrane after cytotoxic signals, 
like B c 1 -x l  and Bcl-w. They inhibit cell death neutralising the activity of the pro- 
apoptotic members, hence preventing MOMP (Youle and Strasser, 2008).
The family of pro-apoptotic members is further divided into two subgroups 
according to whether they possess multi-domains or only the BH3 domain. The 
first group is named the pro-apoptotic multidomains or Bax-like subfamily, 
which lacks the BH4 domains and includes Bax (Bcl-2 associated-x), Bak (BH3 
homologous agonist killer) and Bok (Bcl-2 related ovarian killer).
The BH3-only subfamily contains only the BH3 domain and it is a structurally 
different group of proteins that includes Bid (BH3 interacting domain death 
agonist), Bim (Bcl-2 interacting mediator), Bik (Bcl-2 interacting killer), Bad 
(Bcl-2 associated death promoter), Bmf (Bcl-2 modifying factor, Hrk (Hara-kiri), 
Noxa (named for “damage”), and PUMA (p53 upregulated modulator of 
apoptosis).
The pro-apoptotic proteins requisite is to promote apoptosis acting with two 
diverse maimers on the basis of their subgroup. In fact, BH3-only proteins 
function as direct antagonists of the anti-apoptotic proteins, whereas, the Bax- 
like proteins are believed to play a role in the mitochondrial disruption 
contributing to MOMP, allowing the release of apoptotic proteins (Gross et al., 
1999a).
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Figure 1.3: Sequence alignment of Bcl-2 homology (BH) domains between 
Bcl-2 family proteins. Sequence homologies of the BH1, BH2, BH3, BH4 and 
TM (transmembrane domain) regions are shown. Members of the Bcl-2 family 
contain at least one of the four conserved BH domains. Anti-apoptotic members, 
Bcl-2, Bcl-xL, Bcl-w and Mcl-1, Bcl-2A1 and Bcl-B contain all four BH 
domains. Pro-apoptotic proteins are subdivided in multi-domain members, Bax, 
Bak and Bok, that contain three BH domains; and in BH3-only members, Bik, 
Hrk, Bim, Bad, Bid, PUMA Noxa and Bmf that contain only the third BH 
domain, the BH3 domain (BH3-only) (Taylor et al., 2008).
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Whereas, the anti-apoptotic proteins are localised in the mitochondria, ER, or 
nuclear membranes (Krajewski et a l, 1993), the pro-apoptotic family is 
predominantly found in the cytosol or cytoskeleton prior to a cytotoxic stimulus 
or post-transcriptionally modified (Gross et al., 1998, Puthalakath et al., 1999).
1.6.5.1 Bax (Bcl-2 associated-x)
Bax was the first Bcl-2 homologue to be identified and belongs to the Bcl-2 pro- 
apoptotic Bax-like subfamily which acts as apoptosis executers. Bax is normally 
localised in the cytosol or loosely attached to the mitochondria. Upon a variety of 
apoptotic stimuli, Bax undergoes conformational changes, leading to 
translocation and insertion into the outer mitochondrial membrane (Hsu et al,
1997, Goping et a l, 1998). Together with Bak, the other member of this family, 
Bax, allows the release of intermembrane space proteins, including cyt-c, 
Smac/DIABLO and AIF, from the mitochondria to the cytoplasm, thereby 
promoting cell death (Gross et al., 1998, Tikhomirov and Carpenter, 2005, 
Lovell et al., 2008, Galluzzi et a l, 2009). Bax is expressed in various tissues as 
multiple alternative splice variants. The best characterised isoform is the 21 kDa 
Baxa which contains BH1, 2, and 3 and membrane anchor domains and 
colocalises with mitochondria upon stimulation of apoptosis (Wolter et al., 1997, 
Zhou et a l, 1998). Although the structural properties of the other Bax splice 
variants have been defined, their functional properties are still unclear. The 
debate about how Bax and Bak are activated is discussed in the following 
paragraphs.
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The BH3-only protein family members are currently comprised of twelve 
members (Bim, Bad, Bid, Bik, Blk, Bmf, Noxa, PUMA, Hrk, BNIP3, Bcl-G and 
Spike), all of which are implicated in combining specific upstream stress signals 
to promote apoptosis. The BH3-only members have the common characteristic 
of sharing a nine amino acid BH3-domain and are considered to be latent killers 
because they need to be activated. BH3 motif apart, the members are structurally 
different and regulated in distinct ways by a variety of transcriptional and post- 
translational events.
Noxa, PUMA and Bik are transcriptionally upregulated by p53 (Oda et al., 2000,
Nakano and Vousden, 2001, Mathai et al., 2002). Bik, Hrk and PUMA can be
transcriptionally upregulated by E2F transcription factor I (Hershko and
Ginsberg, 2004) and Bim and BNIP3L by the transcription factor Foxo3a
(Dijkers et al., 2000, Real et al., 2005). BH3-only proteins have been shown to
be activated also by post-translational modifications, including phosphorylation,
intracellular displacement, or proteolytic cleavage. Bim and Bmf protein
activation is associated with subcellular delocalisation and upon JNK-mediated
phosphorylation, Bim is released by microtubule-associated dynein motor
complex and Bmf by actin microfilaments (Puthalakath et al., 1999, Puthalakath
et al., 2001). Bad is inactivated through growth-factor-receptor signals that result
in an Akt-mediated phosphorylation mechanism, leading to sequestration by
14-3-3 proteins (Zha et al., 1996, Datta et al., 1997). Bid is activated by
proteolytic cleavage by several cell death-related proteases, such as caspase 8 ,
gran2 yme B, calpains, or cathepsins (Li et al., 1998a, Heibein et al., 2000, Sutton
et a l, 2000, Chen et al., 2001, Stoka et al., 2001, Blomgran et al., 2007). Upon
1.6.6 BH3-only proteins
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cleavage, the inactive cytosolic Bid is processed into a truncated fragment (tBid), 
which translocates to the mitochondria (Li et a l , 1998a, Cullen et a l, 2007).
1.6.6.1 Bid (BH3- only interacting domain death agonist)
Bid, a pro-apoptotic member of the Bcl-2 family of proteins, has been implicated 
in promoting apoptosis, cell survival and proliferation. Although Bid participates 
in a mitosis checkpoint and maintenance of genomic stability (Kamer et a l, 
2005, Zinkel et a l, 2005), the main function of this protein appears to be the 
regulation of the outer mitochondrial membrane permeabilisation (MOMP) 
during death receptor-induced apoptosis (Li et a l, 1998a, Luo et a l, 1998). In 
this pathway, Bid is post-translationally cleaved by caspase 8  into the truncated 
form, tBid, which translocates to the mitochondria and inserts into the MOM 
(Gross et al., 1999a). Bid subsequently drives Bax/Bak oligomerisation and pore 
formation at the MOM (Eskes et al., 2000), eventually leading to MOMP (Wei et 
al., 2000). The cleavage of Bid may not be an absolute requirement for Bid to be 
pro-apoptotic, in fact, full-length Bid can also translocate to the mitochondria 
inducing cyt-c release and permeabilise mitochondria (Tafani et al., 2002, 
Valentijn and Gilmore, 2004, Ward et al., 2006). Interestingly, it has been 
showed that the caspase-mediated cleavage of Bid is involved during the intrinsic 
mitochondrial apoptosis pathway (Scaffidi et al., 1999). Moreover, Bid has also 
been implicated in oxygen (hypoxia) or oxygen/glucose deprivation (OGD), 
where ¿¿¿/-deficient neurons displayed less caspase activation and 
neuroprotection in vitro, and attenuated volume infart and cyt-c release in vivo 
(Plesnila et al., 2001, Yin et al., 2002). Of notable interest, it has been shown that
in response to glutamate-induced excitotoxicity, the full-length Bid can 
translocate to the mitochondria and induce cell death in hippocampal and 
cerebellar granule neurons (Ward et a l, 2006, Konig et a l, 2007). This appears 
to occur in the absence of caspase (Li et a l, 1998a, Gross et a l, 1999b, Wagner 
et a l, 2004) or alternative proteases cleavage (Chen et a l, 2001, Mandic et a l, 
2 0 0 2 ), suggesting that other enzymes, such as calpains and cathepsins may be 
involved in the cleavage of FL-Bid after its translocation to the mitochondria.
A number of novel alternative splicing isoforms of Bid have been identified: the 
22 kDa BidL (long; cytosolic), which is the major full-length isoform of Bid; the 
26 kDa BidEL (extra long; golgi/mitochondrial), which corresponds to full- 
length Bid plus an additional N-terminal sequence; the 14 kDa BidS (short; 
cytosolic), which contains the N-terminal regulatory domains of Bid minus the 
BH3 domain; the 11 kDa BidES (extra short; mitochondrial), which contains 
only the Bid sequence downstream of the BH3 domain (Renshaw et a l, 2004).
1.6.6.2 Bim (Bcl-2 interacting mediator of cell death)
Bim is a pro-apoptotic BH3-only member of Bcl-2 family and induces the 
mitochondrial apoptosis pathway through cytochrome c release from 
mitochondria. Bim plays a key role during apoptotic cell death of T- 
lymphocytes, B-lymphocytes, myeloid cells, neurons, and osteoclasts. The pro- 
apoptotic activity of Bim is modulated at multiple levels, transcriptional, post- 
transcriptional and post-translational. The forkhead-like transcription factor 
Foxo3a is involved in Bim regulation in several types of cells (Gilley et a l, 
2003, Sunters et a l, 2003, Urbich et a l, 2005). Moreover, it has been shown that
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Bim regulation results following phosphorylation and ubiquitination processes. 
Bim is phosphorylated by extracellular-regulatcd kinase (ERK) and this is a 
target for proteasome degradation (Ley et al., 2003, Luciano et al., 2003, Ley et 
al., 2004, Ley et al., 2005); by JNK/c-Jun signalling via dynein motor complexes 
leading to Bim release from the cytoskeleton and subsequent translocation to the 
mitochondria, finally activating the adaptor molecules Bax and Bak (Harris and 
Johnson, 2001, Putcha et al., 2001, Whitfield et al., 2001); by 
phosphatidylinositol-3-kinase (PI3K)/Akt survival pathway, affecting the 
expression level or the pro-apoptotic function of Bim (Dijkers et al., 2000, 
Dijkers et al., 2002, Qi et al., 2006). A number of reports demonstrated that Bim 
is regulated via the ubiquitin-proteasome degradation process, suggesting that 
Bim and other BH3-only proteins might represent a novel strategy against brain 
injury during trauma or stroke (Akiyama et al., 2003, Ley et al., 2003, Luciano et 
al., 2003, Meller et al., 2006). Three main alternative splice isoforms of Bim 
have been reported: the 21 kDa BimL (long), the 19 kDa BimS (short) and the 
full-length 24 kDa BimEL (extra long). Activity-guided studies have shown that, 
with differing potency, they all promote apoptosis (O'Connor et al., 1998, Marani 
et al., 2002). BimL, BimS and BimEL all contain membrane anchor domains in 
addition to the BH3 domains, and they colocalise mainly with mitochondria. 
BimS is the most potent but lowly expressed in many cell types, while BimEL 
represents the most specific form in neuronal apoptosis.
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1.7 MOMP
Mitochondria are bioenergetically active organelles and play a key role in many 
processes, including energy production, redox control, calcium homeostasis, 
metabolic and biosynthetic pathways and physiological cell death mechanisms. 
The initial investigation into the role of mitochondria in apoptosis began with 
two observations made in mammalian cells. First, the Bcl-2 protein was found to 
be located in the mitochondrial membrane; and second, apoptotic changes could 
be produced in Xenopus laevis oocyte extracts, only when a membrane fraction 
enriched in mitochondria was present (Newmeyer et al., 1994). However, the 
interest in the involvement of mitochondria in cell death increased with 
biochemical studies, which led to the identification of cyt-c (Liu et al., 1996) and 
AIF (Kroemer et al., 1997). Cyt-c and AIF are two key mitochondrial proteins 
able to activate the cellular apoptotic machine. It has been identified that the Bcl-
2 family of proteins control the regulation of MOMP and they influence either 
negatively or positively mitochondrial release of pro-apoptotic proteins. The anti- 
apoptotic members of the family inhibit MOMP and cyt-c release by binding to 
and sequestering pro-apoptotic family members (Cory and Adams, 2002). 
Although, the role of Bok in MOMP and apoptosis is not yet fully understood, 
the other two pro-apoptotic members, Bak and Bax, are pro-apoptotic effectors 
and are essential for MOMP and mitochondrial-mediated cell death (Knudson et 
al., 1995, Lindsten et al., 2000, Reed, 2006).
MOMP is believed to be a “point of no return” in the mitochondrial apoptotic 
pathway. The mechanisms of MOMP and its regulation are not fully known and 
currently, there are two principal models proposed to explain MOMP induction:
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in the first, MOMP is regulated by the Bcl-2 family of proteins, and in the 
second, by the permeability transition pore (PTP) (Fig. 1.4).
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Figure 1.4: Two models for MOMP. On the left (i, bax pore), the proposed 
model for Bcl-2 family proteins is presented. According to this, the pro-apoptotic 
members of the Bcl-2 family, Bax and Bak, form a pore in the MOM after 
activation by a BH3-only protein, such as Bid, allowing the consequent release of 
the IMS pro-apoptotic proteins, including cyt c, AIF and Endo G. On the right, 
(ii, PT pore opening), model for the mitochondrial permeability transition is 
illustrated. This model suggests that the opening of the PT pore allows an influx 
of water and ions into the mitochondrial matrix, resulting in osmotic matrix 
swelling, eventually leading to the rapture of the MOM, releasing IMS proteins 
(Bouchier-Hayes et al., 2005).
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The first model considers that Bcl-2 family of proteins promote the formation of 
pores in the mitochondrial outer membrane (MOM). The engagement of the pro- 
apoptotic proteins Bax and Bak results in their oligomerisation and formation of 
a pore in the MOM, thereby leading to MOMP and the release of multiple 
proteins, such as cyt-c, from the mitochondrial intermembrane space (IMS) into 
the cytosol (Harris and Thompson, 2000, Kuwana and Newmeyer, 2003).
The regulation of Bak and Bax and how they are activated during the 
mitochondrial apoptotic death is still controversial and again two models for the 
Bcl-2 family protein in regulating MOMP have been recognised. The first is 
known as the direct activator model and it suggests that BH3-only proteins, such 
as Bid, Bim and PUMA, are thought to possess activator activity and are directly 
engaged in binding Bax and Bak. This engagement induces conformational 
changes and leads to oligomerisation and pore formation at the MOM (Strasser et 
al., 2000, Letai et a l, 2002). This hypothesis also proposes that other BH3-only 
proteins, known as sensitizers (inactivators), including Noxa, Bad, Bmf, Bik and 
Hrk, function to promote Bax/Bak activation by neutralising the anti-apoptotic 
family members (Chipuk and Green, 2008). What is commonly known as the 
displacement model suggests that Bax and Bak are constitutively in an active 
conformation and the BH3-only proteins displace and neutralize the anti- 
apoptotic proteins, such as Mcll and B c 1 -x l , allowing Bax/Bak oligomerisation 
resulting in MOMP (Adams, 2003, Willis et al., 2005). In the displacement 
model, cell death is the default whereas in the direct activator model the default 
is cell survival.
1.7.1 Models for the Bcl-2 family proteins
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Another proposed MOMP model is based on the event known as mitochondrial 
permeability transition (PT) and occurs by mitochondrial matrix swelling and 
rupture of the MOM, releasing of IMS proteins, such as cyt-c and AIF. PT 
involves the rapid permeabilisation of the inner mitochondrial membrane (EMM), 
allowing the opening of the PT pore (PTP), through which all molecules smaller 
that 1.5 kDa pass (Bemardi et al., 1994, Petit et al., 1996). The structure and 
composition of the PTP remain only partially defined, but it is composed of at 
least three proteins, the adenine nucleotide translocator (ANT) in the IMM, the 
soluble matrix protein cyclophilin D (Cyp D), and the voltage-dependent anion 
channel (VDAC) in the MOM. Under physiological conditions, the PTP exists in 
a state of low conductance, however, following a mitochondrial calcium 
overload, the pore irreversibly converts to a high-conductance state, which 
depends on the saturation of the calcium-binding sites of the PTP (Ichas and 
Mazat, 1998). Once PTP has been opened, water and ions diffuse between 
cytosol and matrix, causing the collapse of mitochondrial membrane potential, 
uncoupling of oxidative phosphorylation, swelling of the mitochondrial matrix 
and rupture of MOM and the consequent release of caspase-activating proteins. 
The uncoupling of the respiratory chain results in the mitochondria no longer 
able to synthesise ATP, causing a more necrotic form of cell death.
As mitochondrial matrix swelling does not always occur in apoptotic death, the 
PT model for MOMP and apoptosis have been questioned (Jurgensmeier et al.,
1998, De Giorgi et al., 2002). Moreover, some studies have provided evidence 
that cyt-c release and caspase activation can occur prior to mitochondrial 
depolarisation (Bossy-Wetzel et al., 1998, Krohn et al., 1999). Previous reports
1.7.2 Models for the mitochondrial permeability transition (PT)
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showed that apoptotic death requiring the actions of Bel-2 family members at 
mitochondria does not involve Cyp D-dependent PT, whereas other forms of 
death do (Baines et al., 2005, Nakagawa et a l, 2005), suggesting that the PT 
model could be relevant in response to specific insults or cell type.
1.8 Caspase-dependent and -independent cell death
The caspase family of proteases mediates caspase-dependent apoptotic cell death 
(also named classical or type I apoptosis) in a variety of cellular systems, 
nevertheless, increasing data demonstrates the existence of a caspase- 
independent cell death (termed type II apoptosis) (Leist and Jaattela, 2001). In 
type I cells, apoptosis is promoted by the extrinsic and intrinsic pathways, which 
are interrelated through the activation of caspase 8 . This activation results in the 
induction of downstream caspases, such as caspase-3 and caspase-7, and triggers 
the execution of cell death (Scaffidi et al., 1998). In contrast, in type II cells, 
caspase activation is insufficient and is inhibited at or downstream of the 
apoptosome, for example by calpains (Chua et al., 2000, Lankiewicz et al., 2000, 
Reimertz et al., 2001), resulting in the engagement of a substitute mitochondrial 
pathway.
It was demonstrated that the two cell types do not differ during Fas-mediated
apoptosis at mitochondria level. In fact, they both show cyt-c release and similar
kinetics in the disruption of the mitochondrial membrane potential (Walter et al,
2008). In addition, there is increasing evidence that the cross-talk between
caspase-dependent and -independent apoptotic cell death exits and that it is
mediated by the two cysteine protease families, caspases and calpains.
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Furthermore, Bax and other undefined pathways may play a role in this cross­
talk system (Nakagawa and Yuan, 2000, Neumar et al., 2003). Type I and II cell 
death differentiate either in morphological and biochemical aspects. The first is 
associated with cell shrinkage, membrane blebbing, chromatin condensation, 
nuclear fragmentation, formation of apoptotic bodies and intemucleosomal DNA 
cleavage, whereas type II apoptosis do not show the last three criteria. Type II 
cell death can also include autophagy, which is characterised by a substantial 
accumulation of autophagic vacuoles in the cytoplasm (Golstein and Kroemer, 
2007).
In the latter type of cell death, the cytosolic BH3-only pro-apoptotic Bcl-2 family 
member Bid, and the truncated Bid (tBid) translocates to the mitochondria to 
lead the release of the downstream components, such as AIF and endonuclease 
G, triggering the apoptotic pathway by alternative mechanisms (Li et al., 1998a, 
Luo et al., 1998, Gross et al., 1999a). This process can be associated with 
mitochondrial alterations, including energy depletion, increased ROS generation, 
mitochondria permeability transition, and release of cytotoxic proteins.
1.9 Calpains
Calpains (calcium-dependent protease with papain-like activity) are a family of 
cytoplasmic cysteine proteases (also called, thiol proteases) requiring calcium 
ions for activity. Calpains exist ubiquitously in organisms ranging from humans 
to microorganisms (for example fx- and m-calpains) and also with tissue-specific 
expression patterns (such as calpain 3 in skeletal muscle and stomach smooth- 
muscle-specific calpain 8 ) (Perrin and Huttenlocher, 2002). Calpains are
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abundant in the cytosol of resting cells in its latent form (as pro-enzyme) and are 
translocated to the membranes and activated in response to increases in the 
cellular Ca2+ level.
There are currently 14 known human calpain isoform genes, but the (calpain
I) and m-calpain (calpain II) are the best characterised members of the family 
(Fig. 1.5). Both proteins exist as heterodimers composed of a large -80 kDa 
catalytic subunit and a small -30 kDa regulatory subunit. The former is similar 
within the same tissue and/or animal species while the latter is identical. The 
large subunit comprises four domains (dl-dIV), while the small subunit consists 
of two domains (dV and dVl):
• domain I and II contain the protease function, where dl is the site of autolytic 
cleavage and dll (like other cysteine proteases, such as cathepsins B and L) is 
composed of two subdomains (dlla, dllb) and contains the catalytic 
interaction site with substrates (Hosfield et a l, 1999, Strobl et al., 2000);
• domain III has unknown functions, but due to its topology similarity to C2 
domains found in various proteins including protein kinase C and 
phospholipase C, it has been implicated in calcium and phospholipids 
binding (Rizo and Sudhof, 1998, Hosfield et al., 2001);
• domain IV and VI are Ca2+-binding domains, responsible for 
heterodimerisation of the large and small subunits and necessary for effective 
inhibition by the endogenous calpain inhibitor, calpastatin (Suzuki et al.,
2004);
• domain V is a glycine-rich unstructured domain (Croall and McGrody, 1994).
The (a- and m-calpain differ in the calcium concentration required to induce their 
activity: 2- 80 p.M are required for the activation of ^.-calpain and 0.2 -  0.8 mM
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for m-calpain. Within the brain, p- ealpain exist predominantly in neurons and 
mainly in the dendrites and cell bodies, whereas m-calpain is found particularly 
in axons and glia (Nixon, 1986, Onizuka et al., 1995).
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Figure 1.5: The calpain protease family. Domain structures of mammalian 
calpain family members and their endogenous inhibitor calpastatin are shown. 
The most studied proteins of the calpain family are calpain 1 and calpain 2 and 
they are the ubiquitously expressed. Calpains are composed of: a large 80-kDa 
catalytic subunit, which can be subdivided into four functional domains (I-TV); 
and a small 30-kDa regulatory subunit, that consists of two domains (V and VI). 
To date, at least 12 other mammalian calpain proteins that show homology to the 
large catalytic subunits and are expressed in a tissue-specific manner have been 
identified. In addition, another small regulatory subunit has been described 
(calpain small subunit 2) (Frame et al., 2002).
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Calpain activity is tightly regulated post-transcriptionally by many mechanisms 
including its endogenous inhibitor calpastatin, calcium requirements, 
autoproteolytic cleavage, phosphorylation and probably also by the intracellular 
location and the access to its substrate (Goll et al., 2003).
Calpains possess at least four binding motifs, two calmodulin-like dIV and dVI, 
an acidic loop region in C2-like dill which forms salt bridges with basic residues 
in dll, and the catalytic dll. In the presence of calcium ions, two protease 
subdomains dlla and dllb change conformation and form a functional catalytic 
site (Czogalla and Sikorski, 2005). A two-step mechanism for calpain activation 
by calcium ions has been proposed:
1) The first step is the release of constraints imposed by the circular 
arrangement of the domains, where the binding of Ca2+ to the dIV and 
dVI promotes conformational changes in dill, leading to the dissociation 
of the small subunit from the large subunit;
2) The second step consists of rearrangement of the active site cleft caused 
by cooperative binding of two Ca2+ ions to dlla and dllb (Reverter et al., 
2001).
Once activated, calpains, are able to interact and cleave a variety of substrates, 
including cytoskeletal proteins, such as spectrin, membrane-associated proteins 
and cell adhesion molecules (ion channels, pumps and EGF receptors), 
neurofilaments, microtubules-associated proteins (MAP2, tau), enzymes 
involved in signal transduction, transcription factors and apoptosis-inducing 
factor (Siman and Noszek, 1988, Springer et al., 1997, Carafoli and Molinari,
1.9.1 Activation, regulation and function of calpains
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1998, Chan and Mattson, 1999, Wu et al., 2004, Polster et al, 2005, Cao et a l, 
2007). Calpains cleave preferentially at Val, Leu or lie residues in the P2 
position or at Tyr, Gly or Arg at the Pi position of their target proteins.
Calpain activity is regulated by its specific endogenous inhibitor, calpastatin. 
Calpastatin is a 110 kDa protein which contains four repetitive calpain-inhibition 
domains of -140 amino acids residues and an N-terminal domain L (Takano et 
al, 1988, Croall and DeMartino, 1991). Due to its repeated domain structure, 
each calpastatin molecule is able to inhibit four calpains (Maki el al., 1987). 
Calpastatin, generally found at a higher concentration than calpains, is widely 
expressed and reversibly binds to the Ca2+-binding domains of both the large and 
small subunits of calpain. An additional regulation in calpain activity may also 
be its intracellular distribution in vivo and its phosphorylation by a protein kinase 
A, which leads to a constraint calpain dill movement preventing the activation of 
the protease (Shiraha et al., 2002).
Calpains are also inhibited by synthetic substances by reacting with the cysteine 
residues in the catalytic triad in a nonspecific manner, including E64, leupcptin 
and N-Ac-Leu-Leu-norleucinal, or by interacting with the calmodulin domain, 
such as the nonpeptidic inhibitor PD150606. To study the physiological 
functions of calpain, other pharmacological inhibitors with different calpain 
specificity, such as AK295, MDL-28170 and calpeptin, are commercially 
available and frequently used (Bartus et al., 1994, Wang and Yuen, 1994, 
Tsubuki et al., 1996, Sorimachi et al., 1997).
Calpains are involved in various calcium-regulated cellular processes, including 
signal transduction, integrin-mediated cell migration, membrane fusion, cell 
differentiation and proliferation, cytoskeletal remodelling and apoptosis (Goll et
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al, 2003). Overactivation of calpains, as well as, deregulation of their activity 
cause excessive degradation or accumulation of coexisting cellular proteins 
resulting in serious cellular damage and pathological conditions, including 
muscular dystrophy, rheumatoid arthritis, cataract formation, neurodegenerative 
diseases, diabetes and cancer (Zatz and Starling, 2005).
1.9.2 Calpains in neuronal death
At physiological conditions, when intracellular Ca2+ concentration is -100 nM, 
limited calpain activation is associated with minor proteolytic modification of 
some calpain substrates. These minimal changes induce signals transduction 
and/or triggering cellular functions, such as membrane fusion or cell spreading. 
However, a dysregulation of neuronal calcium homeostasis, for example during 
acute hypoxia, traumatic brain injury, ischemic insult, epileptic seizures or 
excitotoxicity, may result in an overactivation of calpains, damaging cell 
structures thereby inducing cell death (Saito et al., 1993, Bartus et al., 1995a, 
Bartus et al., 1995b). Altered levels of calpain and/or calpastatin have been 
characterised in several chronic neurodegenerative disorders (Bevers and 
Neumar, 2008), including amyotrophic lateral sclerosis (Li et al., 1998b), 
Parkinson’s disease (Mouatt-Prigent et al., 1996), and Alzheimer’s disease 
(Nixon et al., 1994). Calpains have been suggested as pivotal mediators of both 
necrosis and apoptosis, and neuroprotective effects against cell death, in several 
experimental models, are observed in the presence of calpain inhibitors (Squier et 
al, 1994, Pom-Ares et a l, 1998, Wang and Linden, 2000, Crocker et al., 2003, 
Liu et al., 2004b, Camins et a l, 2006).
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Excitotoxic studies in hippocampal neurons in mice deficient for or 
overexpressing calpastatin, demonstrated that calpastatin offers partial 
neuroprotection against excitotoxic injury and calpains can contribute to 
excitotoxic cell death signalling, in a caspase-independent manner (Takano et a l,
2005). In addition, calpain I inhibited the ability of cyt-c to initiate caspase 
activation and inhibition of calpains in a neuronal culture restored caspase 
activation (Lankiewicz et a l, 2000) indicating that calpains may be required for 
caspase independent cell death. These findings are in agreement with recent 
studies that present AIF as a novel calpain substrate, suggesting an interaction 
between calpains and mitochondria, which indicates that calpain activation 
promotes the release of pro apoptotic proteins from the mitochondrial inner 
membrane in caspase-independent apoptosis (Fig.1.6) (Cao et al., 2007, Norberg 
et a l, 2008).
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Figure 1.6: Model of calpain-mediated AIF release. Excitotoxic insult results 
in NMDA receptors overactivation which leads to massive Ca2+ influx. This will 
result in an increased mitochondrial Ca2 buffering capacity which is responsible 
for mitochondria-induced ROS production, DNA damage, and PARP-1 
activation. PARP-1 activation cause further mitochondrial Ca2+ dysregulation, 
which results in mitochondrial calpain activation. Calpains are able to cleave 
AIF, which translocates to the nucleus where it causes DNA fragmentation and 
neuronal death (Kar et al., 2010).
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Although the treatment for numerous pathological conditions including 
neurodegenerative diseases remains limited, calpain activation may offer a 
potential therapeutic target in these neurological disorders.
The physiological function of calpains is not yet completely understood but it has 
been widely demonstrated that calpains exert a key function as cell death 
executioners promoting the pathway of neuronal death. The research, in the last 
few years, has been focusing its attention on the importance of calpain activity 
during excitotoxic injury events and the development of new calpain inhibitors as 
a therapeutic approach for the treatment of neurodegenerative diseases and 
calpain-associated disorders (DePetrillo, 2002, Carragher, 2006, Frederick et ah, 
2008, Samantaray et ah, 2008, Pietsch et ah, 2010, Donkor, 2011). In order to 
develop selective synthetic calpain inhibitors to provide neuronal protection 
and/or prevention for these disorders, investigating how calpain functions, is 
essential. Excitotoxicity, which has been implicated in several neurodegenerative 
disorders, may be a consequence rather than an initiator of many of these 
diseases. However, the identification of these excitotoxic pathways and the role 
that calpains play in them may provide a therapeutic potential for modulating 
calpain activity to treat human diseases.
1.10 Clinical applications
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Although several in vitro and in vivo excitotoxic models have been used to 
determine the mechanisms of neuronal death, the events that lead to glutamate- 
induced injury remain to be elucidated. The data provided in the results chapters 
offer insight into the involvement of calpains in glutamate excitotoxicity and 
identify a novel role of calpains in NMDA-mediated excitotoxic injury.
Therefore, the aims of this study were:
• To establish working models of NMDA-mediated excitotoxic injury 
(tolerance, apoptosis and necrosis) in mouse neocortical neurons;
• To characterise neuronal injury and calpain activity using combined 
biochemical, pharmacological, and single-cell imaging approaches;
• To investigate the relationship between calcium deregulation and calpain 
activation following excitotoxic injury;
• To determine whether calpains act on Bcl-2 family proteins in promoting 
neuronal death;
• To characterise the temporal relationship between calpain activation, 
mitochondrial permeabilisation and calcium deregulation;
• To investigate whether the Bcl-2 family proteins influence Ca2+ 
deregulation.
1.11 Aim of the study
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CHAPTER II
Materials and Methods
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2.1 Materials
Fetal calf serum (FCS), fetal bovine serum (FBS), horse serum (HS), B27 
supplement, minimal essential medium (MEM), neurobasal medium, 
tetramethylrhodamine methyl ester (TMRM), Fluo-4 AM and l,2-bis-(o- 
aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid, tetraacetoxymethyl ester 
(BAPTA-AM) and Lipofectamine 2000 were from Invitrogen (Bio Sciences, 
Dublin, Ireland). Calpeptin was purchased from ENZO Life Sciences (Exeter, 
UK) and ionomycin from Merck Biosciences (Nottingham, UK). Other 
chemicals, including penicillin/streptomycin, bovine serum albumin (BSA), 
phosphate buffered salts (PBS), Trypsin-EDTA, Poly-D-lysine, NMDA, MK- 
801, glycine, embryo-tested mineral oil, Hoechst 33258, propidium iodide, 2- 
Mercaptoethanol came from Sigma-Aldrich (Dublin, Ireland).
2.2 Kits
Kit name Specific type Catalogue no Manufacturer
QIAshredder 79656 QIAgen
DNA Prep Maxi Endofree plasmid 
maxi
12362 QIAgen
WillCo Dish Kit 1 mL dishes HBST-3522 WillCo Wells BV
MicroBC Assay 
Kit
23231-23234 Pierce, Medical 
Supply
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2.3 Bacterial strains
DH5a (JM109): supE44, D (lacZYA-argFV168), deoR, endAl, gyrA96, hsdR17 
(rk- mk+), recAl, relAl. Competent bacterial Escherichia coli DH5a cells are 
commonly used to amplify plasmids. The stability of those plasmids is improved 
by the presence of the recAl and relAl genes in their genome and the DH5a cell 
restriction enzyme deficiency.
2.4 Eukaryotic cell lines
SH-SY5Y is one of three serially isolated neuroblast clones (SH-SY, SH-SY5, 
SH-SY5Y) of the human neuroblastoma cell line SK-N-SH which was 
established in 1970 from a metastatic bone tumor (Biedler et al., 1973). SH- 
SY5Y has a moderate level of dopamine-P-hydroxylasc activity and can convert 
glutamate to the neurotransmitter GABA. The cells have a reported saturation 
density greater than 1 x 106 cells/cm2. The loss of neuronal characteristics has 
been described with increasing passage numbers, therefore it is recommended 
not to use at passage numbers higher than 2 0  or verify specific characteristics 
such as noradrenalin uptake or neuronal tumor markers. SH-SY5Y cells were 
grown in DMEM/Ham’s F 12 (1:1 mixture) culture medium (Lonza) 
supplemented with 15% fetal calf serum, 100 U/mL of Pen/Strep. These cells 
grow as a mixture of floating and adherent cells. To split the cells, the medium 
with the floating cells was removed and the adherent cells were rinsed with 1 to 2  
ml of fresh 0.25% trypsin-EDTA solution. The culture was incubated at 37°C 
with 5% CO2 until the cells detached and it was recovered by centrifugation.
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Fresh medium was added and the cells were plated into new flasks in a 
recommended spilt ratio of 1:4.
NSC34 is a hybrid cell line, produced by fusion of motor neuron enriched, 
embryonic mouse spinal cord cells with mouse neuroblastoma. Cultures contain 
two populations of cells: small, undifferentiated cells that have the capacity to 
undergo cell division and larger, multi-nucleate cells. These cells express many 
properties of motor neurons, including choline acetyltransferase, acetylcholine 
synthesis, storage and release and neurofilament triplet proteins. NSC-34 cells 
have been used for evaluation following exposure of cultures to a selection of 
chemicals know to be neurotoxic to motor neurons. These cells respond to agents 
that affect voltage-gated ion channels, cytoskeletal organisation, and axonal 
transport. The sensitivity of action potential production to various ion channel 
blockers is similar to that in primary motor neurons in culture. Therefore, these 
immortalized motor neuron-like cells have the utility as a model for the 
investigation of neurotoxicity. NSC34 cells were maintained in DMEM (Lonza) 
supplemented with 10% fetal bovine serum, 2mM L-glutamine and 100 U/mL 
Pen/Strep. Cell density is not a concern for the first few days after thawing 
because it is viewed more as a recovery period. Medium is typically changed 
every 2-3 days, depending on rate of growth and it is recommended to split the 
cultures at -80% confluency, as described above, and in a ratio of 1:3-1:4.
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2.5 Plasmid vectors
The pEGFP-Nl vector (BD Bioscience Clontech; Fig. 2.1) was used to allow 
the identification of transfected neurons. pEGFP-Nl encodes a red-shifted 
variant of wild-type GFP which has been optimised for brighter fluorescence and 
higher expression in mammalian cells. (Excitation maximum = 488 nm; emission 
maximum = 507 nm). pEGFP-Nl encodes the GFPmutl variant which contains 
the double-amino-acid substitution of Phe-64 to Leu and Ser-65 to Thr. 
Sequences flanking EGFP have been converted to a Kozak consensus translation 
initiation site to further increase the translation efficiency in eukaryotic cells. The 
MCS in pEGFP-Nl is between the immediate early promoter of CMV (PCMV 
IE) and the EGFP coding sequences. SV40 polyadcnylation signals downstream 
of the EGFP gene direct proper processing of the 3' end of the EGFP mRNA. 
The vector also contains a SV40 origin for replication in mammalian cells 
expressing the SV40 T-antigen. A neomycin-resistance cassette (Neor), 
consisting of the SV40 early promoter, the neomycin/kanamycin resistance gene 
of Tn5, and polyadenylation signals from the Herpes simplex virus thymidine 
kinase (HSV TK) gene, allows stably transfected eukaryotic cells to be selected 
using G418. A bacterial promoter upstream of this cassette expresses kanamycin 
resistance in E. coli. The pEGFP-Nl vector is also provided with a pUC origin of 
replication for propagation in E. coli and an fl origin for single-stranded DNA 
production.
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pEGFP-N1 Vector Information
GenBank Accession #U55762 Æsel
PT3027-5 
Catalog #6085-1
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Figure 2.1: Vector map of pEGFP-Nl (BD Bioscience Clontech).
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The membrane-targeted calpain-sensitive FRET probe, pSCLPaX (D'Orsi et 
al., 2 0 1 2 ), containing the calpain-specific spectrin substrate linker, was prepared 
by Dr. Michael J. Courtney (University of Eastern Finland, Kuopio, Finland) as 
follows. Complementary oligonucleotides 5’G CAG CAG GAG GTG TAC 
GGA GGTAC3’ and 5’C TCC GTA CAC CTC CTG CTG CAGCT3 ’ were 
annealed and ligated into SacI and Kpnl sites between ECFP and Venus in the 
FRET probe subcloning vector pTK-reverse SCAT (Hellwig et al., 2008). This 
generated a cassette consisting of a coding sequence for the calpain substrate 
sequence QQEVYG flanked (18 amino acid linker) at the amino terminus by 
ECFP, a serine tripeptide and a SacI site (encoding glutamate-leucine) and at the 
carboxy-terminus by a Kpnl site (encoding glycine-threonine), a flexible serine- 
glycine-serine tripeptide and Venus. The oligonucleotide sequence immediately 
adjacent to the overhangs were designed to destroy the SacI site upon ligation 
with corresponding vector overhangs and generate a diagnostic PvuII site to 
facilitate exclusion of constructs with multiple concatenated oligonucleotides. 
The resulting pTK-reverse SCLPa vector was digested with BsrGI to generate a 
BsrGI site flanked DNA fragment including calpain substrate motif and Venus 
coding sequence. This was inserted in frame into the BsrGI site of the membrane 
targeted ECFP expression vector pECFP-CAAX to generate the plasmid 
pSCLPaX. The intact FRET probe was anchored to the plasma membrane by a 
CAAX targeting sequence from H-Ras. pECFP-CAAX was generated by 
replacing the coding sequence for EGFP in the plasmid pEGFP-CAAX 
(Hongisto et al., 2008) with the coding sequence for ECFP, using the enzymes 
Agel and BsrGI (Fig. 2.2).
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cu:
Figure 2.2: Vector map of pSCLPaX, calpain-sensitive FRET probe.
50
The Green Fluorescent Protein (GFP)-calpastatin vector (MG209946, 
ORIGENE, Cambridge, UK) was used for calpastatin overexpression 
experiments. The plasmid consists of a bacterial (ColEl), a phagic (fl) and a 
virus (SV40) origin of replication, ampicillin and neomycin antibiotic resistance 
genes, a cytomegalovirus promoter, a Kozak consensus translation initiation site, 
a multiple cloning site, a SV40 virus polyadenylation signal, and a sequence of 
the green fluorescent protein gene (Fig. 2.3).
The MISSION shRNA pLKO.l-puro vectors were used for calpain gene 
silencing experiments. Cells were transfected with a vector expressing either a 
commercial shRNA targeting the large subunit of calpain I  (SHCLNG- 
NM 007600, TRCN0000030664, Sigma) or the large subunit of calpain II 
(SHCLNG-NM 009794, TRCN0000030672, Sigma) or a scramble control 
vector (SHC001, Sigma).
MISSION shRNA clones are sequence-verified shRNA lentiviral plasmids
(pLKO.l-puro) provided as frozen bacterial glycerol stocks (Luria Broth,
carbenicillin at 100 ug/mL and 10% glycerol) in Escherichia coli for propagation
and downstream purification of the shRNA clones. pLKO.l contains fl ori and
pUC ori, origins of replication, a human phosphoglycerate kinase eukaryotic
promoter (hPGK), a SIN/LTR (3' self inactivating long terminal repeat) and a 5'
LTR sequences (5' long terminal repeat). The plasmid also consists of a cppt tract
(central polypurine tract), a Psi sequence (RNA packaging signal), and a RRE
element (Rev response element). Ampicillin and puromycin antibiotic resistance
genes provide selection in bacterial or mammalian cells respectively. Stable gene
silencing is selected using the puromycin selectable marker. In the presence of
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the shRNA inserts, the length of the pLKO.l-puro plasmid is 7,086 bp, as 
indicated in the vector map below (Fig. 2.4), while pLKO.l-puro empty vector 
has a length of 7,052 bp.
The MISSION pLKO.l-puro control vector is a lentivirus plasmid vector. The 
vector does not contain a shRNA insert and is useful as a negative control in 
experiments using the MISSION shRNA library clones. This allows one to 
examine the effect of transfection on gene expression Mid interpret the 
knockdown effect seen with shRNA clones. The pLKO.l-puro Control Vector is 
provided as 10 pg of plasmid DNA in Tris-EDTA (TE) buffer at a concentration 
of 500 ng/pL.
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Figure 2.3: Vector map of pCMV6-AC-GFP (ORIGENE).
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Figure 2.4: Vector map of shRNA pLKO.l-puro (Sigma).
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2.6.1 Preparation of DH5a competent cells
Calcium chloride treatment of bacterial cells is generally used to produce 
competent cells which are capable of DNA uptake following a heat shock step 
(Sambrook manual, 1972). DH5a cells were streaked on Luria Burtani (LB) agar 
(10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl, pH 7.0) supplemented with 
LB broth and incubated at 37 °C overnight. The following day, a colony was 
picked from the agar plate and inoculated at 37 °C overnight in 5 mL of LB broth 
with 200 rpm shaking. One mL of this culture was then diluted in 150 mL of LB 
broth and incubated at 37 °C with 200 rpm agitation until a 0.4-0.6 ODeoo was 
achieved. The bacterial cells were then harvested by centrifugation at 8000 g at 4 
°C for 15 min, resuspended in 10 mL of ice-cold, sterile 0.1 M CaCl2 and 
incubated on ice for 5 min. Following a centrifugation step, competent cells were 
resuspended in 2 mL 0.1 M CaCb and 70 |J.L of DMSO was then added. DH5a 
cells were incubated on ice for 15 min, after which aliquots of 200 (iL each were 
made and stored at -80 °C.
LB aear LB broth
35 g LB agar 15.5 g LB broth
up to 1 L with sterile water up to 1 L with sterile water
2.6 Molecular biology
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Bacterial transformation is the process used in molecular biology for the uptake 
of foreign DNA into bacterial cells. The foreign DNA commonly has an origin of 
replication recognised by the host cell DNA polymerases. The bacteria will 
replicate the foreign DNA along with their own DNA. Plasmids used for the 
cloning and manipulation of DNA have been engineered to harbor the genes for 
antibiotic resistance. Thus, if the bacterial transformation is plated onto media 
containing, for example, ampicillin, only bacteria which possess the plasmid 
DNA will have the ability to metabolize ampicillin and form colonies. In this 
way, bacterial cells containing plasmid DNA are selected.
One day prior to the transformation, LB broth (15.5 g/L) and LB agar (35 g/L) 
was made up. The solidifying temperature is approximately 40 °C and antibiotic 
corresponding to the resistance of the plasmid should be added when the agar 
temperature is between 40 °C and 60 °C to prevent heat inactivation of the 
antibiotic. Following addition of the antibiotic, the agar was dccanted into Petri 
dishes filling approximately 1/3 of the dish. The agar was poured in a bacterial 
hood. The LB Agar and LB broth can be stored in the cold room for 6 - 8  weeks.
A clean area was set out on the bench and a Bunsen burner was lit. Work was 
carried out in close proximity to the flame. Eppendorf tubes containing 100 |iL of 
competent cells for each plasmid and one negative control were set out on ice. To 
100 jiL of competent cells, 50-100 ng (~ 2 (J.L) of plasmid DNA was added to 
each sample. For the negative control, 5 fiL of water was added to the cells 
instead of plasmid DNA. This was mixed by pipetting and then incubated on ice 
for 30 min. Following the incubation, the cells were heat shocked for 45 sec at 42 
°C and were then replaced back on ice for 2 min. In order to help the bacterial
2.6.2 Plasmid transformation
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cells recover from the heat shock, 400 pL of LB broth was then added and the 
cells were incubated for 1 h at 37 °C with vigorous shaking. After 1 h, 200 (iL 
was then transferred to a Petri dish containing LB agar and spread around the 
dish. To prevent cross contamination, different culture spreaders were used for 
each plasmid. The Petri dishes were left for 10 min face up to allow the cell 
suspension to be absorbed into the agar and then were inverted and incubated at 
37 °C for 16 h.
2.6.3 Bacterial culture
The following day, a single colony for cach plasmid was picked from the Petri 
dishes using a sterile pipette tip. Selection of DNA from a single colony ensures 
homogeneity in the DNA as each colony represents DNA from a single 
transformed bacterial cell. The negative control should not contain any colonies.
Picked colonies were separately inoculated in 5 mL of LB broth containing 
antibiotic (for example 100 |xg/mL for ampicillin) as starter culture. The starter 
culture was incubated at 37 °C with 200 rpm shaking until confluent ( 8  - 12 h) 
and inoculated in 250 mL of LB broth supplemented with the antibiotic in a 
conical flask. The flasks were incubated overnight at 37 °C with 250 rpm 
agitation. A flask typically 4 times the volume of the culture is normally used to 
achieve sufficient aeration. Following overnight incubation, the bacterial cells 
were harvested by centrifugation at 8000 x g at 4 °C for 15 min. All the 
supernatant was decanted and the pellet kept for extraction of plasmid DNA. The 
pellet can also be frozen at -  20 °C and later used for Maxi DNA extraction.
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The transformed DNA was then isolated from the bacteria cells using the 
Endofree Plasmid Purification Kit -  DNA-Maxi Prep from QIAGEN as follows: 
(1) QIAfilter cartridges were set up on a QIAgen stand, a cap was placed on the 
end of the cartridges and labelled appropriately for each plasmid being isolated. 
The pellet of bacterial cells, obtained after centrifugation, was resuspended in 10 
mL of chilled Buffer PI. (2) Bacteria were lysed by adding 10 mL of Buffer P2 
and samples were mixed gently by inverting 4-6 times. This was followed by 5 
min incubation at room temperature. (3) Next, 10 mL of chilled Buffer P3 was 
added and samples were immediately mixed by gentle inversion (4-6 times) and 
incubated on ice for 20 min. (4) The lysate was then poured into the QIAfilter 
cartridges and incubated at room temperature for 10 min. During this time the 
cartridges were not disturbed as the precipitate, containing proteins, genomic 
DNA and the detergent, needs to form at the top of the solution without clogging. 
(5) After 10 min, labelled 50 mL tubes were set up underneath the cartridges. 
The caps were removed and the plunger was inserted into the cartridges and all 
the supernatant was forced through the filter into the falcon tubes. The cartridges 
were discarded. (6 ) To the lysate, 2.5 mL of Buffer ER (confidential 
composition) was added and mixed by inverting 1 0  times and then incubated on 
ice for 30 min. During this incubation time, QIAGEN-tip 500 columns were set 
up in the stand and labelled for each plasmid. (7) The columns were equilibrated 
by adding 10 mL of Buffer QBT, allowing the column to drain by gravity flow. 
(8 ) The lysate was then added to the column and allowed to flow through. The 
column was washed with two 30 mL aliquots of Buffer QC and the DNA was 
eluted and collected in 15 mL of Buffer QN. (9) To this elution, 10.5 mL of room
2.6.4 Extraction and purification of plasmid DNA
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temperature isopropanol was added. The solution was immediately mixed and 
centrifuged at 15000 x g at 4 °C for 30 min. The supernatant was decanted very 
carefully. The tubes were marked where the DNA pellet is formed, as the pellet 
is usually small and difficult to see. (10) The pellet was then resuspended in 2 
mL of 70 % endotoxin free ethanol. This was transferred to a 2 mL eppendorf 
tube and centrifuged again at 15000 x g for 10 min. The supernatant was 
carefully poured off and the pellet was allowed to air dry until it became 
translucent. (11) The pellet was then resuspended by gentle pipetting in a suitable 
volume of sterile water depending on the size of the pellet and transferred into an 
eppendorf tube.
Buffer PI Buffer P2 Buffer P3
50 mM Tris-HCl 
lOmMEDTA
200 mM NaOH 
1 % SDS
3 M KAc
pH 8.0 pH 5.5
supplemented with 
100 mg/mL RNase A
Buffer OBT Buffer PC Buffer ON
750 mM NaCl 
50 mM MOPS 
15 % isoproponal
0.15% Triton X -l00
1 M NaCl 
50 mM MOPS
15 % isoproponal
1.25 M NaCl 
50 mM Tris-HCl 
15 % isoproponal
pH 7.0 pH 7.0 pH 8.5
58
2.6.5 Quantification of DNA
The plasmid DNA was quantified using The Thermo Scientific NanoDrop 2000 
spectrophotometer. This system allows for the analysis of 0.5 |xl - 2.0 (il samples, 
without the need for traditional cuvettes or capillaries. Using fiber optic 
technology and surface tension, the sample is held in place between two optical 
surfaces that defme the pathlength in a vertical orientation. During each 
measurement cycle, the sample is assessed at both a 1 -mm and 0 .2 -mm path, 
providing an extensive dynamic range (2 ng/fiL to 3700 ng/|j.L for dsDNA).
The upper and lower optical surfaces of the spectrophotometer were cleaned and 
1 nl of sterile water was loaded onto the lower optical surface (Fig. 2.5 A). The 
sampling arm was closed and blank measurement was initiated selecting the 
nucleic acids module in the NanoDrop software. Once the blank is complete, 
wiping of both optical surfaces with a common laboratory wipe is necessary (Fig.
2.5 B, C). One |xL of DNA sample was then loaded and measured. When all 
measurements were complete, the samples were stored at -20 °C.
Figure 2.5: The Thermo Scientific NanoDrop 2000 spectrophotometer. (A)
Blank or sample was loaded onto the lower optical surface of the 
spectrophotometer. (B, C) The upper and lower optical surfaces of the 
spectrophotometer were cleaned before and after use (V1.0 User Manual).
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All measurements are automatically normalised to 340 nm. The measurement 
and subsequent concentration calculation is volume independent. The software 
automatically calculates the nucleic acid concentration by choosing the 
appropriate constant for the measurements (50 for dsDNA or 40 for RNA).
For nucleic acid quantification, the Beer-Lambert equation is modified to use a 
factor with units of ng-cm/^L. The modified equation is the following:
c = (A * e)/b
c = the nucleic acid concentration in ng/|xL;
A = the absorbance in AU;
s = the wavelength-dependent extinction coefficient in ng-cm/|iL; 
b = the pathlength in cm.
The ratio of absorbance 260/absorbance 280 nm is used to assess the purity of 
DNA and RNA. A ratio ~1.8 is generally accepted as “pure” for DNA and -2.0 
for RNA. If the ratio is appreciably lower in either case, it may indicate the 
presence of protein, phenol or other contaminations.
2.6.6 Agarose gel electrophoresis
In order to verify the integrity of the isolated plasmid DNA, we also performed 
agarose gel electrophoresis. The gel was cast using a 1 % agarose matrix (1 g 
agarose in 100 mL IX TAE buffer). The mixture was heated in a microwave 
until boiling and allowed to cool for 5 min. Ethidium bromide (0.1 fxL /mL) was 
added to the solution and this was poured in a gel tray and a comb was inserted. 
The gel was left to set to allow solidification. To 2 (i.L of isolated DNA, 10 (iL of
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sterile water and 2 (J.L of 6 X DNA loading dye were added. The sample and a 
100 base pair (bp) DNA ladder were loaded and the gel was run at 100 V in a 
BioRad electrophoresis chamber in IX TAE buffer for ~ 30 min. The DNA was 
visualised under UV illumination and images were captured using a Fuji-Film 
imaging system. In a 1% agarose gel, xylene cyanol migrates similar to a 4000 
bp DNA sample, while bromophenol blue migrates similar to a 300 bp DNA 
sample acting as useful markers during electrophoresis. The glycerol in the dye 
acts to weigh down the DNA in the well and reduce potential overspill, while the 
EDTA prevents DNA degradation. Ethidium bromide is suspected to be a 
carcinogen and intercalates into DNA with high affinity.
2.7 Transfection
Transfections are techniques used in molecular biology to insert foreign DNA 
into mammalian cells. There are various methods for allowing DNA to cross the 
cells plasma membrane: chemical-based techniques (calcium phosphate, 
dendrimers, liposomes and cationic polymers); non chemical methods 
(electroporation, sono-poration and gene electrotransfer); particle-based methods 
(gene gun, magnetofection and impalefection) and finally, viral methods (viral 
transduction).
Buffer IX  TAE 6X loading dxe
pH 8.0
40 mM Tris-HCl 
1 mM EDTA
1.25 % bromophenol blue
1.25 % xylene cyanol 
6  mM EDTA
80 % glycerol
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In this study, we used only chemical-based techniques, such as Lipofectamine 
2000 and TurboFect™ for in vitro transient transfection.
2.7.1 Lipofectamine 2000
Use of a commercial reagent such as Lipofectamine 2000 results in more 
consistent transfection efficiency than calcium phosphate, but is considerably 
more expensive. Long incubation times with the Lipofectamine reagent can 
induce damage to neuronal processes and apoptosis. In this thesis, Lipofectamine 
2 0 0 0  was used for transfection of mouse cortical neurons and motor neuron-like 
cell line NSC34.
For a 24 well plate, we used ~ 0.2 (ig of DNA per well. In total, 5 |ig of DNA 
was added to 500 jiL of Opti-MEM. Twenty microlitres of Lipofectamine 
reagent was added to another 1.5 mL tube containing 500 |xL of Opti-MEM. The 
eppendorf tubes were mixed by flicking them with my finger for 30 s and then 
left for 5 min at room temperature. Following this, the two tubes containing 
DNA-Opti-MEM and Lipofectamine-Opti-MEM were mixed by flicking for 30 s 
and left at room temperature for 20 min. During this incubation time, conditioned 
media from the 24 well plate was removed and stored. To each well, 300 \iL of 
Opti-MEM was added. After the 20 min incubation, ~ 40 (iL of the mixture was 
added to each well drop by drop, dispersing evenly. The plate was placed back 
into the incubator at 37 °C and 5% CO2 for 45 min. The cells were checked every 
20 min for signs of cytotoxicity. After 45 min, the medium was removed and the 
conditioned medium replaced.
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TurboFect™ in vitro Transfection Reagent is a sterile solution of a cationic 
polymer in water. The polymer forms compact, stable, positively charged 
complexes with DNA. The complexes protect DNA from degradation and 
facilitate gene delivery into eukaryotic cells. This technique is ideal for 
transfection of a variety of cells, including primary and difficult-to-transfect 
cells. Transfection can be performed in the presence or absence of serum. 
TurboFect™ demonstrates superior transfection efficiency and minimal toxicity 
when compared to lipid-based or other polymer-based transfection reagents. In 
this work, TurboFect™ was used for transfection of human neuroblastoma SH- 
SY5Y cells.
For a 6  well plate, we used 4 pg of DNA and 6  pL of TurboFect™ per well. In 
total, 24 fig of DNA was added to 2.4 mL of serum-free DMEM (400 pL each 
well). Twenty six microlitres of TurboFect™ reagent was added to the diluted 
DNA. The tube was mixed immediately by pipetting or vortexing and incubated
15-20 min at room temperature. Following this incubation, 400 pL of the mixture 
was added to each well drop by drop. The plate was placed back into the 
incubator at 37 °C and 5% C02 and left for 24 h. The day after, the medium was 
removed and replaced with fresh medium.
2.8 Western blotting
Western blotting allows the identification and quantification, with appropriate 
antibodies, of a specific protein that has been separated from others, according to 
its size, by gel electrophoresis. Total protein from a cell lysate is quantified and
2.7.2 TurboFect™ in vitro Transfection Reagent
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equal amounts of protein are loaded onto a SDS polyacrylamide gel. Proteins are 
separated on the gel and then transferred to a membrane, almost always of 
nitrocellulose or polyvinylidene fluoride (PVDF). The application of an electrical 
currcnt induces the proteins in the gel to move to the membrane, where they 
adhere. The membrane is then a replica of the gel’s protein pattern and can be 
subsequently stained with labelled antibodies specific to the proteins of interest, 
allowing for their detection and quantification.
Antibodies typically recognise a small portion of the protein of interest (epitope) 
and this domain usually resides within the 3D conformation of the protein. To 
enable access of the antibody to this portion, it is necessary to unfold the protein,
i.e. denature it.
For denaturation, samples are resuspended in a buffer “Laemmli” which contains 
Sodium Dodecyl Sulfate (SDS) and P-Mercaptoethanol. The first is an anionic 
surfactant which disrupts non-covalent bonds in the proteins, denaturing and 
maintaining them in a linear state. The binding of SDS to the protein causes the 
molecules to lose their native shape (conformation), where the secondary and 
tertiary structures have been removed (S-S and S-H bonds by heating samples to 
95 °C) and it confers a uniform negative charge across all proteins. P- 
Mercaptoethanol is a hybrid of ethylene glycol (HOCH2CH2OH) and 1,2- 
ethanedithiol (HSCH2CH2SH) and reduces disulphide bridges in proteins before 
they adopt the random-coil configuration.
In denaturing SDS-PAGE separations, by applying a potential difference across a 
gel, proteins can be separated not on the basis of their intrinsic electrical charge, 
but by their molecular weight. Polyacrylamide gels have a pore structure which 
allow smaller proteins to migrate faster that larger ones. By varying the
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percentage of acrylamide in the gel, we then vary the pore size within the gel. 
This results in a more efficient resolution of protein bands on the gel.
2.8.1 Sample preparation
To prepare samples for running a gel, cells were harvested at specific time points 
following treatment to enable detection of the proteins of interest. Generally, 
three wells of a six well plate, plated at 1.4 million cells per well, gives 
approximately enough protein to carry out 4-6 Western blots (30 (xg per time 
point). A cell scraper was used to scrape all cells from each well into the media. 
Media from each time point was pooled into 15 mL tubes. The tubes were 
centrifuged at 1500 rpm for 3 min to obtain a cell pellet. All the supernatant was 
aspirated and the pellet was re-suspended in PBS and again centrifuged at 1500 
rpm for 3 min to obtain a cell pellet.
Cells were then lysed in 50-300 |j.L (depending on how many wells were used for 
time point) of Radio Immuno Precipitation Assay buffer (RIPA). This is a 
popular buffer for studying proteins that are cytoplasmic, or membrane-bound, or 
for whole cell extracts.
The lysates were then stored at -  80 °C or directly used for determination of 
protein concentration.
RIPA buffer
150 mM NaCl 
1% NP40
1% Sodium deoxycholate 
0.1% SDS
25 mM Tris HC1 (pH 7.6)
Add protease and phosphatase inhibitors mix (1:100)
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2.8.2 MicroBC method of protein quantification
To measure the total protein in each lysate, a protein quantification kit (Uptima) 
containing Reagent A, Reagent B, Reagent C and a 2 fig/fiL BSA standard was 
used. The protein assay was carried out in a clear flat bottomed 96 well plate. 
Samples were measured in quadruplicate and BSA standard curve was measured 
in duplicate. Reagent A, B and C were mixed in the ratio 25:25:1 up to a volume 
required for 150 |j,L per sample plus standard curve, (0-12 jig BSA). One 
hundred and fifty microlitres of Reagent A, B, C mix and 150 (J.L of 0.9% NaCl 
was added to each well, plus 2 p.L of sample or appropriate volume of standard.
The plate was left in the dark for 30 min. Following this incubation, the 
absorbance was measured using a plate reader at 560 nm of absorbance. The 
average value of the blank (0 \ig BSA) was subtracted from the average values of 
BSA standard. The resulting values were plotted and the slope of the regression 
line determined. The average sample absorbance was extrapolated against this 
curve and the concentration of the protein determined. An excel template was 
used for fast extrapolation and quantification of numerous samples.
2.8.3 Gel preparation
Polyacrylamide gels are formed from the polymerization of two compounds: 
acrylamide and N,N-methylenebis-acrylamide (Bis). The latter one is a cross- 
linking agent for the gels and the polymerisation is initiated by the addition of 
ammonium persulfate along with TEMED. The gels arc neutral, hydrophilic, 
three-dimensional network of long hydrocarbons crosslinked by methylene 
groups. The separation of molecules is determined by the relative size of the
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pores formed within the gel. As the total amount of acrylamide increases, the 
pore size decreases.
The gel is composed of two parts, the “stacking” and “resolving” gel. The 
stacking gel (5% acrylamide, Table 2.1) is used to compact all the proteins 
together so that they all start from the same starting point once they enter the 
resolving gel. The resolving gel (6-15% acrylamide, Table 2.2) separates the 
proteins by mass/charge with larger proteins migrating slower than smaller 
proteins. Typically, the smaller the protein of interest, the higher the percentage 
of acrylamide used to resolve the proteins and Vice Versa (Table 2.3).
Table 2.1: Resolving gel recipes
Resolving gel (5 mL)
Gel percentage 6 % 8% 1 0 % 1 2 % 15% Units
H20 2 . 6 2.3 1.9 1 . 6 1 . 1 mL
30% Mix-acrylamide 1 . 0 1.3 1.7 2 . 0 2.5 mL
1.5 M Tris-HCl (pH 8 .8 ) 1.3 1.3 1.3 1.3 1.3 mL
10% SDS 50 50 50 50 50 pL
10% APS 50 50 50 50 50 pL
TEMED 4 3 5 5 2 pL
Table 2.2: Stacking gel recipe
Stacking gel (3 mL)
Gel percentage 5% Units
H20 2 . 1 mL
30% Mix-acrylamide 500 pL
1.0 M Tris-HCl (pH 6 .8 ) 380 pL
10% SDS 30 pL
10% APS 30 pL
TEMED 7 pL
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Table 2.3: Gel percentage relative to protein size of interest
Protein size (kDa) Gel percentage (%)
4-40 2 0
12-45 15
10-70 1 2
15-100 1 0
25-200 8
50-250 6
A Mini-PROTEAN Tetra Electrophoresis System from BioRAD was used to 
prepare the gels. Glass plates, 0.75 mm, 1mm or 1.5 mm were washed first with 
water and then with 70% ethanol and assembled in the glass plate assembly kit 
provided. The assembly was arranged so as to cast a gel 0.75, 1 or 1.5 mm in 
width, 8  cm x 8  cm in length and breath. Water was added to the cast up to the 
top and left for 10 min to test for leakage. If leakage occurred, the plates were set 
again. Resolving gel (5-8 mL) was poured between the plates until the gel was 
approximately 2-3 cm from the top. Isopropanol was added to the top of the gel 
(preventing the gel from drying out). The gel was left to set until polymerized 
(approx 15 min). Following this, the isopropanol was removed by tipping the 
whole system on its side and decanting out the alcohol. Any residual alcohol was 
removed using tissue or piece of Whatman filter paper. The remaining 2-4 cm 
gap in the gel was then filled with stacking gel and a 10 or 15 comb-wells was 
inserted. The gel was then left to set.
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Protein samples were made up in reaction tubes to give a final quantity of 30 jig 
of protein. To guarantee the complete dénaturation of the proteins, appropriate 
quantities of Laemmli buffer 6 X was added to the samples to make IX and the 
remainder made up with water. The samples were boiled at 95 °C for 5-10 min. 
Electrophoresis buffer IX was then added to fill completely the inner chamber 
and to half fill the outer chamber of the BioRAD electrophoresis system. 
Following this, the samples were loaded onto the gel. Four microlitres of protein 
marker (PageRuler, Fermentas, Germany) was added, generally to the first lane 
to determine protein migration.
2.8.4 Loading samples
Laemmli buffer 6X Electrophoresis buffer 5X
70% 0.5 M Tris HC1 pH 6 . 8  12.8 mM Tris-base
30% Glycerol 1.25 M glycine
10% SDS 17.3 mM SDS
5% P-Mercaptoethanol
0.012% Bromophenol Blue up to 10 L with filtered water, pH 8.3
2.8.5 Sodium Dodecyl Sulfate PolyAcrylamide Gel Electrophoresis (SDS- 
PAGE)
Gels are loaded into the BioRad electrophoresis system, which comprises a 
mounting unit holding the gels and two electrodes at either end. The anode (+ 
electrode) must be connected to the bottom chamber and the cathode to the top 
chamber. The negatively-charged proteins will migrate downwards, toward the 
anode. The unit is immersed in a tris-glycine electrophoresis buffer. The gel is 
run at 60-80 V until the protein reaches the resolving gel and 120-150 V
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thereafter. Following electrophoresis, the proteins were transferred to a 
membrane for immunoblotting.
A crucial parameter to the successful separation of protein on the gel is pH. 
Proteins are trapped in what is called a moving boundary in the stacking gel. 
Chloride ions from the tris-HCl and electrophoresis buffer form the front of the 
boundary while glycine ions form the back of the boundary. The net effect is 
packing of the protein into a thin film across the stacking gel. When the protein 
reaches the running gel, all proteins arrive together. Glycine is amphoteric: it has 
both acidic and basic side chains which give it either acidic or basic properties, 
depending on the pH of its environment. In an acid, it is has basic properties, 
while in a base it has acidic properties. The change in pH from the stacking gel 
pH 6 . 8  to pH 8 . 8  in the running gel and causes the glycine to ionise, accepting 
more H+. The net effect is that the glycine accelerates towards the anode 
overtaking the protein and releasing them from the boundary, allowing them to 
separate on the basis of their charge to mass ratio.
When the dye front reached the bottom of the gel, the gel is usually stopped as 
the lowest molecular weight proteins are nearing the end of the gel. If greater 
separation was needed, the lower molecular weight proteins were run off the gel 
until sufficient separation of the target protein was achieved, as judged by the 
separation of the marker bands.
Following electrophoresis, the gel was prepared for transfer using the iBlot™ dry 
blotting system.
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The iBlot™ Dry Blotting System consists of the iBlot™ Gel Transfer Device and 
iBlot™ Gel Transfer Stacks that allows efficient and reliable transfer of proteins 
from polyacrylamide gels in 7-8 minutes without the need for buffers or an 
external power supply. The proteins transferred using the iBlot™ Dry Blotting 
System exhibit higher immunodetection sensitivity when compared to proteins 
transferred using conventional semi-dry or semi-wet blotting methods. To use the 
iBlot™ Dry Blotting System for protein transfer, the iBlot'” Gel Transfer Stacks 
Regular, containing the nitrocellulose transfer membrane, were assembled with 
the pre-electrophoresed gel on the iBlot™ Gel Transfer Device (Fig. 2.6). This 
system contains the following components: cathode stacks (top); anode stacks 
(bottom); disposable sponges and filter papers.
The iBlot™ Gel Transfer Stacks act as ion reservoirs, which contain the 
appropriate anode/cathode buffers incorporated into the gel matrix (transfer 
stacks) instead of buffer tanks or soaked papers (Fig. 2.7).
The high density and availability of ions in the gel matrix enables rapid protein 
transfers. The iBlot™ Gel Transfer Stacks also contain the copper electrodes 
(anode and cathode) required for electrophoresis.
During blotting, the copper anode docs not generate oxygen gas as a result of 
water electrolysis, as compared to conventional inert electrodes present in other 
blotting systems. The design of the iBlot™ Gel Transfer Device reduces the 
distance between the electrodes and the integrated power supply. This unique 
design combined with the gel matrix technology of the iBlot™ Gel Transfer 
Stacks allows the system to generate high field strength and high protein currents 
increasing the transfer speed.
2.8.6 Western blotting using the iBlot™ dry blotting system
+ + + + + + + + +
Figure 2.7: iBlot™ transfer principle. Instead of layered filter paper or buffer 
tanks, the top and bottom stacks contain the necessary buffers. The bottom stack 
includes an integrated 0 . 2  fxm nitrocellulose.
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The lid of the iBlot™ Gel Transfer Device was lifted and the system was cleaned 
with ethanol. The gel was then removed from the electrophoresis system. The 
stacking gel was removed and discarded. The resolving gel was transferred into 
sterile water for 30 sec. The package labelled iBlot™ Anode Stack, Bottom, 
which contains a copper electrode and nitrocellulose (0 . 2  pm), was placed on the 
transfer device system to the left of the blotting surfacc area. Then, the pre-run 
gel was placed on the top of the anode stack. This was followed by a filter paper 
(previously soaked in sterile water) and the iBlot™ Cathode Stack, Top. Any 
trapped air bubbles that interfere with efficient protein transfer were removed 
using the blotting roller. The disposable sponge was then placed on the inner side 
of the lid such that the metal contact is to the top right. The sponge absorbs any 
excess liquid generated during blotting and exerts an even pressure on the stack 
surface. The lid was closed and latch secured. The program P3 (20 V) was run 
for 8  min to allow even the transfer of proteins > 150 kDa.
Following completion of the transfer, membranes were rinsed and rehydrated in 
TBS-T. To check for success of transfer and even protein loading across the 
lanes, each membrane was immersed in Ponceau Red (diluted 1:10) for 30 s. The 
membranes were washed in TBS-T until the remaining Ponceau Red was rinsed 
away and the protein bands were well-defined. The membranes were visually 
inspected for efficient protein transfer and protein loading. If the transfer was 
successful, the membranes were then washed repeatedly in TBS-T and used for 
immunoblotting.
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Ponceau Red TBS IPX TBS-T
2% Ponceau S 24.23 g Trizma HC1
30% trichloroacetic 80.06 g NaCl
30% sulfosalicylic acid
100 mL TBS 10X 
900 mL filtered water
1 mL tween20
up to 1 L with filtered water 
pH 7.6
2.8.7 Immunoblotting
Immunoblotting employs antibodies raised against a specific antigen of interest. 
This antibody is used to bind with high affinity a target protein on the membrane. 
This antibody is known as the primary antibody. Knowing the animal from 
which antibody was raised allows us to detect the primary antibody with a 
second antibody that is labelled with a chemiluminescent horse radish peroxidise 
(HRP): the secondary antibody. The signal from the chemiluminescent secondary 
antibody is proportional to the amount of primary antibody bound, which is 
proportional to the amount of target protein present in the sample. Therefore, we 
can make a direct correlation between the chemiluminescent signal and the 
amount of protein of interest present in the sample.
Prior to immunoblotting, the membrane is blocked with blocking buffer. This is 
bccausc the membrane has a high affinity for protein; therefore the antibodies 
may bind to areas where no protein has transferred. By blocking with powdered 
milk or Bovine Serum Albumin (BSA), the naked portions of the membrane are 
covered with a neutral protein and this reduces non specific binding to the 
membrane.
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Each membrane was incubated at room temperature on a rocker in 5% powdered 
milk for 1 h. Following this, the milk was discarded and the membrane rinsed in 
tris-buffered saline-tween 20 (TBS-T). The membrane was then cut into sections, 
separating out each protein of interest, including beta actin, a housekeeping gene 
used as a control for total protein loading onto the gel. The primary antibody was 
made up in blocking buffer according to the manufacturer’s instructions. 
Normally these were in the range of 1/500 -1/2000 dilutions. Each membrane 
segment was incubated with primary antibody on the rocker for 2  h at room 
temperature or overnight at 4 °C.
Following this, the membrane was washed three times for 5 min with TBS-T. 
Each membrane segment was incubatcd on a rocker for 1 h with its respective 
secondary antibody labelled with HRP diluted 1/2000 to 1/10000 in blocking 
buffer. Following secondary antibody incubation, the membrane was again 
washed three times for 5 min with TBS-T. The HRP signal was activated by 
rinsing the membranes with 500 |xL of chemiluminescent substrate (Millipore) 
for 1 min. The resultant signals were detected and captured with several exposure 
times using a Fujifilm LAS 3000 digital imaging system. An image of the protein 
marker was also captured with white light.
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Table 2.4: Western blotting antibody list
Antibody
name
clone Antibody
type
Manufacturer Dilution Time
anti-a- 
fodrin (all- 
Spectrin)
AA6 Mouse
monoclonal
Millipore o o o 2  h
anti-calpain
large
subunit
p-type Rabbit
polyclonal
Cell Signaling 1:500 ON
anti-GFP peptide
26-39
Rabbit
polyclonal
Calbiochem 1 : 1 0 0 0 ON
anti P-Actin DM 1A Mouse
monoclonal
Sigma 1:5000 2  h
Horseradish
peroxidase
conjugated
secondary
Various Various Pierce 1 / 1 0 0 0 0 1 h
2.9 Gene targeted mice
Mouse mating pairs from the background strain C57/Black 6  were procured from 
Prof. Andreas Strasser at the Walter and Eliza Hall institute of Medical Research 
(WEH1), Melbourne. The generation and genotyping of bidf~ and bim" mice has 
previously been described (Bouillet et al., 1999, Villunger et al., 2003, 
Kaufmann et ah, 2007). Several pairs of heterozygous breeding pairs of bax- 
deficient mice were obtained from The Jackson Laboratory (Bar Harbor, Maine) 
and maintained in house.
The bid1' strain was generated on an inbred C57BL/6 background, using 
C57BL/6 derived ES cells. The bax'A and bim1' mice were originally generated 
on a mixed C57BL/6xl29SV genetic background, using 129SV derived ES cells, 
but were backcrossed for >12 generations onto the C57BL/6 background. Wild
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type, heterozygote, and gene knockout mice were generated and maintained in 
house, in the Biological Research Facility.
The genotype of bidA baxA and birri1' mice was confirmed by a PCR with 
specific primers (see paragraph 2.8). Ethical approval was received for this 
project from the RCSI Research Ethics Committee. Ref: REC145. A licence was 
obtained from the Irish government, so that procedures to isolate embryonic 
mouse cortex could be legally carried out. This was granted under the Cruelty to 
Animals Act, 1976. Ref: B100/4248. A record of sacrificed animals was kept and 
annual reports were submitted to the Department of Health and Children.
2.10 DNA extraction and genotyping
DNA was extracted from tail snips using High Pure PCR Template Preparation 
Kit (Roche, Sussex, UK) by experienced technicians in the laboratory.
Genotyping was performed using three specific primers as follows: 
5'GGTCTGTGTGGAGAGCAAAC3' (common),
5TCAGGTGCCAGTGGAGATGAACTC3' (wild type allele-specific) and 
5 'GAGT CAT ACTT ACTT CCT CCGAC3' (mutant allele-specific) for bid; 
5'CATTCTCGTAAGTCCGAGTCT3' (common),
5'GTGCTAACTGAAACCAGATTA3' (wild type allele-specific) and
5'CTCAGTCCATTCATCAACAG3' (mutant allele-specific) for Bim;
5 'GTT GACC AGAGTGGCGT AGG3' (common),
5'GAGCTGATCAGAACCATCATG3' (wild type allele-specific) and
5'CCGCTTCCATTGCTCAGCGG3' (mutant allele-specific) for bax. The sizes 
of the expected PCR products are illustrated in the results chapters V and VI.
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2.11 Preparation of mouse neocortical neuron cultures
Sterile dissection buffer was made up containing phosphate buffered saline 
(PBS), bovine serum albumin (BSA) and glucose. Two types of media were used 
during culture, the first, a plating media that contained serum and growth factors 
to help the neurons survive following dissociation and initial plating. The second 
medium, a feeding medium was used to support neuronal survival while 
inhibiting proliferation of glia.
Dissection Buffer Platine Media Feeding Media
*One tablet dissolved in 200 mL of sterile water yields 0.01 M phosphate buffer, 0.0027 
M potassium chloride and 0.137 M sodium chloride, pH 7.4, at 25 °C.
All multi-well plates and Willco dishes were pre-coated with a poly-D-lysine 
matrix to aid the adhesion of neurons. Poly-D-lysine was made up in sterile water 
to a final concentration of 5 |ig/mL. Two mL of this were added to each well of a
6  well plate, 500 (J.L to each well of a 24 well plate and 1 mL to each Willco. 
These were then incubated at 37 °C for 1 h. After 1 h, the solution was aspirated 
and each well washed three times with sterile water.
Primary cultures of cortical neurons were prepared from embryonic gestation day
16-18 (E16-E18). To isolate the cortical neurons, hysterectomies of the uterus of
2 (1.8 g) PBS tablets*
1 g glucose
1.2 g BSA
QS 400 mL sterile water
445 mL MEM (- L Glu) 
25 mL FCS/FBS 
25 mL HS 
5 mL P/S
5 mL Glutamine (Q)
3 g D-Glucose
500 mL NBM 
5 mL P/S
5 mL Glutamine (Q) 
Add B27 supplement 
(1/50) prior to use
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pregnant mice were carried out using an abdominal injection of 40 mg/kg of 
pentobarbital (Dolethal) as lethal anaesthesia. The mouse was determined to be 
sedated by assessing its pinch-reflex. The cerebral cortices were isolated from 
each embryo and pooled in the dissection buffer on ice. The embryos were 
decapitated and a cortical dissection was carried out using a dissection 
microscope.
First, the embryo was held face forward with a tweezers. A single incision was 
made at a 60 degree angle from the front of the embryo, cutting just behind the 
eyes. This incision completely removed the front portion of the head. The whole 
cerebrum was then isolated from the head using gentle strokes of the tweezers 
along the top of the head of the embryo. The cortex and midbrain was then cut 
away from the rest of the brain as illustrated in figure 2.8. Each cortex was cut 
away from the midbrain and the meninges (three distinct connective tissue 
membranes that enclose and protect the CNS) were removed. Tissue from the 
other hemisphere was isolated in the same manner. The tissue from all the 
embryos was then pooled in a 15 mL tube containing ice cold dissection buffer. 
Following dissection, the dissection media was aspirated and the cortical tissue 
was finely chopped with a sterile blade. The tissue was then transferred to a 15 
mL centrifuge tube and incubated with 0.25% trypsin-EDTA at 37 °C for 15 min. 
The tube was inverted every 5 min during incubation. After incubation, the 
trypsinisation was stopped by adding 20 mL of plating media, containing sera. 
The tube was then centrifuged at 1500 rpm for 3 min to pellet the cells. The 
media was aspirated and 5 mL of fresh plating media was added. The neurons 
were then dissociated by gentle pipetting, using a 1 mL pipette. Plating media 
was added up to the 20-40 mL mark (approx 5 mL per embryo) and the media
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was passed through a 40 fxm filter. The cells were counted using a 
haemocytometer, plated at 2 x 10s cells per cm2 on poly-D-lysine-coated plates, 
and then incubated at 37°C, 5% C02.
The following day, the cells were washed twice with D-MEM to remove non 
adherent cells. The plating medium was exchanged with 50% feeding medium, 
50% plating medium with additional mitotic inhibitor cytosine arabinofuranoside 
(600 nM). Two days later, the medium was again exchanged for feeding medium 
and experiments were performed on days in vitro (DIV) 8 to 11.
Figure 2.8: Preparation of cortical neuron cultures. (A) Dissection 
microscope and dissection utensils used in the preparation of mouse cortical 
neurons. (B) The brain was removed from the embryo. (C) One hemisphere of 
the cortex was removed from the rest of the forebrain. (D) The meninges were 
removed from the outer layer of the cortex. (E) The isolated cortical tissue 
remained.
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2.12 Preparation of organotypic hippocampal slice cultures
Organotypic hippocampal slices cultures (OHSCs) were prepared and cultured 
according to the modified procedure (Kristensen et al., 2001) by Dr. Helena 
Bonner in our laboratory. The brain from postnatal day 10 mouse pups was 
isolated and transferred to dissection medium containing HBSS (Invitrogen), 20 
mM Hepes, 100 U/mL penicillin/streptomycin, and 0.65% glucose. Isolated 
hippocampi were placed on a Mcllwain tissue chopper (Mickle Laboratory 
Engineering, Guildford, UK) and cut into 450-(im-thick sections. The slices were 
then transferred into fresh dissection medium and selected for clear hippocampal 
morphology [intact CA regions and dentate gyrus (DG)], and placed on porous 
(0.4 jxm) membrane of Millicell inserts (Millipore, Cork, Ireland). The inserts 
were placed in 6 -well tissue culture plates with 1 ml of culture medium 
consisting of MEM supplemented with 25% horse serum, 4 mM 1-glutamine, 6  
mg/ml d-glucose, 2% B27, 50 U/ml penicillin G, and 50 ng/ml streptomycin. 
The slices were maintained in a humidified incubator with 5% C02 at 35°C with 
media changes every second day. All experiments were performed at DIV 10.
2.13 Models of neuronal injury
2.13.1 NMDA-induced excitotoxicity
Cortical neuron cultures were incubated for 8-9 days in vitro to allow for 
expression of the NMD A receptors. To induce excitotoxic injury, murine 
neocortical neurons were exposed to NMDA (30 (xM NMDA for 5 min, 100 fiM 
NMDA for 5 min or 300 fxM NMDA for 60 min). The NMDA was made up in
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sterilised (0.2 |iM) experimental buffer supplemented with 15 mM glucose, 1.2 
mM CaCl2and 10 |iM glycine (excitation buffer).
The conditioned media from each well was removed and stored at 37 °C in a 
water bath. Experimental buffer without NMDA was used as sham. All media 
being added or replaced was done gently by placing the pipette tip off the side of 
the well, so as not to destroy the neuronal processes and limit endogenous 
glutamate release. After stimulation, the NMDA was aspirated and the 
conditioned media was replaced. In the case of confocal microscopy, a baseline 
was determined prior to the insult and MK-801 was used to as an open channel 
blocker of the NMDARs. Experiments were carried out over 24 h.
Experimental Buffer
120 mM NaCl
3.5 mM KC1 
0.4 mM KH2P 0 4 
20 mM HEPES 
5 mM NaHC03
1.2 mM Na2SC>4
pH 7.4
Up to 1 L with sterile 
water
Excitation Buffer
experimental buffer 
15 mM glucose
1.2 mM CaCl2
NMDA (30, 100 or 300 jiM) 
10 (xM glycine
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Slices were tested for viability with Propidium Iodide (5 (iM) prior to the oxygen 
and glucose deprivation experiments. Healthy slices from wild type and box" 
mice were transferred to the hypoxic chamber (COY Lab Products Inc., Grass 
Lakem MI, USA). The hypoxic chamber had an atmosphere comprising 1.5 %
O2 , 5% CO2 , and 85% N2 , and the temperature was maintained at 35 °C. The 
slices were transferred to wells containing pre-equilibrated and de-oxygenated 
OGD medium (bubbled with N2 for 1 h before use). The OGD medium consisted 
of (in mM) 2 CaCl2, 125 NaCl, 25 NaHC03, 2.5 KC1, 1.25 NaH2P 0 4, 2 MgS04, 
and 10 Sucrose and had a pH of 6 .8 . After 45 min of OGD, the slices were 
transferred to fresh oxygenated culture medium and placed in normoxic 
conditions (21% O2 and 5% C 02) and PI uptake was observed over a 24 h period. 
Control slices were free from OGD. Images were acquired with an Eclipse TE 
300 inverted microscope (Nikon) and a 4X dry objective with Wasabi Software 
version 5.0 (Hamamatsu Photonics, Germany). The CA1 region was selected 
from wild type and baxf' hippocampal slices following OGD treatment and the 
mean fluorescent intensity was determined. The regional grey-level intensity was 
measured using the Wasabi interactive tool, background grey-level was 
corrected, and the average intensity plotted for nine slices per treatment. 
Neuronal injury was expressed as percentage of total injury (OGD performed for
4 h and recovery for 24 h). After each time point, slices were placed into a 6  well 
plate without media and 90 (iL of lysis buffer (2% SDS (w/v), 67.5 mM Tris/Cl- 
Ph 6 .8 , 10% glycerol) was added to each insert containing three slices. Slices 
were removed using a pipette and transferred into an eppendorf 1 ml tube. The 
protein was then stored at -80°C.
2.13.2 Oxygen-Glucose Deprivation (OGD) in OHSCs
2.14 Determination of neuronal injury - Hoechst and Propidium 
Iodide staining of nuclear chromatin
Neocortical neurons on 24-well plates were stained live with 1 (ig/mL Hoechst 
33258 (Sigma, Dublin, Ireland) and 5 (xM propidium iodide (Sigma) dissolved in 
culture medium. Hoechst 33258 is a ¿»w-benzimidc, which is excited by 
ultraviolet light at ~350 nm and emits blue/cyan fluorescence close to maximum 
emission of 461 nm. Hoechst 33258 stains the condensed chromatin in apoptotic 
cells more brightly than the chromatin in healthy cells. The intact membrane of 
living cells excludes cationic dyes, such as propidium iodide (PI). PI, a cell- 
impermeable red fluorescent dye intercalates with nucleic acids in cells with 
membrane leakage, resulting in emission of a fluorescent signal at 615 nm when 
excited at 488 nm. Nuclear morphology was assessed using an Eclipse TE 300 
inverted microscope (Nikon Düsseldorf, Germany) with 20 x 0.43 NA phase 
contrast objective using the appropriate filter set for Hoechst, PI and a charge- 
coupled device camera (SPOT RT SE 6 , Diagnostic Instruments, Sterling 
Heights, MI). All experiments were performed at least three times with 
independent cultures and for each time point, images of nuclei were captured in 
three subfields containing -300-400 neurons each and repeated in triplicate. The 
number of PI positive cells was expressed as a percentage of total cells in the 
field. Resultant images were processed using Image J (Wayne Rasband, National 
Institutes of Health, USA).
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2.15 Microscopy
2.15.1 Light microscopes
The Light microscope, so called because it employs visible light to visualise cells 
and to detect small objects, is the standard tool used in our laboratory. They are 
compound microscopes with objective lenses from 4 to 40 times magnification 
with an eyepiece of 10 times magnification. The total magnification is the 
combined magnification of the eyepiece and objective lens. These microscopes 
were used to count cells (with a haemocytometer) and to study cell morphology 
during culture. Two light microscopes used in this project were the Nikon eclipse 
TS100 and the Olympus CKX 41.
2.15.2 Dissecting microscopes
Dissecting microscopes in the lab were used in the preparation of mouse cortical 
neurons or organotypic hippocampal slices cultures.
The configuration is such to allow low magnification of three dimensional 
objects (objects too large for the compound microscope). There are two types of 
illumination for these microscopes: a spider light or some external light can be 
used to illuminate the object by shining light directly on the object; alternatively, 
the microscope can have an internal light built into the base of the stage. A range 
of magnification for these microscopes is typically from 10 to 40 X. Two 
dissection microscopes were used in this project: the Olympus SZ51 and the 
Meiji Techno EMZ.
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Fluorescent microscopy was used in this study to quantify cell death using 
Hoechst 33258 and propidium iodide staining of nuclear chromatin. Spot 
imaging software was used to capture images which were saved as TIFF files.
Fluorescent microscopy has become an essential tool in biology. It utilises the 
phenomenon of fluorescence and phosphorescence instead of light adsorption 
and reflection. The use of multiple fluorescent labelled molecules allows the 
simultaneous identification of different probes. The basic function of a 
fluorescence microscope is to excite the sample with a desired and specific 
wavelength which is absorbed by the fluorophore, and then to emit a longer 
wavelength from the excitation light. Only the emission light should reach the 
eye or detector and the limits of detection generally depend on the darkness of 
the background.
The excitation for the sample is usually provided by a Mercury (HBO) or Xenon 
(XBO) lamp which emits light between 300-1000 nm and optimally between 
400-700 nm. Fluorescence microscopes possess an excitation filter that only 
allows passage of a short range of light to excite the fluorophore. Wavelengths 
passed by the excitation filter are passed through a beam splitting mirror or 
dichroic mirror that generally reflects light shorter than a certain wavelength but 
transmits light of longer wavelength. The emission light of the fluorophore is 
filtered by an emission filter, or barrier, which transmits specific wavelengths 
and blocks other excitation wavelengths. The most common detector is a charged 
coupled device (CCD). The photons from the fluorescence hit the photodiode in 
the CCD and photons are converted to an electrical signal and intensity given as 
a digital output. Since the output is a digital signal and not a form of light, the
2.15.3 Fluorescent microscopy
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colour we observe is pseudocolour and can be readily changed using imaging 
software.
2.15.4 Confocal microscopy
Confocal microscopes (LSM 510 Meta and LSM 5Live duoscan) were used in 
this study to monitor: (i) changes in mitochondrial membrane potential and 
cytoplasmic calcium homeostasis, using respectively the tetramethylrhodamine 
methyl ester (TMRM) and Fluo-4AM, in single cell; (ii) calpain activity using 
Forster resonance energy transfer (FRET).
In contrast to other forms of microscopy, the key of the confocal approach is to 
illuminate the sample point-by-point, and using a spatial filtering (pinhole), to 
reject out-of-focus light. In turn, the strength of the optical sectioning depends 
strongly on the size of the pinhole. A consequence of focusing on only one plane 
is that there is less light collected from the sample. In order to compensate for 
this, high power lasers are used as the excitation source, which deliver high 
powered excitation and little fluctuation compared to HBO or XBO lamps.
The ability of a confocal microscope to create sharp optical sections makes it 
possible to reconstruct three-dimensional (3D) images at short and regular 
intervals along the optical axis.
A problem often encountered in fluorescent microscopy, especially with high 
power lasers is that fluorophores can irreversibly fade when exposed to 
excitation light, becoming bleached. This occurs when a fluorophore molecule 
becomcs over excited and transits from the singlet excited state to the triplet 
excited state. Excessive laser power is also cytotoxic inducing DNA damage
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especially at shorter wavelengths. Therefore, it is important to balance signal 
intensity and laser power and run control experiments to determine bleaching and 
cytotoxic effects.
2.15.4.1 Real-time live cell imaging using Fluo-4AM and TMRM
Primary neocortical neurons on Willco dishes were coloaded with Fluo-4AM (3 
p.M) and TMRM (20 nM) for 30 min at 37 °C (in the dark) in experimental 
buffer. The TMRM concentration used (20 nM) is low enough to avoid 
quenching effects (non-quenched mode). The cells were washed and bathed in 2 
ml of experimental buffer containing TMRM and a thin layer of mineral oil was 
added to prevent evaporation. Neurons were placed on the stage of a LSM 510 
Meta confocal microscope equipped with a 63 x 1.3 NA oil immersion objective 
and a thermostatically regulated chamber (Carl Zeiss, Jena, Germany). Following 
30 min equilibration time, neurons were exposed to NMDA-induced excitotoxic 
injury (30 (xM NMDA for 5 min, 100 jiM NMDA for 5 min or 300 (iM NMDA 
for 60 min) and glycine (10 |iM) with MK-801 (5 jxM) added to block NMDA 
receptor activation as required. TMRM was excited at 543 nm and the emission 
collected with a 560 nm long pass filter; Fluo-4 AM was excited at 488 nm and 
the emission was collected through a 505-550 nm barrier filter. Images were 
captured every 30 s during NMDA excitation and every 5 min during the rest of 
the experiments.
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Förster resonance energy transfer (FRET) is a technique that employs two 
fluorophores to exploit an energy transfer that exists when two proteins are 
physically close to each other. The phenomenon was discovered in 1948 by 
Therador Förster (Förster, 1948). In molecular biology, variants of the enhanced 
green fluorescent protein (EGFP), cyan fluorescent protein (CFP) and yellow 
fluorescent protein (YFP) are commonly used as fluorophores. This particular 
mechanism has become the basis for a useful technique involving the study of 
molecular interactions, such as protein-protein interaction, DNA-protein 
interaction, and protein conformational changes.
In our experiments, neurons transfected with the calpain-sensitive FRET probe 
(D'Orsi et al., 2012) and loaded with TMRM (20 nM) in experimental buffer, 
were placed on the stage of a LSM 5Live duoscan confocal microscope equipped 
with a 40 x 1.3 NA oil immersion objective and a thermostatically regulated 
chamber set at 37 °C (1080, Carl Zeiss, Jena, Germany). Following a 30 min 
equilibration time, drug dissolved in experimental buffer was added to the 
medium. TMRM was excited at 561 nm, and the emission was collected by a 575 
nm long pass filter. Cyan fluorescent protein (CFP) was excited at 405 nm, and 
emission was collected at 445-505 nm and 505-555 nm for FRET. YFP was 
excited directly using the 489 nm laser diode and detected with the same band 
pass filter used for FRET. Images were captured every 5 min throughout these 
experiments. All microscope settings including laser intensity and scan time were 
kept constant for the whole set of experiments. Control experiments under these 
conditions were also carried out and showed that photo toxicity had a negligible 
impact.
2.15.4.2 Förster resonance energy transfer (FRET)
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The donor unquenching control experiment was performed in neurons 
transfected with the FRET probe on the LSM 51ive duoscan using the same mode 
of detection as stated above, except the missing delay between consecutive scans. 
Bleach scans were performed using the point scanner of the microscope to scan 
predefined regions only with the 489 nm DPSS laser AOTF transmission set to 
100% and using an 80/20 beam splitter in order to bleach Venus (see chapter IV).
2.15.5 Image processing
All images were processed and analyzed using MetaMorph Software version 7.5 
(Universal Imaging Co., Westchester, PA, USA) or ImageJ (freeware) imaging 
software. Image analysis involved conversion of the image from files into stacks 
and subtraction of background noise. The resultant fluorescence data were 
subsequently exported to Microsoft Excel, where traces were normalised to 
baseline response.
2.16 Statistics
Data are given as means ± S.E.M (standard error of the mean). For statistical 
comparison, a one-way analysis of variance (ANOVA) followed by Tukey's post 
hoc test was employed, p  values were determined with the aid of the statistical 
product and service solutions (SPSS) version 15 software and when < 0.05 were 
considered to be statistically significant.
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CHAPTER III
Characterisation of calpain 
activity in response to NMDA- 
induced excitotoxic cell death
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Overactivation of glutamate receptors (‘excitotoxicity’) has been implicated in 
the pathophysiology of stroke (Zipfel et a l,  1999), and several chronic 
neurodegenerative disorders (Rothstein et al., 1990, Lipton, 2007, Mattson, 
2007). The excessive activation of N-methyl-D-aspartate (NMDA) and a-amino- 
3-hydroxy-5-isoxazole-4-propionic acid receptors significantly disrupt cellular 
ion homeostasis. As a result, a largely Ca2+ dependent cell death occurs (Choi, 
1987). After an intense and sustained period of glutamate receptor 
overactivation, the loss of ion homeostasis is frequently irreversible, ATP levels 
deplete, cell integrity collapses, and excitotoxic necrosis is activated (Tymianski 
et al., 1993, Ankarcrona et al., 1995, Budd and Nicholls, 1996, White and 
Reynolds, 1996, Vergun et al., 1999, Ward et a l, 2000). Conversely, transient 
ionic overloading often results in a less severe disturbance, allowing the cells to 
initially recover and restore their ionic gradients. Nevertheless, following the 
insult, neurons can either build upon their initial recovery and survive, or initiate 
cell death machinery resulting in excitotoxic apoptosis (Ankarcrona et a l, 1995, 
Lankiewicz et al., 2000, Luetjens et a l, 2000). A number of studies addressed 
the differential activation of apoptosis and necrosis in particular during ischemic 
brain injury (Manabat et al., 2003, Liu et a l, 2004a, Wei et a l, 2004). Increasing 
evidence implicates the rapid loading of the mitochondrial matrix with Ca2+ as a 
critical factor in the propagation of the injury within neurons, suggesting that 
mitochondrial dysfunction plays a significant role in the initiation and or 
propagation of many neurodegenerative disorders, including Ischemic stroke, 
ALS, Parkinson’s, Alzheimer’s and Huntington’s disease. Calcium accumulation 
within the mitochondrial matrix is monitored by the analysis of a key parameter,
3.1 Introduction
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the mitochondrial membrane potential (Ai//m) (Nicholls and Ferguson, 1992, 
Nicholls and Budd, 2000). The most commonly used probe to study Ai//m 
dynamics is the fluorescent membrane-permeant cationic probe 
tetramethylrhodamine methyl ester (TMRM). TMRM was found to have minimal 
phototoxicity, low photobleaching and the ability to use it in either a quenched 
(aggregated probe) or non-quenched (without probe aggregation) mode 
(Ehrenberg et al., 1988, Nicholls and Ward, 2000, Buckman et al., 2001, 
Gerencser and Adam-Vizi, 2005). Glutamate excitotoxicity has been previously 
characterised in cerebellar granular neurons (CGN) by increase of calcium influx 
following by a decay to basal levels and a secondary irreversible increase in 
calcium, termed “Delayed Calcium Deregulation” (DCD), and cell death occurs 
(Nicholls and Budd, 1998). In addition, Ward et al., had investigated the 
bioenergetics involved in the onset of apoptotic and necrotic glutamate induced 
cell death in CGNs (Ward et al., 2007) and real time analysis of caspase 
dependent and caspase independent apoptosis (Ward et al., 2006). In neurons, 
however, caspase activation is frequently sub-optimal despite the engagement of 
the mitochondrial apoptosis pathway (Budd et al., 2000, Lankiewicz et al., 
2000). This phenomenon may be attributable to high expression levels of the 
caspase inhibitor XIAP (Potts et al., 2003) or reduction in protein levels of 
APAF-1 during neuronal maturation (Wright et al., 2007).
The crucial identified components of excitotoxicity are calcium (Choi, 1985, 
Hori et al., 1985), the ionotropic receptors responsible, NMDA, Kainate and 
AMPA (Pullan et al., 1987, Roberts and Davies, 1987, Monaghan et al., 1988), 
the cysteine proteases calpains (Brorson et al., 1994, Bednarski et al., 1995) and 
mitochondria (Ankarcrona et al., 1995, Maragos and Silverstein, 1995, Reynolds
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and Hastings, 1995, Schinder et a l, 1996). Of note, the activation of the Ca2+- 
activated calpain I has also been implicated in excitotoxic neuron death (Siman et 
a l, 1989, Brorson et a l, 1995, Lankiewicz et al., 2000). Similar to caspases, 
calpain I cleaves a variety of cytoskeletal proteins, enzymes and transcription 
factors, and may induce morphological alterations that mimic caspase-dependcnt 
apoptosis (Croall and DeMartino, 1991, Wolf et al., 1999). Furthermore, calpain 
has been shown to cleave and inactivate pro-caspase 9, pro-caspase 3 and APAF- 
1 (Chua et a l, 2000, Lankiewicz et a l, 2000, Reimertz et al., 2001). Because 
calpains are activated by significant increases in cytosolic Ca2+, calpains may 
specifically play a role in cell demolition during excitotoxic necrosis, however 
this has not yet been experimentally tested. In this study, we aimed to investigate 
excitotoxic injury mechanisms with a focus on identifying the activation and role 
of calpains during these cell death pathways. The characterisation of calpain 
activation following excitotoxic injury may be relevant in providing prevention 
of excessive neuronal loss following stroke or other ncurodegenerative diseases.
3.2 Results
In order to obtain reproducible results and the greatest neuronal survival, the first 
step of this study was the optimisation of a protocol for our murine neocortical 
cultures. It had been shown that astrocytic glial cells can provide neuronal 
support and protection against glutamate induced excitotoxicity (McLennan and 
Wheal, 1976, Rosenberg et al., 1992, Ye and Sontheimer, 1998). Therefore, to 
avoid any variability in the excitotoxic insult, we utilised the mitotic inhibitor 
cytosine arabinoside (araC) and as our excitatory stimulus, an analogue of
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glutamate, NMDA and its coagonist glycine. AraC, used at the concentration of 
600 nM, is not cytotoxic in primary neuronal cultures and stops glial cell 
proliferation. Although in the presence of araC, ~10% of glial cells persist in our 
cultures, estimated by using the glial GFAP and neuronal NeuN markers (data 
not shown).
To explore the role of calpains in excitotoxic neuronal injury, we employed three 
models of NMDA-induced excitotoxicity in primary mouse cortical neurons. In 
order to recreate a transient glutamate receptor overactivation, which reflects the 
neuronal damage occurring during ischemia mainly within the penumbra, we 
established two models of excitotoxic injury: 30 (mild concentration) or 100 p,M 
(moderate concentration) NMDA exposure for 5 min. On the other hand, in order 
to reproduce a prolonged and intense glutamate receptor overactivation, which 
occurs in the core region of the ischemic brain, we set up a model of immediate 
neuronal injury: 300 fiM NMDA exposure (high concentration) for 60 min. 
These models and their mechanisms are discussed in detail in the following 
paragraphs.
3.2.1 Mild NMDA receptor overactivation induces neuronal tolerance
Murine cortical neurons plated on Willco dishes were exposed to 30 jiM NMDA 
for 5 min, allowed to recover, and monitored over 24 h (Fig. 3.1 A). Cytosolic 
Ca2+ and mitochondrial membrane potential (At//m) responses were assessed by 
confocal imaging using respectively the fluorescent calcium indicator Fluo-4 
AM, and the membrane-permeant cationic fluorescent probe TMRM. Following 
a brief equilibration baseline (30 min), the addition of NMDA (30 |oM) to the
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experimental buffer, produced an influx of calcium ions into the cytoplasm and 
an initial Ai//m depolarisation, detected by an increase of Fluo-4 AM fluorescence 
and a parallel decrease of TMRM fluorescence (Fig. 3.1 B). The excitotoxic 
insult was stopped after 5 min, by adding into the medium the NMDA receptor 
antagonist MK-801. After inhibition of glutamate receptor overactivation, the 
cytosolic Ca2+ completely and persistently recovers to stable basal levels. This 
event is coupled with a recovery and an extent hyperpolarisation of the 
mitochondrial membrane potential even at later times post excitation, generally 
associated with neuronal survival rather than injury (Ward et al., 2007, Weisova 
et al., 2009). Analysis of individual Ca2+ responses in relation to the NMDA 
receptor overactivation revealed three major groups of neurons, designated 
‘tolerant’, ‘apoptotic/DCD’ and ‘necrotic/ICD’ (Ankarcrona et al., 1995, Ward et 
al., 2007): (i) tolerant neuron with recovery of neuronal Ca2+ overloading and 
extensive hyperpolarisation of (ii) excitotoxic apoptosis where neuronal 
mitochondria transiently recovered their energetics and a late Ai//m depolarisation 
and delayed calcium deregulation (DCD) occurred hours after the initial 
excitation; (iii) ICD/necrosis with an acute and immediate calcium deregulation 
(ICD) associated with a rapid collapse of membrane potential. Quantification of 
these cellular responses demonstrated that the mild NMDA exposure of 30 fiM 
for 5 min (peak Fluo-4 fluorescence 1.94 ± 0.13 A.U.) largely produced neuronal 
tolerance (65%), while only the 20% underwent DCD and the remaining 15% 
ICD (Fig. 3.1 C). The initial calcium influx, loss of mitochondrial membrane 
potential following NMDA treatment, the subsequent neuronal recovery with cell 
survival is illustrated in figure 3.1 D.
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Figure 3.1: Mild concentrations of NMDA mainly result in neuronal 
tolerance. (A) A schematic of the 30 jiM NMDA for 5 min excitotoxic model. 
Murine cortical neurons cultured in Willco dishes were loaded with TMRM (20 
nM) and Fluo-4 AM (3 (iM) for 30 min at 37°C before being mounted on a 
thermostatic chamber of a confocal microscope (LSM 510 Meta). A 30 min 
baseline is performed to equilibrate to environmental conditions and then 
neurons were exposed to 30 fxM NMDA for 5 min after which the NMDA open 
channel blocker MK-801 (5 fiM) is added to stop the insult and cells were 
monitored over 24 h. (B) Representative traces measuring alterations in 
mitochondrial membrane potential (TMRM) and cytosolic calcium ions (Fluo-4 
AM), showing a DCD/tolerant neuron with recovery of neuronal Ca2+ 
overloading and extensive hyperpolarisation of Ay/m. (C) Quantification of three 
neuronal responses for the injury model (n = 1 0 2  cells): neurons that maintain 
their mitochondrial membrane potential (Tolerance), neurons that lose 
mitochondrial membrane potential with delayed calcium deregulation (DCD) and 
neurons that lose mitochondrial membrane potential with immediate calcium 
deregulation (ICD). Data are means ± SEM from at least n = 3 independent 
experiments. (D) Representative images of a single neuron loaded with TMRM 
(in red) and Fluo-4 AM (in green) and treated with 30 (¿M NMDA. Baseline 
levels of Ay/m and Ca2+, initial calcium influx following NMDA treatment, 
neuronal Ca2+ recovery, hyperpolarisation of Ai//m and neuronal tolerance are 
observed. Scale bar =10 (im.
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3.2.2 Moderate NMDA-mediated excitotoxicity induces a delayed apoptotic 
neuronal injury
As the previous ‘tolerant’ model mostly resulted in neurons that maintain their 
mitochondrial membrane potential for the 24 h duration of the experiment, we 
decided to induce transient excitotoxicity using a higher concentration of NMD A 
(100 |iM). Neocortical neurons were loaded with TMRM and Fluo-4 AM for 
monitoring changes in Ayjm and cytosolic Ca2+ dynamics before being stimulated 
with 100 (xM NMD A for 5 min. The cells, allowed to recover after termination of 
NMDA exposure, were monitored on stage over a 24 h period (Fig. 3.2 A). 
Following transient exposure to NMDA, as with the tolerant model, a high Ca2+ 
influx during excitation followed by a complete recovery of cytosolic Ca2+ levels
is observed. In the time period of hours post the initial insult, neurons underwent
* 2+a second irreversible increase of cytosolic calcium, termed as delayed Ca
deregulation (DCD), late Ay/m depolarisation and ultimately neuronal death (Fig.
3.2 B, D). In neurons exposed to NMDA, DCD occurred always subsequent to 
the delayed mitochondrial membrane potential depolarisation within a period of 
30 ± 2 min. The number of surviving cells or undergoing DCD and ICD were 
quantified (Fig. 3.2 C). The 5 min exposure to 100 (J.M NMDA (peak Fluo-4 
fluorescence 2.47 ± 0.14 A.U.) produced 48 % of neurons which recovered their 
mitochondrial bioenergetics, and a mix of DCD (38%) and ICD (14%) responses, 
with DCD responses being more prominent. Neurons undergoing DCD showed 
cell shrinkage and chromatin condensation largely in the absence of nuclear 
fragmentation, and may therefore be classified as ‘type II’ apoptotic neurons 
(Leist and Jaattela, 2001).
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Figure 3.2: Moderate concentrations of NMDA produce a more delayed 
form of neuronal death. (A) A schematic of the 100 fiM NMDA for 5 min 
excitotoxic model. Cortical neurons were loaded with TMRM and Fluo-4 AM 
and monitored over 24 h on LSM 510 Meta confocal microscope. Following a 30 
min baseline to equilibrate to environmental conditions, neurons were exposed to 
100 fiM NMDA for 5 min after which the NMDA antagonist MK-801 is added 
to stop the insult. (B) Representative traces measuring alterations in 
mitochondrial membrane potential (TMRM) and cytosolic calcium ions (Fluo-4 
AM), showing an excitotoxic apoptosis where neuronal mitochondria transiently 
recovered their energetics and a late Ay/m depolarisation and delayed calcium 
deregulation (DCD) occurred hours after the initial excitation. (C) Quantification 
of three neuronal responses for the injury model (n = 109 cells): neurons that 
maintain their mitochondrial membrane potential (Tolerance), neurons that lose 
mitochondrial membrane potential with delayed calcium deregulation (DCD) and 
neurons that lose mitochondrial membrane potential with immediate calcium 
deregulation (ICD). Data are means ± SEM from at least n = 3 independent 
experiments. (D) Representative images of cortical neuron loaded with TMRM 
(in red) and Fluo-4 AM (in green) and treated with 100 |nM NMDA. Baseline 
levels of Ay/m and Ca2+, initial calcium influx following NMDA exposure, 
delayed Ca2+ deregulation, Ay/m depolarisation and neuronal death are observed. 
Scale bar = 10 (im.
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3.2.3 Acute NMDA-mediated excitotoxicity induces an immediate necrotic 
neuronal injury
Several in vitro and in vivo models have been so far employed to investigate the 
molecular pathway leading to neuronal injury following prolonged glutamate 
receptor overactivation (Rothman, 1986, Rothman and Olney, 1986, Choi and 
Rothman, 1990). Here, cortical neurons were exposed to 300 NMDA for 60 
min, aiming to mimic a model of excitotoxic necrosis in vitro (Fig. 3.3 A). 
Confocal imaging of individual Ca2+ and Ai//m responses using Fluo-4 AM and 
TMRM, demonstrated that neurons failed to recover their NMDA-induccd 
increase in intracellular Ca2+, showing an immediate and sustained Ca2+ 
deregulation (ICD) and an early and persistent mitochondrial depolarisation (Fig.
3.3 B). Quantification of neuronal outcome showed that prolonged exposure to 
300 (iM NMDA for 60 min induced largely ICD (94%), with the only remaining 
6 % of neurons retaining A<//m and displaying a normal cellular morphology for at 
least a 4 h period. No DCD was observed in these neurons (Fig. 3.3 C). In 
agreement with previous studies (Ward et al., 2000, Ward et al., 2005), a 
massive Ca2+ influx into cytosol, rapid collapse of Ay/m, loss of calcium 
homeostasis, neuronal swelling, and early membrane lysis is observed (as 
illustrated in Fig. 3.3 D). Some neurons characterized by an ICD response still 
showed nuclear pyknosis, suggesting that cells with an ICD response did not 
show a homogenously ‘necrotic’ nuclear morphology.
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Figure 3.3: High concentrations of N M D A  induce predominantly an 
immediate form of neuronal death. (A) A schematic of the 300 (iM NMDA for 
60 min excitotoxic model. Cortical neurons were loaded with TMRM and Fluo-4 
AM and monitored over 4 h on LSM 510 Meta confocal microscope. A 30 min 
baseline is performed to equilibrate to environmental conditions after which 
neurons were exposed to 300 nM NMDA for 60 min. (B) Representative traces 
measuring alterations in mitochondrial membrane potential (TMRM) and 
cytosolic calcium ions (Fluo-4 AM), displaying an ICD/necrosis with an acute 
and immediate calcium deregulation (ICD) associated with a rapid collapse of 
membrane potential. (C) Quantification of three neuronal responses for the injury 
model (n = 129 cells): neurons that maintain their mitochondrial membrane 
potential (Tolerance) and neurons that lose mitochondrial membrane potential 
with immediate calcium deregulation (ICD). Data are means ± SEM from at least 
n = 3 independent experiments. (D) Representative images of cortical neuron 
loaded with TMRM (in red) and Fluo-4 AM (in green) and treated with 300 fiM 
NMDA. Baseline levels of Ay/m and Ca2+, high calcium influx following NMDA 
exposure, immediate loss of Ay/m, Ca2+ deregulation and neuronal swelling are 
observed. Scale bar = 10 |im.
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3.2.4 Neuronal death increases with higher concentrations of N M D A  and 
prolonged exposure
In order to confirm whether the injury observed at the single cell level 
microscopy reflects population based level studies, cell death assays were 
performed. Neuronal injury was determined by Hoechst 33258 (1 fig/ml) and 
propidium iodide (PI; 5 pM) staining of nuclear chromatin. Hoechst 33258 stains 
the condensed chromatin in apoptotic cells more brightly than the chromatin in 
healthy cells, while PI, a cell-impermeable fluorescent dye, intercalates with 
nucleic acids in cells with membrane leakage occurring after primary or 
secondary necrosis. Cortical neurons were plated in a 24 well plate and either 
exposed to NMDA (30 or 100 |iM) for 5 min, or to 300 fiM NMDA for 60 min 
(Fig. 3.4 A, B). Controls were sham-exposed to experimental buffer. After 
NMDA exposure, the excitation medium was replaced with the conditioning 
culture medium and the cells were allowed to recover in the incubator for set 
time points (Control, 1, 2, 4, 8 and 16 h). At each time point, cell death was 
assessed by Hoechst 33258 staining and PI uptake, and images were taken using 
an epifluorescence microscope and a CCD camera. In agreement with the 
preceding findings (see above paragraphs), quantification of PI positive cells, 
expressed as a percentage of the total cells, indicated that prolonged exposure of 
300 joM NMDA for 60 min caused significant amounts of immediate cell death 
within 1 h, while cell death induced by a 5 min exposure to 30 or 100 |iM 
NMDA showed a more delayed profile with a maximal onset at 4 h (Fig. 3.4 B). 
Using DEVDase assay to detect caspase 3-like activity, it had previously 
reported, that this NMDA-induced delayed cell death occurs in a caspase- 
independent manner (Susin et al., 2000, Ward et al., 2006).
Figure 3.4: N M D A  induces dose-dependent excitotoxicity over time. (A)
Representative images of the merged image of propidium iodide (PI; 5 |iM) and 
Hoechst 33258 (1 (ig/ml) stained neurons exposed to 30 jxM NMDA for 5 min, 
100 fiM NMDA for 5 min or 300 fiM NMDA for 60 min. Control and 16 h post 
NMDA excitation neurons are shown. Scale bar = 5 fim. (B) Cortical neurons 
were treated with either 30 (xM NMDA for 5 min, 100 fiM NMDA for 5 min, 
300 fiM NMDA for 60 min or sham conditions for 5 min and allowed to recover 
as indicated. Cell death was assessed by Hoechst and PI staining. Three subfields 
containing 300-400 neurons each were captured and at least 3 wells were 
analyzed per time point. PI positive nuclei were scored as dead neurons and 
expressed as a percentage of the total population. Data are means ± SEM from n 
= 3 separate cultures. * p < 0.05 compared to NMDA-treated control. # p < 0.05 
between NMDA treatments (ANOVA, post-hoc Tukey).
3.2.5 Treatment with the calpain inhibitor calpeptin reduces delayed 
excitotoxic apoptosis in cortical neurons
As the highest fraction of DCD and ICD were detected with 100 fxM/5 min and 
300 i-iM/60 min NMDA, respectively, further experiments were conducted in 
these two injury models. To explore the role of calpains in mediating excitotoxic 
injury, the selective calpain inhibitor, calpeptin, available and already used in the 
laboratory (Anguissola et a l, 2009), was utilized to prevent and/or reduce 
calpain activation.
Calpain inhibition, using pharmacological and genetics approaches, has been 
shown to have neuroprotcctive effects in neurons subjected to excitotoxic and 
oxygen/glucose deprivation-induccd neuronal injury in vitro (Siman et a l, 1989, 
Brorson et a l, 1995, Rami et al., 1997, Lankiewicz et al., 2000) and in vivo (Lee 
et a l, 1991, Rami and Krieglstein, 1993, Hong et al, 1994, Bartus et al., 1995b, 
Wu et al., 2004).
Initially, neurons were pre-treated with calpeptin (5 -  20 |aM) for 2 h, and then 
exposed to 100 pM NMDA for 5 min. When neurons were exposed to conditions 
that favoured DCD, calpeptin treatment exerted a robust dose-dependent and 
long-term neuroprotective effect as detected by phase-contrast microscopy, 
Hoechst 33258 staining, and quantification of PI uptake (Fig. 3.5 A-C).
Calpains mediate the proteolysis of the major protein of the cell membrane 
skeleton, all-spectrin. The involvement of calpains in neuronal cell death can be 
determined from the appearance of two spectrin breakdown degradation products 
(150 and 145 kDa SBDPs). In addition to the action of calpains, all-spectrin is 
also targeted by caspase 3, producing 150 and 120 kDa SBDPs. However, only 
the 145 kDa fragment is the calpain-specific product. These fragments are the
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result of calpain-mediated spectrin degradation and can be detected by antibodies 
against all-spectrin. To verify whether the reduction of cell death by calpeptin is 
confirmed also at protein level, cortical neurons were treated with 100 (iM/5 min 
NMDA or sham conditions and at given time points (Sham, 2, 4, 8, 16 and 24 h) 
post excitation, and extracted for Western blotting. Treatment with calpeptin also 
reduced the accumulation of the calpain-specific 145 kDa SBDP that 
accumulated in NMDA-exposed cultures as determined by quantitative Western 
blot analysis. Significant increases in spectrin cleavage were observed at 4 - 8 h 
compared to the sham-treated cultures, and reduced in cultures pre-treated with 
calpeptin (Fig. 3.5 D).
Surprisingly however, pre-treatment with calpeptin failed to show a significant 
protection under conditions that favour ICD, as induced by the exposure to 300 
jj.M NMDA for 60 min (Fig. 3.6 A). This was confirmed by the analysis of the 
accumulation of the calpain-specific 145 kDa SBDP that accumulated only 
marginally in the neuron cultures (Fig. 3.6 B).
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Figure 3.5: Calpain inhibitor calpeptin protects neurons against excitotoxic 
apoptosis. (A) Representative images of phase-bright and the merged image of 
PI and Hoechst stained neurons exposed to sham conditions or 100 pM NMDA 
for 5 min in the presence and absence of the calpain inhibitor, calpeptin. Images 
were taken at selected time points (8 and 24 h post treatment). Scale bar =10 
(xm. (B) Dose response assay. Neurons were treated with 100 fiM NMDA for 5 
min in the presence (5 |iM or 20 |iM) or the absence of calpeptin for the 
indicated times. The number of PI positive cells was expressed as a percentage of 
total cells in the field. Data represent means ± SEM from n = 3 separate cultures.
* p < 0.05 compared to NMDA-treated controls. * p < 0.05 between NMDA 
treated neurons in the presence of calpeptin (5 fiM or 20 fiM) (ANOVA, post- 
hoc Tukey). (C) Cortical neurons were treated with 100 (iM NMDA for 5 min 
over 24 h in the presence or the absence of calpeptin and the extent of injury was 
assessed with Hoechst and PI. Data represent means ± SEM from n = 3 separate 
cultures. * p < 0.05 compared to NMDA-treated controls (ANOVA, post-hoc 
Tukey). (D) Western blot and densitometric analysis comparing the levels of 
spectrin cleavage in neurons following NMDA treatment (100 fxM NMDA for 5 
min over 24 h) in the presence or the absence of calpeptin. (3 actin was used as 
loading control. Experiments were repeated three times with different 
preparations with similar results. Densitometric data are expressed as a ratio of 
the 145 kDa spectrin breakdown product (BP) and the 280 kDa full-length (FL) 
protein normalized to (3 actin. * p < 0.05 compared to NMDA-treated controls. # 
p < 0.05 between NMDA treated neurons in the presence or the absence of 
calpeptin (ANOVA, post-hoc Tukey).
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Figure 3.6: Calpeptin failed to show a significant neuroprotection against
excitotoxic necrosis. (A) Cortical neurons were treated with 300 f iM  NMDA for 
60 min over 4 h in the presence or the absence of calpeptin and the extent of 
injury was assessed with Hoechst and PI. Data represent means ± SEM from n =
3 separate cultures. * p < 0.05 compared to NMDA-treated controls (ANOVA, 
post-hoc Tukey). (B) Western blot and densitometric analysis comparing the 
levels of spectrin cleavage in neurons following 300 (iM NMDA treatment for 60 
min over 4 h in the presence or the absence of calpeptin. (3 actin was used as 
loading control. Experiments were repeated three times with different 
preparations with similar results. Densitometric data are expressed as a ratio of 
the 145 kDa spectrin breakdown product (BP) and the 280 kDa full-length (FL) 
protein normalized to (3 actin. * p < 0.05 compared to NMDA-treated controls. # 
p < 0.05 between NMDA treated neurons in the presence or the absence of 
calpeptin (ANOVA, post-hoc Tukey).
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3.2.6 Gene silencing of calpain I and II or overexpression of calpastatin 
confirms the selective requirement for calpain activation in delayed 
excitotoxic apoptosis
Because pharmacological agents may have off-target effects, we next 
investigated whether the selective requirement of calpains in delayed excitotoxic 
apoptosis could be confirmed using genetic approaches. In order to inhibit 
calpain activity following NMDA stimulation, two distinct shRNA constructs 
targeting the large calpain subunit of calpain I and II and a scrambled shRNA 
vector were employed. Gene silencing of the large subunit of calpain I and II 
was validated in mouse motor neuron-like cells (NSC-34) after 36 h of 
transfection when compared to cultures transfected with the scramble construct 
as determined by quantitative Western blot analysis (Fig. 3.7 A, B).
The calpain I, II shRNA or scramble plasmids were transiently transfected into 
cortical neurons, 5 days in vitro. A plasmid expressing GFP was used as a marker 
to allow for identification of transfected cells containing calpain I, //knockdown 
or scramble within the neuronal population. At least 36 hours post transfection, 
neurons were stimulated with 100 NMDA for 5 min or 300 (j,M NMDA for 
60 min, and allowed to recover for the indicated time points. Neurons were then 
stained with Hoechst 33258 and PI to assess neuronal death. Of note, transfection 
with calpain I  and II shRNA constructs significantly reduced cell death in 
response to 100 fiM/5 min NMDA compared to cells transfected with a 
scrambled shRNA sequence (Fig. 3.8 A). In contrast, immediate cell death in 
response to 300 (j.M/60 min NMDA was not reduced by gene silencing of the 
large calpain subunit (Fig. 3.8 B).
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Figure 3.7: Validation of calpain knockdown efficacy using RNA 
interference technology. (A, B) NSC-34 cells were transfected with shRNA 
plasmids against the large subunit of calpain I  (shRNA I), calpain II (sliRNA II) 
or scramble shRNA. Reduced expression levels of calpain I and II following 
shRNA expression compared to scramble were assessed by Western blotting and 
densitometric analysis 36 h after transfection. Probing for p actin served as a 
loading control. Experiments were repeated three times with similar results.
Figure 3.8: Calpain inhibition using RNA interference technology attenuates 
NMDA-induced excitotoxic apoptosis. (A, B) Cell death analysis following 100 
(iM NMD A treatment for 5 min assayed over 24 h (C), and 300 p,M NMD A for 
60 min treatment assayed over 4 h (D). Cortical neurons were transfected with 
shRNA plasmids as described in figure 3.7. A plasmid expressing GFP allowed 
for the identification of transfected neurons. The number of PI positive cells in 
transfected neurons was quantified (n= 125-160 cells/time point quantified). 
Experiments were performed in triplicate in three separate cultures * p < 0.05 
compared to NMDA-treated, scramble transfected controls (ANOVA, post-hoc 
Tukey).
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Inhibition of calpain activity can also be achieved by overexpression of the 
endogenous calpain inhibitor, calpastatin. First of all, overexpression of 
calpastatin was validated in human neuroblastoma cells (SH-SY5Y) after 36 h of 
transfection with a mammalian expression vector for calpastatin-GFP when 
compared to non-trasfected cultures as determined by quantitative Western blot 
analysis (Fig. 3.9 A).
Subsequently, neurons were transfected with calpastatin-GFP or with an EGFP 
control vector, and 36 h post transfection, were exposed to 100 pM NMDA for 5 
min or 300 (iM NMDA for 60 min. Hoechst 33258 and PI staining was carried 
out and images were taken at given time points. Analysis of GFP-positive 
neurons indicated that transfection of calpastatin-GFP significantly reduced 
excitotoxic cell death in response to 100 pM/5 min NMDA (Fig. 3.9 B, C). 
Again, immediate cell death in response to 300 fiM/60 min NMDA was not 
reduced by calpastatin-GFP (Fig. 3.9 D). These results confirmed that calpains 
played a predominant role in excitotoxic apoptosis.
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Figure 3.9: Calpain inhibition using overexpression of endogenous calpain 
inhibitor, calpastatin, attenuates NMDA-induced excitotoxic apoptosis. (A)
SH-SY5Y cells were transfected with a plasmid expressing the endogenous 
calpain inhibitor, calpastatin fused with GFP. Overexpression of Calpastatin 
levels was assessed by Western blot and densitometric analysis, p actin was used 
as loading control. (B) Representative images of PI, GFP and Calpastatin over- 
expressing neurons (Cast-GFP) in the absence (sham) and presence of NMDA 
(100 (xM NMDA for 5 min) are shown. Scale bar = 1 0  pm. (C, D) Cortical 
neurons were transfected with either a plasmid expressing calpastatin-GFP or a 
plasmid expressing GFP alone as a control. Neurons were treated with 100 pM 
NMDA for 5 min and assayed over 24 h (C), and 300 |iM NMDA for 60 min and 
assayed over 4 h (D). The number of PI positive cells in transfected neurons was 
quantified (n= 142-173 cells/time point quantified). Experiments were repeated 
three times with independent culture preparations with similar results. * p < 0.05 
compared to NMDA-treated controls (ANOVA, post-hoc Tukey).
I l l
In this results chapter, in order to elucidate the relationship between 
mitochondrial bioenergetics, calcium homeostasis, calpain activation and 
neuronal outcome, we have examined how murine cortical neurons respond to 
models of NMDA-mediated excitotoxic injury. The potentiometric probe TMRM 
and the fluorescent calcium indicator Fluo-4 AM allowed us to evaluate changes 
that occur at Ay/m and Ca2+ level, respectively, in models of NMDA-induced 
tolerance, apoptosis and necrosis. The injury identified during transient and/or 
prolonged NMDA excitation is very much in agreement with previous findings 
in our laboratory (Ward et al., 2007) Following transient NMDA receptor 
excitation, mitochondrial membrane potential reversibly depolarises, followed by 
an extent of Ai//m hyperpolarisation which can persist even hours downstream of 
the initial excitation (Fig. 3.1) or can collapse with the subsequent delayed 
calcium deregulation and cell death (Fig. 3.2). In contrast, the necrotic injury 
induced by prolonged NMDA excitation, is characterised by early collapse of 
Ay/m and parallel immediate calcium deregulation, leading to neuronal swelling 
and cell lysis (Fig. 3.3). In addition, NMDA resulted in dose-dependent 
excitotoxicity over time (Fig. 3.4).
In this study, once we established these transient and prolonged NMDA- 
mediated excitotoxic models in mouse neocortical neurons, we set out to identify 
the role of calpains in response to them.
Our study supports the concept that inhibition of calpain activity provides 
neuroprotection against excitotoxic neuronal injury. One of the limitations in our 
study may be that calpain inhibition slowed down cell death rather than arresting 
it. However, similar neuroprotective effects were observed in hippocampal and
3.3 Discussion
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cortical neurons subjected to excitotoxic and oxygen/glucose deprivation- 
induced neuronal injury in vitro, using the calpain inhibitors calpeptin, MDL- 
28170 and E-64 (Siman et al., 1989, Brorson et al., 1995, Rami et al., 1997, 
Lankiewicz et al., 2000). Similarly, neuroprotection was also observed using 
genetic approaches. Knockdown of p-calpain {calpain I) in an in vitro model of 
oxygen glucose deprivation was able to prevent AIF nuclcar translocation and 
increased cell survival (Cao et al., 2007). Moreover, calpain inhibition was 
neuroprotective in in vivo models of excitotoxic injury (Wu et al., 2004), 
ischemic stroke and neurodegeneration (Lee et al., 1991, Rami and Krieglstein, 
1993, Hong et al., 1994, Bartus et al., 1995b). It has also been reported that 
knockdown of calpain II (m-calpain) increased survival of primary hippocampal 
neurons following NMDA excitotoxicity (Bevers et al., 2009). Importantly, 
previous studies did not fully address the question under which cell death 
conditions calpain inhibition is ncuroprotective, and when in the cell death 
cascade calpains became activated. In the present study, we demonstrate that 
calpains are specifically involved in excitotoxic apoptosis. While treatment with 
calpeptin failed to show any significant protection in neurons undergoing ICD, it 
provided a long-term protection in neurons undergoing DCD/excitotoxic 
apoptosis (Fig. 3.5 - 3.6). These findings were confirmed using genetic 
approaches, including gene silencing of calpain and overexpression of the 
endogenous inhibitor calpastatin (Fig. 3.8 - 3.9). Western blot data also 
suggested that under conditions that favour ICD, calpain-specific spectrin 
proteolysis was not significantly elevated, while neurons exposed to conditions 
that favour DCD showed significant calpain activation (Fig. 3.5 - 3.6).
In summary, our data suggest that, surprisingly calpains do not contribute to
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excitotoxic injury under conditions that are associated with immediate Ca2+ 
deregulation (ICD) and excitotoxic necrosis. Moreover, using pharmacological 
and genetic approaches, we demonstrate that calpains rather play a critical role in 
excitotoxic apoptosis.
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CHAPTER IV
Calpain activation mediates 
excitotoxic apoptosis but does not 
contribute to excitotoxic necrosis
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2_|_ ,The Ca -dependent calpain proteases play an unquestionable role in neuronal 
injury. However, the mechanism of calpain activation is incompletely 
characterised and not yet understood. In vitro, the well-known members of the 
family, |i- (calpain I) and m-calpain (calpain II) are both activated, in response 
of different increases in the cellular Ca2+ level (|iM and mM concentrations, 
respectively) (Goll et al., 2003). Furthermore, the mechanism that tightly 
regulates calpain activity in response to transient influx of calcium is the 
constitutive expression of its endogenous inhibitor, calpastatin (Goll et al., 2003, 
Rami, 2003). In previous results, we have demonstrated that the synthetic calpain 
inhibitor calpeptin, knockdown of calpain I and II and overexpression of 
calpastatin raised the hypothesis that calpain may play a predominant role during 
excitotoxic apoptosis, rather than excitotoxic necrosis. Analysis of the calcium 
responses led us to a designated classification which suggested that NMDA- 
mediated exitotoxic apoptosis induces predominantly delayed calcium 
deregulation (DCD) and NMDA-mediated excitotoxic necrosis induces mainly 
immediate calcium deregulation (ICD). Excitotoxicity has been associated with 
loss of mitochondrial membrane potential and DCD in many models which 
mimic neurological disorders using different stimuli and brain tissues (Tymianski 
et al., 1993, Castilho et al., 1998, Nicholls et al., 1999). DCD is considered a 
predictor of cell death, as it is a point of no-retum for neurons undergoing 
excitotoxic injury, characterised by irreversible loss of intracellular calcium 
homeostasis (Nicholls, 2004). Understanding the events that contribute to DCD 
is a central unresolved matter and could prove beneficial for therapeutic 
intervention as neuronal survival following excitotoxicity is directly related to
4.1 Introduction
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In this study, we investigated on the sequence of events that lead to excitotoxic 
neuronal death with particular interest on calpain activation and its relationship 
with mitochondrial membrane potential depolarisation and DCD.
4.2 Results
4.2.1 Characterisation of the calpain-sensitive FRET probe
Our experiments demonstrated a functional role for calpains during delayed 
excitotoxic apoptosis, however, precise information on the kinetics of calpain 
activation during cell death cascade remained unknown. To provide 
spatiotemporal information on calpain activation and its relationship to cell death 
during excitotoxic injury, Courtney MJ group (University of Eastern Finland, 
Kuopio, Finland) designed a calpain-sensitive Forster resonance energy transfer 
(FRET) probe and monitored calpain activation dynamics by time-lapse 
fluorescence microscopy. The calpain-sensitive FRET probe, comprising of CFP 
and Venus as FRET donor and acceptor, respectively, and an 18 amino acid 
linker that incorporated the QQEVYG calpain-cleavage site of spectrin, was 
prepared as described in details in the materials and methods chapter. The intact 
FRET probe was anchored to the plasma membrane by a CAAX targeting 
sequence. An energy transfer between two fluorescently labelled proteins, in 
which excitation is transferred from a donor molecule to an acceptor molecule, 
occurs only when the fluorescent molecules are in close proximity to one 
another. When they move apart, this energy transfer is disrupted. In our
the onset of DCD.
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experiments, upon calpain activation, FRET probe cleavage of the linker peptide 
results in FRET disruption, as the Venus fluorophore is no longer in close 
proximity to CFP fluorophore. This results in a FRET decrease and a parallel 
CFP fluorescence increase, which can be detected by confocal time-lapse 
microscopy (Fig. 4.1 A).
To confirm that the FRET probe was reporting calpain cleavage, we transfected 
human neuroblastoma SH-SY5Y cells with the FRET probe. After 36 h, the cells 
were exposed to ionomycin (5 pM) and CaC^ (10 mM), a treatment that results 
in significant and rapid calpain activation in SH-SY5Y cells (Reimertz et al., 
2001). Western blot analysis of cytosolic extracts demonstrated that endogenous 
full length-spcctrin was cleaved with similar kinetics than the intact FRET probe 
(detected using a GFP-antibody) upon addition of ionomycin and CaCl2 . 
Moreover, we detected a similar increase in the accumulation of the 145 kDa 
calpain-spectrin cleavage product and the cleaved FRET probe (Fig. 4.1 B; left 
panel). Cleavage of the FRET probe was also sensitive to a treatment with 
calpeptin (Fig. 4.1 B, right panel).
To explore the calpain-sensitive FRET probe efficiency, we next performed 
acceptor photobleaching experiments in control neurons. Neurons transiently 
transfected with the FRET probe, were monitored over time on the LSM 5 live 
duoscan. After establishment of a baseline, repeated bleaching steps of the 
acceptor fluorophore Venus were recorded (Fig. 4.2 A, YFP). The absolute 
fluorescence values for CFP and YFP for a single cell were plotted as a function 
of time (Fig. 4.2 B). Using similar image acquisition settings as in the following 
time-lapse experiments, a quantitative analysis of acceptor photobleaching 
showed a clear detection of donor (CFP) unquenching, which coincided with a
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marked decrease in the acceptor fluorescence (YFP). Upon bleaching, the 
acceptor is incapable of accepting energy transfer from the donor, hence the 
unquenching was completed after 5 consecutive bleaching steps, as indicated in 
figure 4.2 B.
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Figure 4.1: FRET-based single cell analysis of calpain activity. (A) The
calpain-sensitive FRET probe consisted of CFP and Venus fluorophores linked 
together by a region containing the calpain-substrate spectrin sequence. The 
Venus fluorophore is fused to a CAAX motif. Upon cleavage of the spectrin 
linker, the FRET between CFP and Venus is disrupted. This results in decreased 
FRET fluorescent intensity, and increased CFP fluorescent intensity. CFP is 
excited at 405 nm, CFP emission is detected at 470-500 run, and FRET emission 
is collected at 505-550 nm. (B) FRET probe expression and cleavage in vitro 
was validated by Western blotting in SH-SY5Y cells using an anti-GFP antibody. 
After FRET-probe transfection, the cells were treated with ionomycin (5 pM) 
and CaCl2 (10 mM) for the indicated times in the presence (+) or the absence (-) 
of calpeptin. p actin was used as loading control. BP, Breakdown product; CL, 
cleavage; FL, full-length.
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Figure 4.2: Acceptor photobleaching experiments confirm the sensitivity of 
the calpain-sensitive FRET probe. (A, B) The Venus bleaching and correlating 
CFP unquenching kinetics were performed on the LSM 51ive duoscan in control 
neurons transfected with the FRET probe. In A, corresponding time-frame 
images of the cell are illustrated. Bleached region, used to calculate the average 
intensity kinetics, is indicated in red and segmented for the cell area using the 
CFP channel. Scale bar = 10 pm. Quantitative analysis of CFP and YFP 
fluorescence following the bleaching of Venus (B). From the fifth scan onwards 
each scan of a time series was followed by a bleach scan at high laser power at 
488 nm and 514 nm, as indicated by red triangles.
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We previously demonstrated that the 100 uM/5 min NMDA treatment favours 
the induction of delayed excitotoxic apoptosis (see figure 3.2, chapter III) and the 
300 |jM/60 min NMDA treatment favours immediate Ca2+ deregulation (see 
figure 3.3, chapter III). Moreover, via pharmacological and genetic approaches, 
we showed that excitotoxic apoptosis is associated with calpain activation, while 
excitotoxic necrosis did not display such an activity. In order to confirm these 
data and having established that the FRET probe was functional and reported 
calpain activity, we transfected the calpain-sensitive FRET probe into cortical 
neurons and exposed them to NMDA. Becausc ICD and DCD were associated 
with mitochondrial membrane potential depolarisation, we detected in parallel 
changes in mitochondrial membrane potential using the potentiometric probe, 
TMRM, which operated as our indicator of mitochondrial outer membrane 
permeabilisation (MOMP). After at least 24 h probe transfection, neurons were 
loaded with TMRM (20 nM) and placed on the stage of LSM 51ive duoscan 
confocal microscope. Following 100 |iM/5 min NMDA stimulation, cortical 
neurons were monitored over time for changes in FRET, CFP, YFP and TMRM 
fluorescences. Analysis of the FRET probe kinetics disruption in relation to the 
loss of Ay/m was carried out. Interestingly, in neurons that showed a delayed 
excitotoxic apoptosis, we detected significant FRET probe cleavage. However, 
this occurred always subsequent to the delayed mitochondrial depolarisation 
(Fig. 4.3 A, B), within a period of 42 ± 8 min (Fig. 4.3 C). This suggested that 
calpains were predominantly activated during the execution phase of delayed 
excitotoxic apoptosis. Calpain activity lasted on average 58 ± 13 min. Onset of 
cell death, detected by the sudden loss of cytosolic CFP fluorescence due to
4.2.2 Calpain activation occurs late during excitotoxic apoptosis
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plasma membrane leakage, occurred always after onset of the FRET probe 
cleavage, and with an average delay of 96 ± 8 min (Fig. 4.3 C). All traces were 
normalised to the baseline response, processed and analyzed using MetaMorph 
Software version 7.5, and given as CFP/FRET which serves as an internal 
standard for changes in the dynamics of the fluorescent signal obtained. All 
microscope settings including laser intensity and scan time were kept constant 
for the whole set of experiments.
In parallel experiments, cortical neurons were treated with 300 pM NMD A for 
60 min and monitored over a 4 h time period. On the contrary, analysis of 
TMRM and FRET dynamics revealed that neurons displaying an immediate 
excitotoxic necrosis did not show significant FRET probe cleavage either before 
or during ICD (Fig. 4.4 A, B). Analysis of all cells monitored and classified 
according to their type of response (tolerant, DCD or ICD) revealed that calpain 
FRET probe cleavage was selectively detected in cells that showed DCD (Fig.
4.4 C). In contrast, neither tolerant cells nor cells undergoing ICD showed a 
detectable FRET probe cleavage.
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Figure 4.3: Calpain activation is selectively associated with excitotoxic 
apoptosis. (A, B) Cortical neurons were transfected with the calpain-sensitive 
FRET probe and after 24 h mounted on the stage of a LSM 5Live duoscan. 
Neurons were then treated with 100 pM NMDA for 5 min and assayed over 24 h. 
Fluorescent measurements were recorded for TMRM, FRET, CFP and YFP by 
time-lapse confocal microscope. FRET probe imaging data are expressed as a 
ratio of CFP/FRET. TMRM was used as a Ay/m indicator (non-quenched mode). 
In neurons that showed a delayed excitotoxic apoptosis (A), we observed 
significant calpain activation (FRET probe cleavage) subsequent to delayed Ay/m 
depolarisation. The onset of these events (in red and green) and cell death (in 
black) is indicated by arrows (A) and representative time-frame images are 
illustrated (B, pseudocolored CFP/FRET emission ratio and red, TMRM 
images). Scale bar = 1 0  p.m. (C) Analysis of FRET probe cleavage and its 
relation to cellular outcome in cells treated with 100 (xM NMDA for 5 min. Data 
shown represents the mean time taken between the onset of FRET probe 
disruption and onset of Ay/m loss; the mean time taken for complete probe 
cleavage, and the mean time taken between onset of FRET probe cleavage and 
onset of cellular collapse. Data were obtained from 18 separate experiments from 
11 independent cultures (n = 22 neurons).
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Figure 4.4: Calpains do not contribute to excitotoxic necrosis. (A, B) Neurons 
transfected with the calpain-sensitive FRET probe, were treated with 300 pM 
NMDA and assayed over 4 h. Fluorescent measurements were recorded for 
TMRM, FRET, CFP and YFP by time-lapse confocal microscope. FRET probe 
imaging data are expressed as a ratio of CFP/FRET. TMRM was used as a Ay/m 
indicator in the non-quenched mode. In neurons that showed an immediate 
excitotoxic ICD/necrosis, no significant FRET cleavage was observed. The onset 
of these events (in red and green) and cell death (in black) is indicated by arrows 
(A) and representative time-frame images are illustrated (B, pseudocolored 
CFP/FRET emission ratio and red, TMRM images). Scale bar = 1 0  pm. (C) 
Quantification of the number of cells in 100 pM NMD A/5 min treated neurons 
with FRET probe disruption (in black, total number of cells; in grey, cells with 
FRET probe disruption). Neurons were classified according to their type of 
cellular response (DCD, Tolerance, ICD). Data were obtained from 18 separate 
experiments from 11 independent cultures (n = 47 neurons).
124
i
4.2.3 The Ca2+chelator BAPTA-AM leads to significant delay in DCD and 
calpain activation
Hours after the initial overactivation of NMDA receptors, late mitochondrial 
membrane depolarisation occurs followed by a secondary irreversible cytoplamic 
Ca2+ influx, DCD. Having identified that calpains play a selective role during the 
execution stage of excitotoxic cell death, we next investigated whether DCD was 
a trigger for calpain activation in this system. In order to buffer the cytosolic free 
calcium within the cells, we employed the Ca21 chelator, l,2-bis-(o- 
aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid, tetraacetoxymethyl ester 
(BAPTA-AM). BAPTA-AM is a non-fluorescent membrane-permeable chelator 
used to clamp intracellular calcium. It has been shown that BAPTA-AM is 
neuroprotective against excitotoxicity and is more selective and faster compared 
to other Ca2' chelators, such as EGTA and EDTA (Tymianski et al, 1994).
Excitotoxic injury was induced in cortical neurons by an exposure to 100 (iM 
NMDA for 5 min. BAPTA-AM was added on the confocal microscope stage 4 
hours after termination of the NMDA exposure (BAPTA-AM post; Fig. 4.5 A, 
B), prior to delayed calcium deregulation and calpain activation in this model 
(see figure 3.2 and figure 3.5, chapter III). To determine the optimal BAPTA- 
AM concentration, we performed a dose response experiment where cortical 
neurons were either exposed to 500 nM, 5 pM or 10 |iM BAPTA-AM. Analysis 
of the onset of Ay/m depolarisation using TMRM-based confocal fluorescence 
microscopy showed that high concentrations of BAPTA-AM (5 uM or 10 |iM) 
were too cytotoxic, as cell death occurred 5 hours after initiation of the 
experiment (Fig. 4.5 C).
125
NMDA(IOOpM)
*
BAPTA-AM
(PQStj
Time of recovery
30 min 5 min^  4 h 
MK-801B
il600i 
§1200' 
8 800o3
5=
13
¡Z
NMDA
-  Fluo4
BAPTA-AM
— r ~ L
200 400 "600 800 ’
Time (min) 
onset of loss
24 h
Figure 4.5: Dose response assay reveals the optimal concentration of 
BAPTA-AM, 500 nM. (A) A schematic of the BAPTA-AM post NMDA (100 
pM for 5 min) excitotoxic model. Murine cortical neurons cultured in Willco 
dishes were loaded with TMRM (20 nM) and Fluo-4 AM (3 pM) for 30 min at 
37°C before being mounted on a thermostatic chamber of a confocal microscope 
(LSM 510 Meta). A 30 min baseline is performed to equilibrate to environmental 
conditions. Neurons were then exposed to 100 pM NMDA for 5 min, after which 
the NMDA open channel blocker MK-801 (5 pM) is added to stop the insult. 
Four hours after the termination of the NMDA stimulation, BAPTA-AM was 
added (500 nM, 5 pM or 10 pM) and cells were monitored over 24 h. (B) 
Representative trace measuring alterations in cytosolic calcium ions (Fluo-4 
AM), following NMDA and BAPTA-AM addition (indicated). The aim of using 
the Ca2+chelator BAPTA-AM post NMDA addition is to decrease or delay DCD. 
(C) Onset of Ayjm loss for control neurons treated with 100 pM NMDA for 5 min 
in the absence (control, n = 29 neurons) or the presence of BAPTA-AM in 
concentration of 500 nM, 5 pM or 10 pM (n = 16; n = 19; n = 19 neurons 
respectively).
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However, 500 nM BAPTA-AM did not expedite or produce any considerable 
delay in the onset of the Ai//m loss compared to the control neurons, therefore 
further experiments were performed using this concentration.
Simultaneously, to exclude the hypothesis that the initial influx of calcium during 
NMDA receptor overactivation was also a trigger for calpain activation, we 
treated mouse cortical cultures with 500 nM BAPTA-AM, prior to NMDA 
stimulation (BAPTA-AM pre; Fig. 4.6 A, B).
We next compared the kinetics of mitochondrial membrane potential 
depolarisation and delayed calcium deregulation between the treatments 
(BAPTA-AM pre, post and control) using TMRM and Fluo4-based confocal 
microscopy. The onset of injury occurred over the course of the experiment 
(onset of A(//In loss), the mean time taken from the point where the Ai//m deviated 
significantly from its polarised state to the point where complete depolarisation 
(duration of A<//m loss) and the onset of delayed calcium deregulation (onset of 
DCD) were quantified (Fig. 4.7). Cortical neurons pre or post-treated with 
BAPTA-AM showed a greater onset of Ay/m loss, however, overall this was not 
significant (Fig. 4.7 A). In contrast, BAPTA-AM added post-NMDA exposure 
exhibited a considerable delay in the onset of DCD (Fig. 4.7 B), suggesting that 
calpains might be involved in this event.
Furthermore, in cells in the presence of BAPTA-AM pre or post excitotoxic 
treatment, the duration of Ay/m loss was significantly greater than in the control 
neurons (Fig. 4.7 C), indicating that the calcium buffering may affect the 
mechanism through which those neurons lose mitochondrial membrane potential.
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Figure 4.6: Alternative calcium buffering using BAPTA-AM. (A) A
schematic of the BAPTA-AM pre NMDA (100 pM for 5 min) excitotoxic model. 
Cortical neurons were loaded with TMRM and Fluo-4 AM and monitored on 
LSM 510 Meta confocal microscope. A 30 min baseline is performed to 
equilibrate to environmental conditions after which BAPTA-AM (500 nM) was 
added into the experimental medium. Neurons were then exposed to 100 pM 
NMDA for 5 min and allowed to recover for a 24 h time period. (B) 
Representative trace measuring alterations in cytosolic calcium ions (Fluo-4 
AM), following BAPTA-AM and then NMDA addition (indicated). The aim of 
using the Ca2+ chelator BAPTA-AM pre NMDA addition is to decrease or delay 
the initial calcium influx during NMDA exposure.
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Figure 4.7: The Ca2+ chelator BAPTA-AM postpones delayed calcium 
deregulation. (A, B, C) Cortical neurons were exposed to 100 (iM NMD A for 5
min and the Ca2+ chelator BAPTA-AM (500 nM) was added on stage either 30 
min before or 4 hours after NMDA exposure. Alterations in Ai//m and 
intracellular Ca2+ were monitored in single cells using confocal fluorescence 
microscopy. Onset of Ai//m loss (A), onset of DCD (B) and duration of Ai//m loss 
(C) was analyzed in neurons in the absence (control, n = 29 neurons) or the 
presence of BAPTA-AM pre (n = 18 neurons) or post (n = 19 neurons) NMDA 
addition. * p < 0.05 compared to NMDA-treated control (ANOVA, post-hoc 
Tukey).
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To explore whether the substantially delayed onset of DCD in the presence of 
BAPTA-AM had any relationship to calpain activation, we next performed 
imaging experiment using the calpain-sensitive FRET probe in this system. 
Murine cortical neurons transfected with the FRET probe were exposed to 100 
|iM NMDA for 5 min and BAPTA-AM (500 nM) was added 4 hours after 
termination of the NMDA exposure. Analysis of the kinetics of mitochondrial 
membrane potential depolarisation in relation to FRET probe cleavage (Fig. 4.8 
A, B) revealed that BAPTA-AM produced a robust delay in the onset of the 
probe cleavage compared to NMDA-exposed control neurons (Fig. 4.8 C).
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Figure 4.8: The Ca2+ chelator BAPTA-AM delays calpain activation. (A, B,
C) Cortical neurons transfected with the calpain-sensitive FRET probe were 
mounted on the stage of a LSM 5Live duoscan, and treated with 100 |iM NMD A 
for 5 min. Four hours after NMDA exposure, BAPTA-AM was added on stage 
and neurons were assayed over 24 h. Fluorescent measurements were recorded 
for TMRM, FRET, CFP and YFP by time-lapse confocal microscope. 
Representative traces measuring alterations in Ay/m (TMRM; A) and FRET probe 
(CFP/FRET; B) following NMDA and then BAPTA-AM addition (indicated). 
Significant calpain activation (FRET probe cleavage) subsequent to delayed Ay/„, 
depolarisation is observed, which is delayed in the presence of BAPTA-AM (C). 
The onset of the FRET probe cleavage was analyzed in transfected neurons in the 
absence (control, n = 11 neurons) or in the presence of BAPTA-AM (n = 11 
neurons). * p < 0.05 compared to NMDA-treated control neurons (ANOVA, 
post-hoc Tukey).
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In the present study, we have set out to characterise the role of calpains in 
response to transient and prolonged glutamate receptor overactivation in mouse 
neocortical neurons. In agreement with our previous findings (results, chapter 
III), our data here suggest that, surprisingly calpains do not play a role in neurons 
that undergo immediate Ca2+ deregulation (ICD) and NMDA-mediated 
excitotoxic necrosis (Fig. 4.4). On the contrary, we demonstrate that calpains are 
specifically activated in neurons that undergo delayed calcium deregulation 
(DCD) and NMDA-induced excitotoxic apoptosis and are therefore activated as 
cell death effectors during the execution stage (Fig. 4.3).
Importantly, previous studies did not fully address the question of when calpains 
became activated during the cell death cascade. To identify the spatiotemporal 
profile of calpain activation during NMDA-induced excitotoxic cell death, we 
monitored their activation dynamics by time-lapse confocal microscopy using a 
calpain-sensitive FRET probe (Fig. 4.1). The sensitivity of the FRET probe was 
initially assessed by Western blotting and acceptor photobleaching experiments 
(Fig. 4.1 - 4.2). Subsequently, the biochemical data provided in the previous 
results chapter was confirmed by single cell imaging experiments. The FRET 
probe imaging data showed that no significant cleavage of the calpain-sensitive 
FRET probe was detected in the soma of neurons that underwent ICD, while 
neurons undergoing DCD showed a full-blown calpain activity (Fig. 4.3 - 4.4). 
Furthermore, under conditions that favour DCD, calpain activity was detected 
subsequent to the late mitochondrial depolarisation (Fig. 4.3).
These data bring up the question of why ICD did not trigger prominent calpain 
activation on neuronal somata despite the very significant increase in cytosolic
4.3 Discussion
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Ca2+. A prolonged glutamate excitation is characterised by a rapid collapse of 
cellular bioenergetics and rapid ATP depletion (Tymianski et al., 1993, 
Ankarcrona et al., 1995, Budd and Nicholls, 1996, Vergun et al., 1999, Luetjens 
et al., 2000, Ward et al., 2007). It is possible that the activation of calpains 
requires an energy-dependent process and a substantial amount of ATP to be 
present. Alternatively, ICD-associated membrane rupture and cell death may 
occur too rapidly to allow for a controlled calpain activation. We cannot exclude 
that calpains were still activated locally and in defined structures such as 
dendrites, or were activated at undetectable levels. However, our data 
demonstrate that such an activity did not contribute to cell death in neurons that 
underwent ICD. In the present study our data suggested that, analysis of the onset 
of Ay/m depolarisation and DCD using TMRM and Fluo-4-based confocal 
fluorescence microscopy showed that BAPTA-AM did not produce a 
considerable delay in the onset of the Ay/m loss (Fig.7E), but resulted in a 
significant delay in DCD (Fig. 7F).
Our calpain-FRET imaging data support such a hypothesis: activation of calpains 
occurred downstream of At//m depolarisation and with a delay similar to that of 
DCD (Fig. 3.2 chapter III - Fig. 4.3 chapter IV). Furthermore, delayed 
application of the Ca2+ chelator BAPTA-AM post-NMDA exposure led to 
significant delay in DCD and calpain activation (Fig. 4.7 - 4.8). However, this 
does not rule out a possible contribution of other factors, such as growth factor- 
and MAPK-dependent calpain activation (Zadran et al., 2010). As other neuronal 
apoptosis paradigms do not induce a similar mitochondrial Ca2+ overloading, 
activation of calpains may be less pronounced or absent (Lankiewicz et al.,
2000). Once activated, calpains inhibit the ability of cytochrome-c to activate
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caspases by cleavage of procaspase-3 and -9, as well as APAF-1 (Chua et al.,
2000, Lankiewicz et al., 2000, Reimertz et al., 2001). As a consequence, 
caspase-independent excitotoxic apoptosis ensues, that is mediated by calpains. 
Calpains cleave a variety of proteins that are required for neuronal function, 
including cytoskeletal proteins, transcription factors and also their specific 
endogenous inhibitor, calpastatin (Croall and DeMartino, 1991, Blomgren et al., 
1999). Calpains also process and trigger AIF release from mitochondria, and may 
thereby induce cell death (Cregan et a l, 2002, Wang et al., 2004, Cao et a l, 
2007). Calpains may also further increase neuronal Ca2 overloading by cleavage 
and inactivatation of the Na+/Ca2+ exchanger (Bano et a l, 2005). Indeed, the 
overexpression of calpastatin or of a non-cleavable Na+/Ca2+ exchanger has been 
shown to inhibit DCD during excitotoxic neuronal injury (Bano et al., 2005). 
Activation of calpains may therefore initiate a self-amplifying Ca2+-dependent 
cell death cascade eventually resulting in the destruction of the neuron.
In conclusion, the results of this chapter further demonstrate that calpains play a 
critical role in excitotoxic apoptosis but contribute little to the destruction of 
neuron during excitotoxic necrosis and that they are activated downstream of 
mitochondrial engagement. This mechanism may be of particular importance for 
the treatment of neuronal injury associated with sub-maximal glutamate receptor 
overactivation as evident in the ischemic penumbra or during chronic 
neurodegeneration.
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CHAPTER V
Investigation on the role of the 
BH3-only proteins, Bid and Bint, 
in promoting calpain-dependent 
excitotoxic neuronal death
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5.1 Introduction
The mitochondrial apoptosis pathway is controlled by pro- and anti-apoptotic 
Bcl-2 family proteins, with either overexpression of anti-apoptotic bcl-2 or bcl- 
xL, or gene deficiency in the pro-apoptotic bax or bim genes to prevent 
excitotoxic apoptosis (Xiang et al., 1998, Wang et al., 2004, Dietz et al., 2007, 
Semenova et al., 2007, Concannon et al., 2010). In most cells, the key event in 
the mitochondrial pathway is the release of pro-apoptotic factors, including 
cytochrome-c (cyt-c), second mitochondria-derived activator of caspase/direct 
IAP binding protein with low pi (Smac/DIABLO) and apoptosis-inducing factor 
(AIF), from the mitochondrial intermembrane space into the cytoplasm (Green 
and Kroemer, 2004). These factors may trigger caspase-dependent or caspase- 
independent cell death. Cyt-c and Smac/DIABLO allow the formation of the 
apoptosome and by binding to apoptotic protease-activating factor-1 (APAF-1), 
they activate a family of cytosolic cysteine proteases, the caspases (Liu et al., 
1996, Zou et al., 1997). Increasing evidence suggests that AIF translocates to the 
nucleus of neurons that undergo DNA fragmentation and condensation and plays 
a crucial role in glutamate-induccd neuronal death and injured adult brain 
(Plesnila et al., 2004, Culmsee et al., 2005, Landshamer et al., 2008, Slemmer et 
al, 2008). Bcl-2 homology domain (BH) 3-only proteins promote the activation 
of Bax and Bak, which are believed to be essential for pore formation on the 
outer mitochondrial membrane allowing the release of these intermembrane 
proteins (Kuwana et al., 2002). The BH3-only protein Bid has been implicated in 
oxygen/glucose deprivation (OGD) in vitro where Bid knockout neurons 
displayed attenuated caspase activation and neuroprotection against OGD- 
induced cell death and in vivo, where infarct volume and cyt-c release were
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significantly reduced following middle cerebral artery occlusion (MCAO) 
(Plesnila et al., 2001). Bid is involved in the so-called extrinsic apoptosis 
pathway and is proteolytically activated by caspase-8 to generate a truncated 
form (tBid) (Li et a l, 1998a, Luo et a l, 1998). It has also been suggested that 
calpain-mediated cleavage of Bid generates Bid fragments that -similar to tBid- 
may activate the mitochondrial apoptosis pathway (Chen et a l, 2001, Polster et 
al., 2005).
The pro-apoptotic BH3-only protein Bim has been implicated in stroke related 
disease models, such as MCAO, in which increased mitochondrial localisation of 
Bim was reported 3 to 6 hours of MCAO (Shibata et al., 2002). It has also been 
shown that Bim knockdown in neurons confers protection against ischemia- 
induced cell injury and other excitotoxic insults (Meller et al., 2006, Murphy et 
al, 2010). Other studies identified that Bim is an essential mediator for the 
initiation of NMDA-induced excitotoxic cell death and that prolonged AMPK 
activation is associated with the transcriptional induction of Bim and activation 
of Bcl-2-regulated apoptosis (Concannon et al., 2010).
The identification of the BH3-only proteins as principal players in stroke related 
injury models of neuronal death, their involvement in caspase-independent 
pathways and the suggestion that clcavage of FL-Bid after its translocation to the 
mitochondria may involve alternative proteases, such as calpains, led us to 
investigate the mechanisms of excitotoxic injury with a focus on the main BH3- 
only proteins, Bid and Bim in relation to calpain activity.
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5.2 Results
In order to investigate whether the BH3-only proteins are induced in NMDA- 
mediated excitotoxicity and if calpain acted on them to promote cell death, we 
first employed ¿/¿/-deficient mice. One possibility was that calpains activated the 
pro-apoptotic Bcl-2 family of the BH-3 domain-only proteins. Bid may represent 
a prominent candidate for such an activity. To determine the extent of cell death 
in our NMDA models, cortical neurons from ¿/¿/-deficient mice were compared 
to their wild-type counterpart neurons following NMDA exposure. Neurons were 
initially exposed to 30 (xM NMDA for 5 min and allowed to recover in the 
incubator for given time points (Sham, 2, 4, 8, 16 and 24 hours). At each time 
point post NMDA excitation or sham conditions, neuronal injury was determined 
by Hoechst 33258 and PI staining and images were acquired using an 
epifluorescence microscope and a CCD camera. PI positive cells were quantified 
as dead neurons and expressed as a percentage of the total population. We 
determined that cortical neurons from ¿/¿/-deficient mice were equally sensitive 
to NMDA-induced neuronal tolerance as wild-type neurons (Fig. 5.1).
We next explored the extent of cell death in NMDA-induced excitotoxic 
apoptosis and whether calpain played a role on Bid to promote this mode of cell 
death. Neocortical neurons derived from wild-type and ¿/¿/-deficient mice were 
pretreated with the selective calpain inhibitor calpeptin (20 |xM) for 2 h and then 
exposed to 100 jxM NMDA for 5 min. After NMDA exposure, the excitation 
medium was replaced with the conditioning culture medium in the presence or 
the absence of calpeptin and, the cells were allowed to recover in the incubator
5.2.1 Calpain-mediated excitotoxic cell death did not show a bid requirement
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for set time points (Sham, 2, 4, 8, 16 hours). At each time point, cell death was 
assessed by Hoechst 33258 staining and quantification of PI uptake. We did not 
detect any alterations in cell death following delayed apoptotic excitotoxicity in 
gene-targeted bidA compared to their wild type counterparts, but interestingly, 
calpeptin also exerted significant neuroprotection in ¿«/-deficient neurons, 
indicating that calpains were not acting on Bid to promote apoptotic cell death 
(Fig. 5.2).
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Figure 5.1: Cortical neurons lacking Bid are not protected from NMDA- 
induced neuronal tolerance. (A) Representative standard PCR analysis of 
genomic DNA shows indicated strain and expected PCR bands sizes for bid 
genotyping. DNA was extracted from tail snips using High Pure PCR Template 
Preparation Kit. M: 100 bp ladder; NC: negative control without the tail DNA 
template. Genotyping was performed using three specific primers for wild type, 
mutant and common allele-specific. (B) Neocortical neurons from bidA mice and 
WT controls were treated with 30 fiM NMD A for 5 min over 24 h or sham 
conditions for 5 min and allowed to recover as indicated. Cell death was assessed 
by Hoechst and PI staining and the results were quantified as a percentage of 
total neurons in the field. Each field contained approx 300-400 neurons, 3 fields 
were captured per well and at least 3 wells were analysed per time point. Means 
± SEM are shown. * p < 0.05 compared to NMDA-treated WT controls 
(ANOVA, post-hoc Tukey). (C) Representative images of the merged image of 
PI and Hoechst stained neurons exposed to sham conditions or 30 |xM NMD A 
for 5 min. Images of sham and 24 h post NMDA excitation neurons for each 
genotype are shown. Scale bar = 5 pm.
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Figure 5.2: Cortical neurons lacking Bid are protected from NMDA-induced 
excitotoxic apoptosis only in the presence of calpain inhibitor calpeptin. (A)
Neocortical neurons from bid1' mice and WT controls were exposed to 100 (xM 
NMDA for 5 min and allowed to recover up to 16 h or sham conditions for 5 min 
in the presence or the absence of the specific calpain inhibitor calpeptin. Cell 
death was assessed by Hoechst and PI staining and the results were quantified as 
a percentage of total neurons in the field. Three subfields containing 300-400 
neurons each were captured and at least 3 wells were analyzed per time point. 
Means ± SEM are shown. * p < 0.05 compared to NMDA-treated WT controls. # 
p < 0.05 compared with NMDA-treated knockout controls (ANOVA, post-hoc 
Tukey). (B) Representative images of the merged image of PI and Hoechst 
stained neurons exposed to sham conditions or 100 fxM NMDA for 5 min. 
Images of sham and 16 h post NMDA excitation neurons for each genotype and 
treatment are shown. Scale bar = 5 ^m.
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5.2.2 Immediate excitotoxic necrosis may require a functional bid gene
In order to more precisely verify whether the injury observed at population level 
was reflected in single cell level microscopy studies, neocortical neurons were
94-monitored in real time for changes in Ai//m and intracellular Ca .
Our and previous studies have associated excitotoxicity with DCD, 
mitochondrial membrane potential depolarisation and MOMP (Ankarcrona et al., 
1995, Budd et al., 2000, Luetjens et a l, 2000, Ward et al., 2000, Wang et al., 
2004, Ward et al., 2006). We investigated whether the loss of Bid expression 
modulated these events, turning our attention towards the characterisation of 
mitochondrial function, the kinetics of A¡//m loss and the cell responses between 
wild type and bid1' genotypes.
Quantification of the individual Ca2+responses following 100 pM/5 min NMDA 
exposure showed comparable neuronal tolerance and DCD responses between 
wild-type controls and ¿/¿/-deficient neurons (Fig. 5.3 A). Of note, bid gene 
deletion led to a significant reduction in ICD responses after the NMDA 
stimulation, suggesting a potential participation of Bid in this mode of neuronal 
death.
Analysis of the onset of At//m depolarisation using TMRM-based confocal 
fluorescence microscopy showed that bid gene deletion produced a considerable 
delay in the time to onset of Ai//m loss compared to the wild-type controls (Fig.
5.3 B). Because genetic deletions can result in aberrant phenotypes, such as 
alteration in NMDA receptor constitution and the extent and/or the duration of 
the excitotoxic insult, we examined whether bid gene deletion could have 
affected the acute calcium influx at point of NMDA stimulation.
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Figure 5.3: Bid may be required for immediate calcium deregulation cell 
death modes. Wild type and ¿/¿/-deficient cortical neurons cultured separately on 
Willco dishes were loaded with TMRM and Fluo-4 AM for 30 min at 37°C 
before being mounted on a thermostatic chamber of a confocal microscope (LSM 
510 Meta). Neurons were exposed to 100 pM NMDA for 5 min after which 
alterations in Ay/m and intracellular Ca2+ were monitored in single cells over a 24 
h period. (A) Neurons were classified according to their type of cellular response 
(Tolerance, DCD, ICD) and quantification of the three neuronal responses for the 
injury model for WT (n = 275 cells) and ¿/¿/-deficient neurons (n = 331 cells) 
was carried out. Data are means ± SEM from at least n = 3 independent 
experiments. (B) Onset of Ay/m loss was analyzed in WT (n = 56) or ¿/¿/-deficient 
neurons (n = 64). * p < 0.05 compared to NMDA-treated WT controls (ANOVA, 
post-hoc Tukey).
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This approach was previously used in our laboratory to investigate whether the 
SERCA-ATPase pump inhibitor thapsigargin was affecting transient glutamate 
receptor activation in comparison to control neurons (Concannon et al., 2008) 
and to examine how bim gene deletion was influencing NMDA-induced cell 
death (Concannon et al., 2010).
Real time imaging experiments demonstrated that the initial Ca2+ responses in 
¿/¿/-deficient neurons during 100 |iM/5 min NMDA exposure were significantly 
lower that their wild-type counterparts (Fig. 5.4 A, B). The Ca2+ response peak 
for each cell and genotype was measured and quantified (Fig. 5.4 C). Peak 
intensities were normalised to baseline response to account for any differences in 
basal calcium levels or loading between neurons. The route of calcium loading 
into the cells may influence neuronal fate, therefore we might consider that the 
decreased ICD response obtained in response to excitotoxic apoptosis (see figure
5.3 A), can be explained with the hypothesis that bid gene deletion has an effect 
on neuronal Ca2+handling.
Furthermore, quantification of PI positive cells undergoing prolonged exposure 
of 300 p.M NMDA for 60 min indicated that ¿/¿/-deficient neurons were 
significantly protective at 2 hours post NMDA insult, but not at later time points, 
suggesting that Bid may play a role during ICD (Fig. 5.5).
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Figure 5.4: Initial calcium responses during N M D A  exposure result lower in 
bidf’ neurons compared to their WT counterparts. (A, B) Representative 
traces of NMDA treated wild type and bid1' cortical neurons depicting the extent 
of peak calcium influx at point of stimulation (100 (J.M/5 min NMDA). (C) 
Quantification of the peak calcium influx between the genotypes (n= 56 and 64 
neurons for WT and bid/_ respectively). Data are means ± SEM from at least 3 
independent experiments for each genotype. * p < 0.05 compared to NMDA- 
treated WT controls (ANOVA, post-hoc Tukey).
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These data were also confirmed in single cell experiment when mouse cortical 
neurons derived from wild-type and ¿/¿/-deficient mice were exposed to 300 
NMDA for 60 min and monitored over 4 h on the stage of a confocal 
microscope. Confocal imaging of individual Ca2+ and Ay/m responses using Fluo-
4 AM and TMRM, demonstrated that the majority of the neurons in both 
genotypes failed to recover from their NMDA-induced increase in intracellular 
Ca2+, undergoing ICD and showing an early and persistent mitochondrial 
depolarisation. Interestingly, quantification of neuronal outcome showed 
significantly increased neuronal tolerance (as evidenced by decreased ICD) in the 
¿/¿/-deficient neurons compared to the wild-type controls, suggesting again a 
potential role of Bid during ICD. Tolerant neurons retained Ay/m and normal 
cellular morphology for at least the 4 h period of the experiment (Fig. 5.6 A), 
with no DCD observed in these neurons. Quantification of the Ca2+ responses 
between bidA and wild-type neurons revealed a significant difference in the level 
of the acutc Ca2+ influx during NMDA exposure (Fig. 5.6 B).
146
Figure 5.5: Cortical neurons lacking Bid show transient protection against 
immediate cell death within 2 hours. (A) Cortical neurons from b id ' mice and 
WT controls were exposed 300 jj,M NMD A for 60 min or sham conditions and 
allowed to recover over 24 h. Cell death was assessed by Hoechst and PI 
staining. Each field contained 300-400 neurons and each time point was 
measured from at least 3 wells, each in triplicate. PI positive nuclei were 
quantified. Means ± SEM are shown. * p < 0.05 compared to NMDA-treatcd WT 
controls (ANOYA, post-hoc Tukey). (B) Representative merged images of PI 
and Hoechst signals from sham and 24 h post NMDA treated neurons for each 
genotype. Scale bar = 5 |xm.
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Figure 5.6: Exposure of cortical neurons lacking of bid to high 
concentrations of N M D A  results in an increased neuronal tolerance. Neurons 
exposed to 300 NMDA for 60 min were monitored in live cells for 
alterations in Ay/m and intracellular Ca2+ over a 4 h period. (A) Quantification of 
cellular responses (Tolerance, ICD) in neurons from WT (n = 129 cells) and bid- 
deficient mice (n = 163 cells) was performed. (B) Mean peak calcium influx in 
WT (n = 83) and bidA (n = 43) neurons during NMDA exposure (300 (xM/60 
min) is quantified. Data are means ± SEM from at least n = 3 independent 
experiments. * p < 0.05 compared to NMDA-treated WT controls (ANOVA, 
post-hoc Tukey).
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5.2.3 Bid contributes to ischemic cell death in response to oxygen/glucose 
deprivation
Bid has also been implicated in oxygen/glucose deprivation (OGD) in neurons 
through the activation of caspase 8 after focal cerebral ischemia (Plesnila et al.,
2001, Le et al., 2002).
Interestingly, we did not detect any Bid participation in caspase-independent 
excitotoxic apoptosis (Fig. 5.2), nor was Bid activation reported in previous 
excitotoxic models (Ward et al., 2006, Konig et al., 2007). In order to confirm 
the involvement of Bid in mediating ischemic cell death in vitro, we examined 
the effect of OGD on cortical neurons derived from wild-type and ¿»/¿/-deficient 
mice. OGD is a widely used in vitro model of ischemic injury which also 
produces apoptotic (Kalda et al., 1998) and necrotic (Goldberg and Choi, 1993, 
Gwag et al., 1995) cell death phenotypes.
Wild-type and ¿/¿/-deficient cortical neurons were exposed to sham conditions or 
subjected to OGD for 45 min in the presence or the absence of the NMD A 
receptor antagonist MK-801 (5 jjM). Neurons were then allowed to recover 
under normoxic conditions over a 24 h time period. As shown in Figure 5.7, a 45 
min OGD treatment was sufficient to induce an extensive cell death in wild-type 
cultures, whereas the neuronal injury in ¿/¿/-deficient neurons was significantly 
attenuated. The presence of MK-801 pre, during and post OGD treatment exerted 
a significant and equal neuroprotective effect in wild-type and ¿/¿/-deficient 
OGD-treated neurons (Fig. 5.7).
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Figure 5.7: Cortical neurons lacking Bid showed reduced in vitro ischemic 
cell death after oxygen/glucose deprivation. Neurons from bid1' mice and WT 
controls were either exposed to oxygen-glucose deprivation (OGD) for 45 min in 
the presence or the absence of MK-801 (5 pM), or sham conditions, and allowed 
to recover for 24 h. Quantification of injury was assessed by Hoechst and PI 
staining 24 h after treatment. PI positive nuclei were scored as dead neurons and 
quantified as a percentage of total population in the field. Each field contained 
approx 300-400 neurons, 3 fields were captured per well and at least 3 wells 
were analysed per condition. Means ± SEM are shown. * p < 0.05 compared to 
OGD-treated WT controls (ANOVA, post-hoc Tukey). (B) Representative 
images of the merged image of PI and Hoechst stained neurons exposed to sham 
conditions or OGD for 45 min. Images of sham and 24 h post OGD or OGD in 
the presence of MK-801 neurons for each genotype are shown. Scale bar =10 
fim.
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5.2.4 Cortical neurons deficient in bim are protected from NMDA-induced 
injury but calpains are not acting on Bim to promote cell death
Previous studies in our laboratory demonstrated that the activation of the pro- 
apoptotic BH3-only protein Bim plays a key role in inducing apoptotic signalling 
pathways during excitotoxic injury. Concannon et al. showed that the depletion 
of cellular ATP is the central switch in the activation of the energy sensor 
AMPK, which mediates excitotoxic apoptosis in a Bim-dependent manner 
(Concannon et al., 2010).
In order to confirm the selective requirement of Bim in our paradigms and 
establish whether calpains acted on this BH3-only protein to promote NMDA- 
mediated excitotoxicity cell death, we employed in our study èzm-deficient mice. 
We first investigated whether the loss of Bim expression modulated the critical 
events associated with excitotoxic injury, such as mitochondrial membrane 
potential depolarisation and delayed calcium deregulation.
Excitotoxic injury was induced in cortical neurons, derived from wild type and 
bim1' mice, by an exposure to 100 jxM NMDA for 5 min. Confocal imaging of 
individual Ca2+ and Ay/m responses, using respectively Fluo-4 AM and TMRM, 
was performed.
Quantification of the Ca21 responses in response to NMDA stimulation showed a 
significant increase of neuronal tolerance with decreased DCD and ICD 
responses between wild-type controls and ¿>/'m-deficient neurons (Fig. 5.8 A). 
Analysis of the onset of Ai//m depolarisation revealed that bim gene deletion 
produced a considerable delay in the onset of this event compared to the wild- 
type controls (Fig. 5.8 B).
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Figure 5.8: Bim expression is essential for the late A^Irl collapse after 
NMDA-induced apoptosis. Wild type and ¿»/^-deficient cortical neurons 
cultured separately on Willco dishes were loaded with TMRM and Fluo-4 AM 
for 30 min at 37°C before being mounted on a thermostatic chamber of a 
confocal microscope (LSM 510 Meta). Neurons were exposed to 100 ^M 
NMDA for 5 min after which alterations in Ai//m and intracellular Ca2+ were 
monitored in single cells over a 24 h period. (A) Neurons were classified 
according to their type of cellular response (Tolerance, DCD, ICD) and 
quantification of three neuronal responses for the injury model for WT (n = 109 
cells) and Ww-deficient neurons (n = 98 cells) was carried out. Data are means ± 
SEM from at least n = 3 independent experiments. (B) Onset of Ay/m loss was 
analyzed in WT (n = 39) or ¿¿/«-deficient neurons (n = 24). * p < 0.05 compared 
to NMDA-treated WT controls (ANOVA, post-hoc Tukey).
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/  • « « 2+ Therefore, the majority of him" neurons maintained their Ay/m and Ca
homeostasis for considerably longer periods than their wild-type littermates.
Analysis of the initial Ca2+ peaks during 100 (iM/5 min NMD A exposure
revealed they were comparable between wild-type and 6/m-deficient neurons
(Fig. 5.9 A - C).
Figure 5.9: Bim deletion does not lead to differences in initial calcium influx 
during N M D A  exposure compared to W T  controls. (A, B) Representative 
traces of NMDA treated wild type and bim1' cortical neurons depicting the extent 
of peak calcium influx at point of stimulation (100 (xM/5 min NMDA). (C) Mean 
peak calcium influx between the genotypes (n= 39 and 24 neurons for WT and 
bim1' respectively). Data are means ± SEM from at least 3 independent 
experiments for each genotype (p < 0.05; ANOVA, post-hoc Tukey).
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The above results, showing that the numbers of neurons which lost Ai//m in bim- 
deficient mice was significantly less than in wild-type neurons, were consistent 
with parallel assessment of cell death by population counts.
Cortical neurons from wild type and ¿//«-deficient mice were pretreated with 
calpeptin for 2 h and then exposed to 100 (iM NMDA for 5 min. The number of 
PI positive cells was quantified at given time points post NMDA or sham 
treatments in the presence or the absence of calpeptin. We first observed a 
reduced amount of cell death in gene-targeted bim'1' compared to their wild type 
counterparts 16 h following NMDA excitation, indicating that loss of bim gene 
provides neuronal protection. Of note, calpeptin also exerted significant 
neuroprotection in ¿/m-deficient neurons, indicating that calpains were not acting 
on Bim to promote apoptotic cell death (Fig. 5.10).
Taken all results together, these data confirm our previous findings in which we 
assigned a predominant role of calpains downstream the mitochondrial apoptotic 
pathway (see results chapter IV).
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Figure 5.10: Cortical neurons lacking Bim are protected from NMDA- 
induced excitotoxic apoptosis either in the absence or the presence of 
calpeptin. (A) Neocortical neurons from bim' mice and WT controls were 
exposed to 100 NMD A for 5 min or sham conditions for 5 min in the 
presence or the absence of calpeptin. Cell death was assessed by Hoechst and PI 
staining and the results were quantified as a percentage of total neurons in the 
field. Three subfields containing 300-400 neurons each were captured and at 
least 3 wells were analyzed per time point. Means ± SEM are shown. * p < 0.05 
compared to NMDA-treated WT controls. # p < 0.05 compared with NMDA- 
treated knockout controls (ANOVA, post-hoc Tukey). (B) Representative images 
of the merged image of PI and Hoechst stained neurons exposed to sham 
conditions or 100 (xM NMDA for 5 min. Images of sham and 24 h post NMD A 
excitation neurons for each genotype and treatment are shown. Scale bar = 5 pm.
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5.2.5 Cortical neurons undergoing NMDA-induced excitotoxic necrosis are 
insensitive to bim gene deletion
Having identified Bim as being implicated in NMDA induced excitotoxicity, the 
next step was to identify whether this BH3-only protein played any relevant role 
in mediating NMDA-induced excitotoxic necrosis.
Thus, mouse cortical neurons from bim" and wild-type mice were exposed to 
300 |iM NMDA for 60 min and cells were monitored over a 4 h time period 
using confocal live cell imaging to detect any changes in mitochondrial 
membrane potential and intracellular calcium kinetics. TMRM- and Fluo-4AM- 
based confocal analysis revealed comparable Ay/m and cytosolic Ca dynamics 
in response to acute NMDA stimulation between genotypes (data not shown) and 
quantification of individual Ca21 cellular responses demonstrated that prolonged 
exposure of 300 jiM NMDA for 60 min induced primarily and equally ICD in 
both 6zm-deficient and wild-type neurons (Fig. 5.11 A). The acute calcium influx 
at the point of NMDA excitation evaluated on the base of peak initial Fluo-4AM 
between each genotype was determined not to be significantly (Fig. 5.11 B).
The absence of a bim requirement for NMDA-induced excitotoxic necrosis was 
also confirmed by population-based data, where 6/m-deficient and wild-type 
neurons were compared by determination of neuronal injury using Hoechst and 
PI staining of nuclear chromatin. Cortical neurons derived from both genotypes 
were exposed to 300 jj.M/60 min NMDA treatment and allowed to recover for the 
given time points (Sham, 1, 2, 4 h), after which cell death was assessed by 
Hoechst 33258 staining and PI uptake. No significant alterations in neuronal 
death following immediate necrotic excitotoxicity were detected in gene-targeted 
bim'1' compared to their wild type counterparts (Fig. 5.12).
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Figure 5.11: Neurons exposed to high concentrations of N M D A  are 
insensitive to ¿//«-gene deletion. Neurons were exposed to 300 jiM NMDA for 
60 min after which alterations in Ai//rn and intracellular Ca2+ were monitored in 
live cells over a 4 h period. (A) Quantification of cellular responses (Tolerance, 
ICD) in neurons from WT (n = 129 cells) and ¿//«-deficient mice (n = 73 cells) 
was carried out. (B) Mean peak calcium influx in WT (n = 53) and bim' (n = 31) 
neurons during NMDA exposure (300 |iM/60 min) is quantified. Data are means 
± SEM from at least n = 3 independent experiments (p < 0.05; ANOVA, post-hoc 
Tukey).
Figure 5.12: Cortical neurons lacking Bim are not protected from NMDA- 
induced neuronal necrosis. (A) Cortical neurons from bim ' mice and WT 
controls were exposed to 300 |iM NMDA for 60 min or sham conditions, and 
allowed to recover over 4 h. Cell death was assessed by Hoechst and PI staining. 
Each field contained 300-400 neurons and each time point was measured from at 
least 3 wells, each in triplicate. PI positive nuclei were quantified. Means ± SEM 
are shown (p < 0.05; ANOVA, post-hoc Tukey). (B) PI and Hoechst 
representative merged images of sham and 4 h post insult neurons for each 
genotype treated as described in A arc illustrated. Scale bar = 5 (im.
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In this chapter, we investigated the potential role for the two major BH3-only 
members of Bcl-2 protein family, Bid and Bim, in mediating NMDA-induced 
excitotoxic cell death and in relation to calpain activation.
The role of Bid in excitotoxic cell death is not yet clear. Bid has been suggested 
as key mediator role of cell death in several neurodegeneration models, in 
particular contributing to post-ischemic neuronal cell death (Culmsee and 
Landshamer, 2006).
In line with our findings (Fig. 5.7), it had been shown that ¿/¿/-deficient mice 
revealed neuroprotection in cultured neurons when exposed to oxygen/glucose 
deprivation (OGD) (Plesnila et al., 2001). Moreover, gene deletion of bid 
showed significantly reduced damage brain in mice after transient cerebral 
ischemia and brain trauma (Yin et al., 2002, Bermpohl et al., 2006). Bid has been 
involved in extrinsic death receptor-induced apoptosis pathway through the 
activation of caspase 8 (Li et a l, 1998a, Luo et a l, 1998). Bid has also been 
implicated in preventing nuclear AIF translocation after hypoxia- hypoglycemia- 
induced neuronal cell death, suggesting that this pro-apoptotic BH3-only protein 
may be responsible for mitochondrial membrane pore formation and subsequent 
AIF release from mitochondria (Culmsee et al., 2005), although the mechanism 
by which AIF is released from mitochondria is still not elucidated.
Our data did not show a bid requirement for excitotoxic apoptosis or for calpain- 
dependent cell death, as ¿/¿/-deficient and wild-type mice were similarly sensitive 
to NMDA-induced apoptosis and calpain inhibition was equally protective in 
¿/¿/-deficient and wild-type mice (Fig. 5.2). The inconsistencies seen between the 
NMDA versus OGD stimulation may be dependent on the differences in cell
5.3 Discussion
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death pathways activated in the different paradigms. Although OGD will activate 
a glutamate-dependent cell death, other glutamate-independent cell death 
mechanisms are activated in parallel. These differences in cell death pathways 
activated may account for the observed discrepancies in protection in bid- 
deficient mice between the excitotoxicity and OGD-induced cell death.
Polster et al. (2005) suggested in isolated mitochondria studies that the activation 
of caspase 8 by Bid was not sufficient to induce release of AIF from 
mitochondria, but Bid cleavage and the release of pro-apoptotic factors was 
calpain-dependent. In intact neurons, such a mechanism may not operate in the 
setting of excitotoxic apoptosis.
Here, our data also suggest that Bid may actually play a critical role in 
contributing in excitotoxic injury under conditions that are associated with ICD 
and excitotoxic necrosis (Fig. 5.3 -  5.5 - 5.6). Furthermore, bid gene deletion 
produced decreased levels of Ca2+ peak responses denoting that Bid may have an 
effect on the neuronal Ca2+buffering by mitochondria.
Of note, Bid, as well as other Bcl-2 family proteins, such as Bax, Bcl-2 and Bcl- 
xL, is thought to form large pores on the MOM, contributing in the 
destabilisation of the lipid bilayer, and it has been implicated in regulating the 
PTP opening (Kuwana et al., 2002). Bid has also been involved in disturbing 
mitochondrial dynamics by disrupting the assembly of Opal oligomers, thereby 
causing cristae remodelling and mitochondrial fragmentation (Kroemer et al., 
2007).
In agreement with previous study (Concannon et al., 2010), we also provided 
evidence that the other pro-apoptotic BH3-only protein Bim is an essential 
mediator of NMDA-induced excitotoxic apoptosis, as bim gene deletion led to
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neuronal protection from excitotoxic apoptotic injury (Fig. 5.8 - 5.10). 
Concannon et al. also demonstrated that bim transcriptional induction requires 
the activation of AMPK and that prolonged AMPK activation can be sufficient to 
stimulate bim gene expression and to trigger a ¿zm-dependent cell death 
(Concannon et a l, 2010). Other several factors have been associated with bim 
gene regulation, including JNK/c-Jun (Harris and Johnson, 2001, Whitfield et al.,
2001), Foxo3a (Sunters et al., 2003, Biswas et al., 2007), and C-myb (Biswas et 
al, 2007).
In addition, our data also indicates that calpain inhibition by calpeptin produced 
alterations in cell death following apoptotic excitotoxicity in gene-targeted bim ' 
compared to their wild type counterparts, suggesting that Bim-mediated calpain 
activation may not be required in this paradigm. Excitotoxic apoptosis differed 
from excitotoxic necrosis where lack of Bim was not associated with this injury 
(Fig. 5.11-5.12).
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CHAPTER VI
Role of Bax in excitotoxic cell 
death and NMDA-induced Ca
dysregulation
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6.1 Introduction
The Bel-2 protein family proteins consist of a network of pro-apoptotic and anti- 
apoptotic members that through their interaction with each other function as the 
major regulators and effectors of mitochondria-dependent apoptotic death 
(Tsujimoto, 2003, Danial and Korsmeyer, 2004). The anti-apoptotic family 
members include Bcl-2, Bcl-xL, Bcl-w and Mcl-1, that function to prevent the 
disruption of mitochondrial integrity, while pro-apoptotic proteins comprise of 
the BH3-only proteins (Bid, Bim, Bad and Puma) and the Bax subfamily (such as 
Bax and Bak) which act as apoptosis initiators (Bouillet and Strasser, 2002, 
Villunger, 2004) and executers (Reed et a l, 1998, Cory and Adams, 2002, 
Polster and Fiskum, 2004, Ward et al., 2004) respectively. In response to 
apoptotic stimulation, select BH3-only proteins, such as Bid, Bim and Puma, can 
lead to the release of pro-apoptotic proteins from the mitochondria in a Bax- 
dependent manner (Labi et a l, 2006). In healthy cells, while Bak resides in the 
mitochondria, Bax is essentially cytosolic or loosely bound to mitochondria (Hsu 
et al., 1997, Goping et al., 1998, Hsu and Youle, 1998). Following a death 
stimulus, Bax protein translocates to mitochondria, where it forms and/or 
regulates channels to finally promote mitochondrial permeabilisation and release 
intermembrane space proteins into the cytoplasm (Woltcr et al., 1997, 
Nechushtan et al., 1999). Several studies proved that those critical steps require 
previous activation of Bax protein, but the upstream and downstream signaling 
mechanisms still remain to be clearly defined.
The Ca21-dependent cysteine proteases calpains represent pivotal mediators of 
cell death following acute hypoxia, traumatic brain injury, chronic degeneration,
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or excitotoxicity (Gafni and Ellerby, 2002, Liu et al., 2002, Crocker et al., 2003, 
Nixon, 2003, Mansouri et al., 2007). It has been previously suggested that 
calpain induces Bax cleavage during apoptosis (Wood et al., 1998) and that the 
calpain-induced Bax-cleavage product is a more potent inducer of cell death than 
wild-type Bax (Wood and Newcomb, 2000, Toyota et al., 2003).
The crucial role that Bax plays in the execution of the mitochondria-dependent 
apoptotic pathway was also determined by the employment of transgenic mice. 
In the absence of the bax gene, a variety of cell types displayed a resistance 
against different cell death stimuli both in vitro (Cregan et al., 1999, Steckley et 
al., 2007) and in vivo (Gibson et al., 2001, Perez-Navarro et al., 2005, Tehranian 
et al., 2008) experimental models.
Interestingly, we previously showed that calpains were predominantly activated 
downstream of mitochondrial engagement during the execution phase of delayed 
excitotoxic apoptosis (results, chapter IV). Therefore, the aim of our study was to 
determine whether calpain activation can be regulated by bax gene deficiency 
and how this deletion affects NMDA-induced excitotoxicity.
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6.2 Results
6.2.1 The protective activity of calpeptin requires a functional mitochondrial 
apoptosis pathway
In the previous chapter, our data did not show a bid or him requirement for 
calpain-dependent cell death, because calpain inhibition was equally protective in 
bid- or bim-deficient and wild-type mice. In order to determine how the pro- 
apoptotic Bcl-2 member Bax is involved in our model of NMDA-induced 
excitotoxic apoptosis and whether calpain acted on this protein to promote 
neuronal death, we employed ¿ax-deficient mice.
Mouse cortical neurons from ¿ax-deficient mice were compared to their wild- 
type counterpart and cell death assays were performed. The selective calpain 
inhibitor calpeptin (20 |oM) was initially added to cultured neurons derived from 
wild-type and ¿ax-deficient mice 2 h prior NMD A exposure (100 pM/5 min 
NMDA). Following NMDA exposure, neurons were allowed to recover in the 
incubator for given time points (Sham, 8 and 24 h) and neuronal injury was 
determined by Hoechst 33258 and PI staining of nuclear chromatin in the 
absence or the presence of calpeptin. Quantification of PI positive cells, 
expressed as a percentage of the total population of neurons, indicated that ¿ax- 
deficient cortical neurons were highly resistant to NMDA-induced excitotoxic 
apoptosis (Fig. 6.1). Moreover, calpeptin failed to provide a significant 
protection in ¿ax-deficient mice, suggesting that deficiency in bax was dominant 
over the pro-apopotitic activity of calpain, and that calpains required a functional 
mitochondrial apoptosis pathway to mediate excitotoxic apoptosis.
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Figure 6.1: Cortical neurons lacking Bax are protected only in NMDA- 
induced excitotoxic apoptosis and not in the presence of calpain inhibitor 
calpeptin. (A) Representative standard PCR analysis of genomic DNA shows 
indicated strain and expected PCR bands sizes for bax genotyping. DNA was 
extracted from tail snips using High Pure PCR Template Preparation Kit. M: 100 
bp ladder; NC: negative control without the tail DNA template. Genotyping was 
performed using three specific primers for wild type, mutant and common allele- 
specific. (B) Neocortical neurons from box1' mice and WT controls were treated 
with 100 (j,M NMDA for 5 min over 24 h or sham conditions for 5 min and 
allowed to recover as indicated. Cell death was assessed by Hoechst and PI 
staining and the results were quantified as a percentage of total neurons in the 
field. Each field contained approx 300-400 neurons, 3 fields were captured per 
well and at least 3 wells were analysed per time point. Means ± SEM are shown.
* p < 0.05 compared to NMDA-treated WT controls (ANOVA, post-hoc Tukey). 
(C) Representative images of the merged image of PI and Hoechst stained 
neurons exposed to sham conditions or 100 jjM NMDA for 5 min. Images of 
sham and 24 h post NMDA excitation neurons for each genotype are shown. 
Scale bar = 5 jim.
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Similarly to the characterisation of the BH3-only protein Bid and Bim in the 
previous chapter, the central roles of DCD, At//m depolarisation and MOMP in 
excitotoxicity led us to explore whether the loss of Bax expression altered these 
events. Cortical neurons from ¿ax-deficient mice were compared to their wild- 
type controls and cytosolic Ca2+ and mitochondrial membrane potential 
responses were assessed by confocal live-imaging using respectively the 
fluorescent indicators Fluo-4 AM and TMRM (Fig. 6.2; Fig. 6.4).
Analysis of the kinetics of the Ay/m using single cell TMRM-based confocal 
imaging identified a significant increase in the whole-cell TMRM fluorescence 
of the wild-type neurons undergoing DCD within 1-2 h period after NMDA 
excitation. In contrast, box gene deletion did not produce a considerable 
hyperpolarisation of the mitochondrial membrane potential, as evidenced by 
constant basal levels of TMRM fluorescence still 4 hours after the initial NMDA 
exposure (Fig. 6.2 A-C).
Assessment of cell death by Hoechst and PI staining following NMDA excitation 
previously displayed elevated survival rate in ¿ax-deficient neurons (Fig. 6.1). 
Quantification of the individual Ca2 responses at single cell level after 100 (j.M/5 
min NMDA exposure also showed increased neuronal tolerance in the ¿ax- 
deficient mice compared to the wild type controls, as evidenced by decreased 
DCD responses (Fig. 6.3 A). Of note, box gene deletion also led to a significant 
reduction in ICD responses after the exposure to 100 jj.M/5 min NMDA, 
suggesting that ICD may accompany several cell death modes, or that bax gene 
deletion has an effect on neuronal Ca2+ handling.
6.2.2 Bax is required for mitochondrial bioenergetics and calcium handling
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Figure 6.2: Bax gene deletion causes dysregulated mitochondrial functions.
Cortical neurons derived from wild type and box1' mice were pre-loaded with 
TMRM and Fluo-4AM and exposed to NMDA (100 |iM/5 min NMD A). (A, B) 
Representative TMRM traces measuring alterations in mitochondrial membrane 
potential of NMDA treated wild type and box'"A cortical neurons. Traces show an 
excitotoxic apoptosis where neuronal mitochondria transiently recovered their 
energetics and a late At//m depolarisation occurred hours after the initial NMDA 
excitation. (C) Average of TMRM fluorescence in wild type (n = 71) and bax" 
(n = 52) neurons before and after NMDA excitation are represented. Means ± 
SEM are shown. * p < 0.05 compared to sham-treated WT controls. # p < 0.05 
compared with NMDA-treated WT controls (ANOVA, post-hoc Tukey).
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Analysis of the onset of Ai//m depolarisation using TMRM-based confocal 
fluorescence microscopy showed that bax gene deletion also produced a 
considerable delay in the onset of Ai//m loss compared to the wild-type controls 
(Fig. 6.3 B).
Time-lapse imaging of the cytosolic calcium responses using Fluo-4AM 
identified, when the bax gene is deleted, an atypical Ca2+ influx following 
transient NMDA exposure. NMDA excitation (100 (.iM/5 min NMDA) resulted 
in an initial increase of intracellular Ca2+ that rapidly returned to baseline levels 
in both genotypes. However, in the hours following the insult, neurons derived 
from ¿ox-deficient mice maintained their Ca2+ homeostasis for longer periods 
compared to their wild-type controls: cells derived from wild-type mice and 
undergoing excitotoxic apoptosis displayed DCD within 6-16 h of stimulation, 
while ¿ax-deficient neurons within a period of 15-25 h after NMDA exposure 
(Fig. 6.4). Moreover, stimulation of neurons with 100 (iM NMDA for 5 min 
produced a lower Ca2+ influx during excitation in the ¿ax-deficient mice
 ^|compared to their wild-type counterparts, as evidenced by decreased acute Ca 
responses and smaller area under the Ca2+ curve during NMDA stimulation (Fig. 
6.5 A, B).
Furthermore, ¿ax-deficient neurons underwent DCD at much lower frequency 
and the extension of DCD, when visible, was inferior compared to their wild- 
type counterparts (Fig. 6.4; Fig. 6.5 C).
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Figure 6.3: Exposure of cortical neurons lacking of bax to moderate 
concentrations of NMDA mainly results in neuronal tolerance. Wild type and 
¿<xt-deficient cortical neurons cultured separately on Willco dishes were pre- 
loaded with TMRM and Fluo-4 AM for 30 min at 37°C before being monitored 
by a confocal microscope (LSM 510 Meta). Neurons were exposed to 100 pM 
NMDA for 5 min after which alterations in Ay/m and intracellular Ca2+ were 
monitored in single cells over a 24 h period. (A) Quantification of cellular 
responses in neurons from box1' mice (n = 373 neurons) and WT controls (n = 
275 neurons) treated with 100 pM NMDA for 5 min. Data were obtained from at 
least 4 independent experiments. Means ± SEM are shown. (B) Onset of Ai//m 
loss was analysed in WT (n = 71) or èax-deficient neurons (n = 52). * p < 0.05 
compared to NMDA-treated WT controls (ANOVA, post-hoc Tukey).
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Figure 6.4: Bax gene deletion leads to reduced intracellular calcium 
accumulation. (A, B) Representative traces of NMD A treated wild type and box' 
/_ cortical neurons depicting the extent of peak calcium influx at point of 
stimulation (100 fiM/5 min NMD A).
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Figure 6.5: Analysis of calcium influx during and after N M D A  exposure 
revealed significant divergences in the box neurons compared to W T  
controls. (A, B) Mean peak calcium influx and mean area under calcium curve 
between the genotypes (n = 71 and 52 neurons for WT and box'A respectively) 
during NMDA exposure (100 |j.M/5 min) are quantified. (C) Analysis of the 
frequency of WT (n = 71) and baxf~ (n = 52) neurons showing DCD. Data are 
means ± SEM from at least 3 independent experiments for each genotype. * p < 
0.05 compared to NMDA-treated WT controls (ANOVA, post-hoc Tukey).
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6.2.3 Cortical neurons exposed to NMDA-induced excitotoxic necrosis are 
insensitive to box gene deletion
In the preceding chapter, we determined that decreased ICD responses in neurons 
lacking bid, subjected to a model of excitotoxic apoptosis, reflected a different 
neuronal calcium influx and also a potential role in excitotoxic necrosis. 
Moreover, our data also demonstrated that calpains are specifically activated 
during ¿ax-dependent apoptosis as downstream effectors.
In order to verify if the decreased ICD cellular outcomes observed in the ¿ax- 
deficient neurons in response to 100 pM/5 min NMD A could indicate a possible 
box role in NMDA-mediated excitotoxic necrosis, cortical neurons from ¿ox'A 
and wild-type mice were exposed to 300 pM NMD A for 60 min.
Analysis of mitochondrial membrane potential and calcium using TMRM and 
Fluo-4AM respectively, revealed comparable Ay/m and intracellular Ca2 
dynamics following acute NMDA exposure between genotypes (Fig. 6.6). 
Turning our attention towards the acute calcium influx during NMDA excitation, 
we observed, once more, a lower intracellular Ca2+ response in the ¿ax-deficient 
neurons compared to their wild-type controls, as indicated by significant 
decreased peak initial Fluo-4AM fluorescence (Fig. 6.7 A). However, this 
different calcium handling did not produce an alteration on the overall cellular 
responses between wild-type and box1' neurons. In fact, neurons displaying an 
ICD response after a 60 min exposure to 300 pM NMDA were insensitive to 
¿ax-gene deletion, showing analogous levels of neuronal outcomes (Fig. 6.7 B).
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Figure 6.6: Characterisation of mitochondrial membrane potential and 
cytosolic calcium in ¿ox-deficient cortical neurons in response to acute 
N M D A  stimulation. (A-D) Cortical neurons derived from wild type and bax'A 
mice were pre-loaded with TMRM and Fluo-4AM and exposed to NMDA (300 
(iM/60 min NMDA). Representative TMRM and Fluo-4AM traces measuring 
alterations in Ay/m and Ca2+ of NMDA treated wild type and box'1' cortical 
neurons. Traces show an excitotoxic nccrosis characterised by immediate 
deregulation of Ca2+ homeostasis and a persistent Ay/m depolarisation 
immediately after the initial NMDA excitation.
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Figure 6.7: Cortical neurons exposed to high concentrations of N M D A  are 
insensitive to box gene deletion. Neurons were exposed to 300 |j,M NMDA for 
60 min after which alterations in A y/m and intracellular Ca2+ were monitored in 
single cells over a 4 h period. (A) Mean peak calcium influx in WT (n = 83) and 
box'' (n = 48) neurons during NMDA exposure (300 fxM/60 min) is quantified. 
(B) Quantification of cellular responses (Tolerance, ICD) in neurons from WT (n 
= 129 cells) and ¿ax-deficient mice (n = 129 cells) was carried out. Data are 
means ± SEM from at least n = 3 independent experiments. * p < 0.05 compared 
to NMDA-treated WT controls (ANOVA, post-hoc Tukey).
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6.2.4 Calpains are activated during ¿ox-dependent neuronal injury induced 
by oxygen-glucose deprivation
To validate our hypothesis that activation of calpains played a predominant role 
in ¿ax-dependent cell death in a more clinically relevant setting, we performed 
experiments using organotypic hippocampal slices cultures (OHSCs) subjected to 
oxygen-glucose deprivation (OGD). OGD is an in vitro model commonly used 
to mimic the effects of ischemia. OHSCs derived from wild type and ¿ax- 
deficient mice were kindly prepared and cultured according to the modified 
procedure (Kristensen et al., 2001) by Dr. Helena Bonner in our laboratory. 
Hippocampal slices were then exposed to OGD for 45 min in the absence or the 
presence of calpcptin (20 |iM) and allowed to recover under normoxic conditions 
over 24 h. As shown in Fig. 6.8 B, a 45 min OGD treatment was sufficient to 
induce CA1 damage in wild-type OHSCs, whereas the neuronal injury in ¿ax- 
deficient slice cultures was significantly attenuated. Calpeptin treatment exerted 
a significant neuroprotective effect in wild-type OGD-treated OHSCs, but not in 
the ¿ax-deficient slice cultures (Fig.6.8 A, B). Hippocampal slices, prepared 
from wild-type and b o x ' cultures, were harvested at specific time points 
following OGD. Consistent with the absence of a role for calpains in mediating 
¿ax-independent excitotoxic apoptosis described in this work, western blot 
analysis revealed an increased accumulation of the calpain-specific, 145 kDa 
spectrin breakdown product in the wild type OHSCs OGD-treated, but not in the 
¿ax-deficient slice cultures (Fig. 6.8 C).
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Figure 6.8: Organotypic hippocampal slice cultures isolated from bax- 
deficient mice show reduced calpain activation in response to oxygen- 
glucose deprivation (OGD). (A) Representative images of OHSCs derived from 
wild-type and box1' mice. The slices were sham-exposed or subjected to OGD 
conditions for 45 min in the absence (control) or the presence of calpeptin (20 
|xM) and allowed to recover for 24 h. Scale bar =100 jim. (B) Hippocampal slice 
cultures from wild-type and box1' mice were treated as described in A and 
quantification of injury was assessed by PI staining 24 h post-treatment (n = 5 
slice cultures for each condition). Means ± SEM are shown. * p < 0.05 compared 
to OGD-treated WT control (ANOVA, post-hoc Tukey). (C) Whole-cell extracts 
were prepared from wild-type and bax ' hippocampal slice cultures treated to 45 
min OGD and allowed to recover under normoxic conditions for the indicated 
time points. Spectrin cleavage was assessed by Western blotting, p actin served 
as loading control. BP, Breakdown product; FL, Full-length.
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In this study, in order to ultimately investigate whether calpains acted on the pro- 
apoptotic Bcl-2 protein Bax to promote cell death, we initially examined how 
bax gene deficiency influences excitotoxic injury and its general contribution in 
stimulus-induced cell death. In our experiments, where èax-deficient mice were 
compared to their wild-type counterparts, bax gene deletion exerted a significant 
neuroprotection against cell death stimuli, including NMDA-mediated 
excitotoxic apoptosis in mouse cortical neurons and oxygcn-glucose deprivation- 
induced injury in organotypic hippocampal slice cultures (Fig. 6.1 - 6.3 - 6.8). 
These results are consistent with known protective effects of bax absence, both in 
vitro and in vivo experimental models. Of note, it has been previously shown that 
èax-deficient sympathetic neurons and motoneurons were less sensitive in 
response to trophic factor withdrawal (Deckwerth et al., 1996) and, cerebellar 
and cortical neurons showed resistance following potassium deprivation and 
glutamate-induced excitotoxicity respectively (Miller et al., 1997, Xiang et al., 
1998). Furthermore, èax-deficient mice show less dopaminergic cell death after 
l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine administration (MPTP) (Vila et 
al., 2001), resistance to ischemia-mediating neuronal loss in the hippocampus 
(Gibson et al., 2001) and a reduction in striatal cell death induced by 
excitotoxicity (Perez-Navarro et al., 2005).
Our study also suggests that calpains are specifically involved in ¿ox-dependent 
excitotoxic apoptosis and in this setting work as cell death executioners (Fig. 6.1 
- 6 .8).
Detailed analysis of mitochondrial membrane potential and calcium kinetics 
brought up the observations that Bax is also involved in neuronal Ca2+ handling.
6.3 Discussion
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Cortical neurons lacking box displayed less intense intracellular calcium 
overload and did not show a substantial mitochondrial membrane potential 
hyperpolarisation compared to their wild-type counterparts following NMDA 
excitotoxic stimulus and, hence, attenuated delayed depolarisation of Ai//m (Fig.
6.2 - 6.4 - 6.5). The increase in cellular TMRM fluorescence, in response to 
glutamate excitation, may be attributable to an increased accumulation of the 
probe within the mitochondrial matrix after hyperpolarisation of Ay/m (Nicholls 
and Ward, 2000, Ward et al., 2007, Weisova et al., 2009), or may also be a 
function of amplified mitochondrial biogenesis in response to energy depletion 
following glutamate excitation within the neurons. However, how At//m is altered 
in neurons in response to an excitotoxic stimulus is still unclear.
In line with our findings, two recent studies also suggested an involvement of 
Bax in mitochondrial and calcium functions in neurons and oligodendrocytes 
(Gavalda et al., 2008, Sanchez-Gomez et al., 2011).
Of remarkable note, several studies reported that Bax, and perhaps other 
members of the Bcl-2 family, is involved in mitochondrial fission-fusion 
dynamics, suggesting that the alteration of these crucial events in cellular 
physiology may contribute to the propagation of apoptotic signalling (for review 
see (Chipuk et al., 2010)). During apoptosis, Bax and Bak promote 
fragmentation of the mitochondrial network, possibly by activating the 
mechanism of mitochondrial fission, which may contribute the release of cyt-c 
from mitochondria (Frank et al., 2001, Lee et al., 2004, Youle and Karbowski,
2005, Brooks et al., 2007), although this has been a subject of debate.
Moreover, a recent study by Hoppins et al. (2011) suggests that Bax can promote 
mitochondrial fusion in a Mitofusin 2-dependent manner (Hoppins et al., 2011).
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Furthermore, Bax and Bak have also been implicated to induce MOMP and cyt-c 
release either independently or interacting with proteins from the PTP complex, 
such as ANT, VDAC and CypD, and these two mechanisms may cooperate and 
coexist (De Giorgi et al., 2002, Wigdal et al., 2002, Precht et al., 2005, Weaver 
et al., 2005).
Mitochondria play a major role in regulating Ca2+ in neurons and may participate 
in its spatial localisation. Therefore, the absence of box may cause defects in the 
mitochondrial fission/fusion regulators and/or in the PTP opening, leading to 
mitochondrial dysfunction and calcium deregulation.
Here, we also provided evidence indicating that ¿»ox-deficient neurons were 
resistant to excitotoxic apoptosis but did not alter the quantity of neuronal 
survival under conditions associated with ICD and excitotoxic necrosis (Fig. 6.3 
-6.7).
In conclusion, our data (i) reveal that Bax is an essential mediator of the 
mitochondrial phase of cell death and calpains play a role in ¿»ax-dependent 
excitotoxic apoptosis and here activated, in response to excitotoxicity, as cell 
death effectors during the execution stage and (ii) suggest the identification of a 
novel potential role for Bax in neuronal calcium handling and mitochondrial 
bioenergetics.
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CHAPTER VII
General discussion
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7.1 The role of glutamate excito toxicity
Glutamate is the principal excitatory neurotransmitter found in the mammalian 
central nervous system, which facilitates communication between neurons and 
mediates various metabolic pathways (Attwell, 2000, Petroff, 2002). Similar to 
other neurosecretory molecules, glutamate is synthesised by the ER and 
additionally processed by the Golgi apparatus. Glutamate is then encapsulated in 
neurosecretory vesicles and is transported by a complex system of microtubules 
along the axon via an anterograde motion. This process is energy-dependent 
which is provided by mitochondrial ATP. Once glutamate has reached the axonal 
tip, in physiological conditions of excitatory synaptic transmission, waves of 
axonal membrane depolarisation by a Ca2+-dependent mechanism involving 
voltage-dependent calcium channels triggers glutamate exocytosis from the pre- 
synaptic terminals into the synaptic cleft (Anderson and Swanson, 2000, 
Meldrum, 2000). The interaction between glutamate and specific glutamate 
receptors on the post-synaptic neuron leads to a cascade of molecular events. 
Activation of glutamate receptors has been implicated in a variety of 
physiological CNS functions, including synaptic plasticity, long-term neuronal 
potentiation, cognitive functions as learning and memory and non-physiological 
functions such as excitotoxicity (Dinglcdine et al., 1999). Excitotoxicity resulting 
from excessive release of glutamate from the pre-synaptic neuronal terminal 
consequently leads to overstimulation of glutamate receptors, especially NMDA 
receptors, due to their high capacitance for calcium ions (Koh and Choi, 1987, 
Gagliardi, 2000). This results in neuronal calcium overload and cell swelling 
triggering a cascade of membrane, cytoplasmic and nuclear events eventually 
inducing cell death (Mark et al., 2001). Glutamate excitotoxicity has been
implicated in neuronal injury associated with several neurological disorders, 
including ischemic stroke, trauma, epilepsy, and even chronic neurodegenerative 
diseases, such as Huntington’s, Parkinson’s, Alzheimer’s diseases and 
amyotrophic lateral sclerosis (Waggie et al., 1999).
7.2 Characterisation of working models and relative limitations
Previous works have developed and characterised models of neuronal injury 
utilising experimental model of prolonged or transient glutamate receptor 
overactivation (Ward et al., 2000, Ward et al., 2006, Ward et al., 2007). These 
models were designed to reflect the damage that can occur in the penumbra or in 
the core region of the brain following an ischemic event. The core region is the 
initial area of neuronal death where affected neurons die primarily via necrosis 
and their recovery is negligible and thought to be nonexistent (Beilharz et al., 
1995). Cells undergoing necrosis release their intracellular contents into the 
surrounding extracellular space, which create an ionic equilibrium disruption and 
diffuse to adjacent neurons form the core region to the penumbra (Lipton, 1999, 
Zheng et al., 2003, Brouns and De Deyn, 2009). This in combination with the 
persistent hypoxia and hypoglycemia leads to a secondary stage of neuronal 
damage where neurons mostly die via apoptosis (Astrup et al., 1981, Hossmann, 
1994, Lipton, 1999).
One of the current challenges is to employ various stroke models in order to 
examine and search for neuroprotective compounds against an ischemic insult 
(Durukan and Tatlisumak, 2007).
Several in vitro and in vivo models are currently used in stroke research to
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determine the efficacy of therapeutics aiming neuronal survival in the core and/or 
penumbra (Garcia de Arriba et al., 1999, Jarvis et al., 2001, Larsen et al., 2005, 
Ward et al., 2007, Weng and Kriz, 2007, Saleh et al., 2009, Ye et al., 2009). 
Although in vivo models are more physiologically accurate, they require large 
numbers of animals and high-quality technical experience, which results in a 
very high cost per data point (Graham et al., 2004). In addition, the 
determination of the action mechanism for therapeutic interventions may prove 
complex. On the contrary, the use of in vitro models overcomes many of these 
problems. Unfortunately, the limitations of these models is the physiological 
accuracy, as utilising cultured neurons consequently correspond to lack of 
normal synaptic connections and interactions with other neurons (Lossi et al., 
2009).
Therefore, in order to mimic neuronal damage occurring during ischemia within 
the core and/or the penumbra, in the present study, we employed different 
models of ischemic injury, including NMDA-induced excitotoxic cell death and 
oxygen/glucose deprivation, that produce necrotic, apoptotic cell death and 
neuronal tolerance phenotypes. To reproduce in mouse cortical neurons the 
delayed onset of apoptotic cell death that occurs in the penumbra region of an 
ischemic brain, we set up models of transient glutamate excitation using 30 or 
100 (iM NMDA for a period of 5 min. In contrast, to mimic the immediate 
necrotic pathways in the core region, a model of prolonged and intense NMDA 
receptor overactivation was established using 300 jxM NMDA exposure for 60 
min.
Transient NMDA receptor overexcitation resulted in a reversible mitochondrial 
membrane potential depolarisation that is followed by an extent of Ai//m
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hyperpolarisation. At this point, hyperpolarisation of Ay/m can endure and 
neurons tolerate the insult, or Ai//m can subsequently collapse inducing a delayed 
neuronal injury (see Chapter III) (D'Orsi et a l, 2012). Previous studies from our 
laboratory suggested that the hyperpolarisation of Ay/m promote or indicate 
neuronal survival and it appears to be a function of the availability of ATP within 
the cell (Ward et al., 2007, Weisova et al., 2009).
In contrast, prolonged and severe NMDA overactivation resulted in a necrotic 
injury characterised by a rapid collapse of At//m which does not recover its 
energetics even hours after the initial excitation. The excitotoxic insult is 
dependent on the duration and the severity of NMDA exposure (D'Orsi et al., 
2012).
All the studies in this work included as an excitatory stimulus the exposure of 
murine cortical neurons to NMDA, after which the NMDA open channel blocker 
MK-801 was added or the excitation medium was washed-out and replaced with 
conditioning medium in order to stop the neuronal insult. NMDA was preferred 
over the endogenous neurotransmitter glutamate as our neuronal cultures also 
contained a small amount of glia (10 %). With the aim of restraining the 
percentage of the glial population, inhibitors of mitosis such as cytoarabinoside 
were used however the compound results in neurotoxicity at concentrations of 1 
mM or higher. Several studies reported the ability of astrocytes to grant 
neuroprotection against glutamate excitotoxicity (McLennan and Wheal, 1976, 
Rosenberg et a l, 1992, Ye and Sontheimer, 1998) and this factor may affect the 
experimental reproducibility.
Given the central role of NMDA receptors in memory formation, LTP and 
calcium homeostasis, the excessive use of the NMDA antagonist MK-801 may
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not be ideal in long term experiments. Therefore, the use of an alternative 
NMDA blocker such as Memantine may be more suitable for in vivo studies or 
wash-out with additional magnesium in vitro.
7.3 Mitochondrial membrane potential and Calcium imaging
One of critical factors in deciding the fate of the cell in terms of survival, 
apoptosis or necrosis, is mitochondrial bioenergetics and their implications in 
regulating intracellular calcium homeostasis, respiration, cellular ATP synthesis 
and generation of ROS (van Belzen et al., 1997, Nicholls and Budd, 2000, 
Brookes et al., 2004). Mitochondria influence intracellular Ca2+ homeostasis
• ■ 9+directly by regulating the extent, position and propagation of cytosolic Ca 
influx and its recycling towards the ER, and indirectly, by generating cellular 
energy in the form of ATP, which is used to pump Ca2+ out of the cell or into 
intracellular stores by Ca2+-dependent ATPases (PMCA and SERCA 
respectively) (Hajnoczky et al., 1999).
The importance of mitochondrial dysfunction and calcium handling during cell 
death led us to accurately investigate the two central parameters in excitotoxicity: 
mitochondrial membrane potential and cellular calcium dynamics. 
Membrane-permeant fluorescent dyes, such as the fluorescent cationic probe 
tetramethylrhodamine methyl ester (TMRM) and the fluorescent calcium 
indicator Fluo4-AM are widely used to estimate, in that order, electrical potential 
across the inner mitochondrial membrane (Ai//m) and Ca2+ kinetics (Nicholls and 
Ward, 2000, Grienberger and Konnerth, 2012).
Several mitochondrial membrane potential probes, including Rhodamine 123,
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TMRE, DiOC6(3), JC1, MitoTracker Orange, have been used in research over 
the past years, however, due to its very low mitochondrial toxicity, TMRM 
represents the best candidate to determine Ay/m in live cell imaging. Moreover, 
TMRM does not exhibit inhibitory effect on mitochondrial respiration when used 
at low concentrations, equilibrates readily across the plasma membrane, and can 
be used in both matrix-quenching and non-quenching modes (Farkas et a l, 1989, 
Scaduto and Grotyohann, 1999, Nicholls and Ward, 2000).
Fluorometric Ca2+ imaging is another sensitive method to monitor neuronal 
activity, based on the fact that in living cells, most depolarizing electrical signals 
arc associated with Ca2+ influx attributable to the activation of one or more of the 
numerous types of voltage-gated Ca24 channels (Tsien and Tsien, 1990, Berridge 
et a l, 2000). The advantage of Ca2+ imaging is that it allows real-time analyses 
of individual cells and subcellular compartments simultaneously.
Numerous fluorometric calcium indicators are used for monitoring the dynamics 
of cellular calcium signalling and four categories can be distinguished:
• Bioluminescent proteins, such as aequorin which binds calcium ions 
leading to the oxidation of the prosthetic group coelcnterazine to 
colenteramide and in the emission of a photon of 470 nm (Shimomura et 
al., 1962, Ashley and Ridgway, 1968);
• Chemical indicators, such as Fluo-4 and Fura-2, that respond to Ca2+ 
binding with a change in the emitted fluorescence (Tsien, 1989, Gee et 
a l, 2000);
• FRET-based genetically encoded calcium indicator (GECI), consisted of 
the two fluorescent proteins, ECFP (donor) and Venus (acceptor)
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connected by a linker sequence of calcium-binding protein calmodulin. 
After binding of calcium ions, spatial distance between the donor and the 
acceptor decreases enabling FRET (Nagai et al., 2004);
• Single-fluorophore genetically encoded calcium indicator (GECI), which 
consist of a circular permuted EGFP, flanked with the calcium-binding
2_i- • J  *protein calmodulin and calmodulin-binding peptide M l3. Ca -binding 
leads to an increase in the emitted fluorescence (Nakai et al., 2001, Tian 
et al., 2009).
In this thesis, the fluorescent Ca2+-indicator dye Fluo-4AM has been used. This 
indicator is a membrane-permeant acetoxymethyl (AM) ester, which exhibits 
high fluorescence emission, improved signal-to-noise ratio, high rate of cell 
permeation, and a large dynamic range of fluorescence changes upon Ca2+ 
binding (Gee et al., 2000, Sato et al., 2007). Because of its higher fluorescence 
emission intensity, the dye can be excited with lower intensity illumination, 
decreasing photobleaching and hence cellular phototoxicity, and it can be used at 
lower concentrations, reducing Ca2+buffering effects (Hall et al., 1997, Fleet et 
al., 1998) and minimizing potential toxicity from acetoxymethyl ester hydrolysis. 
Fluo-4AM is widely used for photometric and imaging applications in confocal 
microscopy, flowcytometry, spectrofluorometry, and in fluorometric high- 
throughput microplate screening assays (Gee et al., 2000). Limitations of using 
Fluo-4AM might be leakage of intracellular dye, photobleaching, non-uniform 
dye loading, and cell size differences (Gee el a l, 2000). Moreover, in case of 
quantitative determination of calcium concentration independently of the 
intraccllular dye concentration, ratiometric probes, such as Fura-2, have to be 
utilised for Ca2+recordings (Tsien et al., 1985).
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In the present work, with the employment of confocal fluorescence microscopy, 
Fluo-4AM and TMRM has been successfully applied for simultaneous 
recordings of individual neuronal Ca2+ and Ai//m responses in relation to NMDA- 
induced excitotoxicity.
7.4 Delayed Calcium Deregulation versus Immediate Calcium 
Deregulation
The characterisation of NMDA-induced excitotoxic models also revealed 
differentiation in the Ca2+ homeostasis in response to the stimulation within the 
neurons. In fact, following excitotoxic insult, cells either displayed: a constantly 
recovered cytosolic Ca2+to stable basal levels and neuronal survival (Tolerance); 
a loss of cytoplasmic Ca2+ followed by an initial recovery of Ca2+ levels and a 
secondary failure of neuronal Ca2+ homeostasis termed delayed calcium 
deregulation (DCD); or a cytoplasmic Ca2+ failure and immediate calcium 
deregulation (ICD) (D'Orsi et a l, 2012).
In order to elucidate the molecular events leading to neuronal injury, our 
laboratory and also other groups have investigated the relationship between
9 +mitochondrial membrane potential depolarisation and NMDA-receptor Ca
accumulation, associated with DCD and ICD (Budd and Nicholls, 1996, Castilho
et al., 1998, Ward et al., 2000, Rego et al., 2001, Ward et al., 2007, Weisova et
al., 2011, D'Orsi et a l, 2012). Therefore, it is important to establish the
distinction between DCD and ICD. It has been demonstrated that glutamate-
induced ICD in cerebellar granule neurons is caused by an acute ATP deficit, in
condition of glucose limitation, following protonophore or respiratory chain
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inhibitors addition and in the absence of the inhibitor of oxidative 
phosphorylation oligomycin (Budd and Nicholls, 1996, Castilho et a l, 1998). 
Interestingly, DCD can be distinguished from the ICD, as the latter can be 
reversed by restoring metabolic competence, such as by the combination of 
inhibitors, like oligomycin and MK-801, whereas DCD, once under way, is an 
irreversible process (Castilho et al., 1998, Nicholls et al., 2003). The assessment 
that neurons undergoing DCD can not restore their Ca2w homeostasis suggests a 
failure of the PMCA, either as a result of damage (proteolytic or oxidative) to the 
enzyme, or as a consequence of ATP restriction (Castilho et al., 1998).
7.5 Temporal relationship between \y /m loss, DCD and calpains 
in neuronal injury
In this study, we described the diverse mechanisms of cell death in excitotoxicity 
in relation to the neuronal Ca2+ responses and classified them into three groups: 
Tolerant, apoptotic/DCD and necrotic/ICD (Ankarcrona et al., 1995, Ward et al., 
2007, D'Orsi et a l, 2012). Having established the working models, we 
characterised the role of calpains in response to transient and prolonged 
glutamate receptor overactivation in primary neurons. Our data suggest that, 
surprisingly calpains do not contribute to excitotoxic injury under conditions that 
are associated with ICD and excitotoxic necrosis. Using pharmacological, 
genetic and single-cell imaging approaches, we demonstrated that calpains rather 
play a critical role in neurons undergoing DCD and delayed excitotoxic 
apoptosis.
Moreover, confocal time-lapse microscopy experiments demonstrated that in
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NMDA-induced excitotoxicity: mitochondrial membrane potential depolarisation 
is coupled with calcium deregulation, where the former always precedes the 
latter; calpain activation occurs downstream of mitochondrial engagement during 
excitotoxic apoptosis with similar kinetics to that of DCD and upstream ccll 
lysis; and finally, calcium chelator addition delayed both calpain activation and 
DCD. Taking all results together, our data demonstrated that calpain activation is 
Ca2+-dependent, occurs downstream of ¿»ax-dependent mitochondrial dysfunction 
and calpains function as effectors during the execution stage of neuronal death, 
and lastly it may be triggered by DCD (D'Orsi et al., 2012).
7.6 The Bcl-2 proteins in excitotoxic injury
The Bcl-2 family of proteins are essential intermediate and mediators of the 
mitochondrial pathway of apoptosis by controlling the mitochondrial outer 
membrane (MOM) integrity (Green and Evan, 2002, Tsujimoto, 2003, Danial 
and Korsmeyer, 2004). Within this family, some members inhibit cell death 
(such as Bcl-2 and Bcl-xL), while others promote cell death (for example BH3- 
only proteins and the effector proteins, Bax and Bak). The classical apoptotic 
signalling cascade is initiated by the pro-apoptotic Bcl-2 family members, Bax 
and Bak (Wei et al., 2001), which, upon activation, oligomerise into proteolipid 
pores within the MOM to promote permeabilisation of the outer mitochondrial 
membrane. This allows for the release of soluble molecules, such as cyt-c, AIF, 
Smac/DIABLO and Omi from the IMS to diffuse into the cytosol (Liu et al., 
1996, Susin et al., 1996, Du et al., 2000, Kuwana et al., 2002). Cyt-c and 
Smac/DLABLO engage APAF-1 to oligomerise into a caspase activation
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platform termed the apoptosome, which binds and promotes the activation of 
caspase 9. This initiator caspase activates the executioner caspases, such as 
caspases 3 and 7, eventually leading to apoptotic cell death (Riedl and Salvescn,
2007). After MOMP, caspase activation and apoptosis often ensue within 
minutes.
The BH3-only proteins, such as Bid, Bim and Puma, are capable of promoting 
Bax/Bak activation in a direct-manner, their oligomerisation and MOMP (Huang 
and Strasser, 2000) and the subsequent activation of apoptotic signalling.
The activation of the apoptosis caspase cascadc is not the only pathway observed 
in neuronal injury. In fact, a caspase-indcpendent cell death is mediated by the 
activation of several enzymes, including phospholipases, endonucleases, and 
proteases, such as cathepsins and calpains. In this process, BH3-only proteins 
may still be activated and the release of pro-apoptotic proteins from 
mitochondria, such as AIF and endonuclease G, are responsible for triggering 
cell death signalling (Herdegen, 2004).
Several studies have demonstrated that overexpression of anti-apoptotic proteins, 
including bcl-2 and bcl-xL, and genetic deficiency or biochemical inhibition of 
pro-apoptotic members, such as bim and bax, protect neurons from excitotoxic 
injury (Jia et ah, 1996, Lawrence et ah, 1996, Asoh et ah, 2002, Garrity-Moses 
et ah, 2005, Iriyama et ah, 2009). Despite evidence that only the combined 
absence of bax and bak provides resistance to cell death of neuroprogenitors 
(D'Sa et ah, 2003, Lindsten et ah, 2003), several reports demonstrated that single 
deletion of bax is sufficient to confer protection against neurotrophic factors 
deprivation, excitotoxicity and DNA damage (Deckwerth et al., 1996, Miller et 
al., 1997, Deshmukh and Johnson, 1998, Xiang et ah, 1998), whereas the
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absence of bak gene failed to provide protection (Putcha el al., 2002). This raises 
the possibility that the functions of Bax and Bak may not be redundant in 
neurons and suggest that Bak is not functionally coupled to apoptosis. This lack 
of redundancy may be caused by the fact that full-length Bak is not expressed at 
detectable levels in neurons (Sun et al., 2001). However, recent studies identified 
a novel neuron-specific splice variant of Bak (N-Bak) that only contains the BH3 
domain, suggesting its potential role upstream of Bax to promote cell death (Sun 
et al., 2001, Uo et al., 2005).
7.7 The Bcl-2 family in calcium and mitochondrial dysfunction
The importance of the Bcl-2 family proteins in the induction of cell death and 
their intermediate position in the apoptotic cascade led us in investigating on the 
role of these members in promoting excitotoxic cell death and in relation to 
calpain activation. Also in our study, box and èrâ-deficiency exerted 
ncuroprotection against excitotoxic apoptosis. In contrast, ¿/¿/-deficiency did not 
afford any significant protection in NMDA-induced apoptotic cell death. 
Moreover, our data demonstrated that calpain-dependent cell death required a 
functional /;ax-dependent mitochondrial apoptosis pathway in which calpains 
function downstream of the BH3-only proteins, Bid and Bim, as cell-death 
executioners. Furthermore, box gene deletion produced alteration in 
mitochondrial bioenergetics and the neuronal calcium handling, raising the 
hypothesis that Bax is responsible for these effects (Chapter V and VI) (D'Orsi et 
al., 2012).
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Mitochondria continually interact with other mitochondria of neighbour cells to 
sustain metabolic function, to rapidly repair damaged mitochondria and to 
exchange components, such as DNA and proteins between mitochondria. These 
dynamic features are believed to be due to two disparate mitochondrial 
remodelling processes, fusion and fission, which operate simultaneously (Chan,
2006, Cerveny et a l, 2007). Efficient mitochondrial function is vital for the 
preservation of healthy cells and thus, defective mitochondrial fusion and fission 
is thought to promote the development and progression of neurodegenerative 
diseases (Chen and Chan, 2009, Su et al., 2010). Neurons are particularly 
dependent on mitochondria for energy production and calcium buffering, hence, 
they are sensitive to alterations of mitochondrial function, which may result in 
dysfunctional synapses, axonal degeneration, and eventually cell death.
The three large GTPase, Mitofusins 1 and 2 (Mfnl/2) associated with the MOM, 
and optic atrophy 1 (Opal) in the mitochondrial inner membrane (MIM), are 
essential for mitochondrial fusion (Santel and Fuller, 2001, Olichon et al., 2003, 
Santel et al., 2003, Koshiba et al., 2004), whereas the dynamin related protein 
Drpl and its receptor Fisl promotes the constriction of mitochondria followed by 
mitochondrial fission (Smirnova et al., 1998, Smirnova et al., 2001, James et al., 
2003). Following pro-apoptotic stimulation, activation of Bax and Bak leads to 
MOMP resulting in the release of inner mitochondrial proteins, such as cyt-c. 
The observations that apoptosis is accompanied by mitochondrial fragmentation 
and this can often coincide with MOMP and cyt-c release provided indication of 
a cross-talk between the Bcl-2 family function and mitochondrial dynamics
7.7.1 Bcl-2 family proteins and mitochondrial fusion/fission dynamics
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(Frank et a i, 2001, Karbowski et a i, 2002, Perfettini et al., 2005, Autret and 
Martin, 2009). During apoptosis, components of the mitochondrial fusion and 
fission machinery, such as Drpl and Mfn2, are recruited to mitochondrial 
scission sites and colocalise with Bax (Frank et al., 2001, Karbowski et a i, 
2002). Moreover, box and bak gene deletion results in reduced fusion in mouse 
embryonic fibroblasts (Karbowski et a i, 2006). However, overexprcssion of Bax 
and Bak similarly induces mitochondrial fission (Sheridan et al., 2008). 
Therefore, the localisation of many Bcl-2 family members in MOM and changes 
in the ratios of pro-apoptotic Bax and Bak versus anti-apoptotic Bcl-2 family 
members may influence mitochondrial morphology, modulating the activity and 
interactions of other fusion and fission mediators. Bax and Bak are not the only 
Bcl-2 proteins linked to mitochondrial dynamics. Recent studies showed that 
Bcl-2 and Bcl-xL can associate with Mfn2 and promote mitochondrial fusion 
(Chipuk et al., 2010).
Nevertheless, the molecular basis for the role of Bcl-2 family proteins in 
mitochondrial fusion/fission remains unknown and a clear hypothesis for their 
function is currently lacking.
Mitochondrial dysfunction includes fragmentation of the mitochondrial network 
and remodelling of the cristae, characterised by fusion of individual cristae and 
widening of the cristae junctions, resulting in the removal of the diffusion barrier 
and mobilisation of cyt-c from intra cristae space to IMS (Frank et al., 2001, 
Scorrano et al., 2002). Several proteins that are involved in mitochondrial fusion 
and fission may play an essential role in the pro-apoptotic remodelling of cristae. 
Of note, Drpl, key component for mitochondrial fission, is required for the 
optimal release of cyt-c, likely through its contribution to cristae remodelling
(Germain et al., 2005). Other studies suggested that Opal oligomers contribute to 
maintain the cristae structure and its proteolytic activation cause mitochondrial 
fragmentation and alters the shape of the cristae (Olichon et al., 2003). Upon 
apoptosis induction, BH3-only proteins, Bid and Bik, disrupt Opal oligomers, 
causing rearrangements of the submitochondrial structure and loss of their 
compartmentalisation, cyt-c mobilisation, MOMP and release of IMS proteins 
(Scorrano et al., 2002, Germain et al., 2005).
7.7.2 Bcl-2 family proteins and the PTP
The mitochondrial permeability transition pore (PTP) is located between MOM 
and MIM and allows the release of cyt-c ad other intermembrane space proteins 
(Zamzami and Kroemer, 2001). Its molecular structure is not yet clear, but the 
adenine-nucleotide translocator (ANT), a voltage-dependent anion channel 
(VDAC) and cyclophilin D are considered to be major components of this 
mitochondrial megachannel. In response to an apoptotic stimulus, two models of 
cyt-c release have been proposed, where MOMP occurs either by opening of PTP 
or by MOM rupturing. In the first, mitochondrial calcium levels increase and 
activate voltage operated PT pore, causing persistent opening of the pore 
complex and allowing not only Ca2+ but also low-molecular-mass matrix 
components to easily pass through the mitochondrial membranes (Green and 
Kroemer, 2004). The other model suggests that initial permeabilisation of MIM 
exerts osmotic pressure on the mitochondrial matrix thereby leading to a cascade 
of events, including swelling and christae reorganisation, MOM rupture and 
MOMP, and subsequent release of intermembrane space proteins (Feldmann et
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The Bel-2 family of proteins have also been suggested to regulate the opening of 
PTP, forming large channels or pores in the MOM. Bax and Bid, as well as Bcl- 
xL and Bcl-2, form functional pores in synthetic lipid vesicles and planar lipid 
membranes (Antonsson et al., 1997, Minn et a l, 1997, Schlesinger et al., 1997, 
Schendel et al., 1999). This model predicts that anti-apoptotic Bcl-2 family 
members, including Bcl-2 and Bcl-xL, modulate the pore by maintaining it in a 
close conformation, while pro-apoptotic proteins, such as Bax and Bak, engage 
proteins from the PTP complex, i.e. ANT and/or VDAC, to induce the PTP 
opening and MOMP (Marzo et al., 1998, Shimizu et a l, 1999). PTP opening 
should lead to MOMP, however, several studies suggested that Bax binds tBid, 
which trigger Bax oligomerisation and mitochondrial insertion allowing the 
release of cyt-c independently of PTP components (Eskes et al., 1998, Eskes et 
al., 2000, von Ahsen el al., 2000, Wei et a l, 2000, Martinou and Green, 2001). 
These two models of Bax-mediated MOMP are not mutually exclusive, indeed 
they may coexist in specific pro-apoptotic settings. Moreover, the contribution of 
the PTP to Bax-mediated MOMP may be dependent on the concentration of Bax 
and its oligomerisation status (Pastorino et a l, 1999).
The current challenge is a further investigation to determine how different pro- 
apoptotic effectors, including proteins of the Bcl-2 family and PTP constituents, 
interact with the molecular machinery that mediates mitochondrial dynamics, 
cristae remodelling and apoptosis.
al., 2000).
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Excitotoxic insult to neurons is dependent on Ca2+ entry through glutamate 
receptors, which alters calcium homeostasis, induces oxidative stress and 
mitochondrial depolarisation, leading to release of pro-apoptotic molecules, such 
as cyt-c and AIF. Mitochondria, through a tightly controlled process involving 
Ca2+-sensitive dehydrogenases, regulate Ca2+ accumulation from the cytosol. 
However, excessive levels of Ca2+ load leads to subsequent mitochondrial 
dysfunction, including mitochondrial fusion and fission, and can trigger cell 
death by activating proteases, such as calpains resulting in protein degradation; 
by reinforcing signals leading to caspase activation or by triggering other 
catabolic processes mediated by lipases and nucleases (Zundorf and Reiser, 
2011). The activation of the Bcl-2 protein Bax and its translocation from the 
cytosol into the mitochondrial membrane is a necessary event to trigger 
mitochondrial dysfunction and induce apoptosis (Hsu et al., 1997, Itoh et al., 
2003, Lin et al., 2005, Perier et al., 2007, Gavathiotis et al., 2008, Galluzzi et al., 
2009). Here, we provided evidence that bax is required to induce excitotoxic 
apoptosis in primary neurons as bax gene deletion provides significant protection 
against excitotoxic death stimuli. In addition, the absence of bax also prevented 
NMDA-induced alteration of mitochondrial membrane potential, as 
hyperpolarisation and depolarisation were notably diminished, and affected 
neuronal calcium handling, resulting in increased neuronal survival (Chapter VI). 
In conclusion, these results suggest that neurons lacking bax may display 
interrupted cascade of events leading to calcium overload and mitochondrial 
dysfunction.
7.7.3 Bax and calcium dysregulation
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Mitochondria not only interact with themselves but also with the ER within 
neurons. Another role assigned to the Bcl-2 family is the possible regulation of 
the interaction between mitochondria and ER by influencing ER calcium stores 
and signalling (Chipuk et al., 2010). Rong et al. suggested that the direct 
interaction between the BH4 domain of Bcl-2 and IP3R is responsible for the 
inhibition of the IP3R activity and apoptosis, reducing resting ER Ca2+ levels and 
cytosolic Ca2+ oscillations (Rong et al., 2009). Bax and Bak had also been 
suggested in regulating ER Ca2+ storage, possibly by inactivating the inhibitory 
functions of Bcl-2 and Bcl-xL on the IP3R (Scorrano et al., 2003, Oakes et al., 
2005).
Involvement of mitochondria and ER in Ca2+ homeostasis is an important 
common theme in neurodegenerative diseases, since these organelles are 
intimately involved in neuronal cell death.
7.8 Calpain-mediated neuronal injury
Calpain is a ubiquitous calcium-sensitive protease, essential for normal 
physiological neuronal function (Goll et al., 2003). However, uncontrolled 
release of glutamate results in increased calcium influx, causing pathologic 
activation of calpains in a number of neurodegenerative diseases, including 
Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, multiple 
sclerosis, and amylotrophic lateral sclerosis (Vosler et al., 2008). Initially, 
calpains were believed to be involved only in necrotic cell death pathways, while 
caspases could rather cause apoptosis. Afterward, several studies showed the 
requirement of calpains in both apoptotic and necrotic cell death, and in various
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experimental models, the use of calpain inhibitors conferred neuroprotection 
from injury (Squier et al., 1994, Pom-Ares et al., 1998, Wang and Linden, 2000, 
Crocker et al., 2003, Liu et al., 2004b, Camins et a l, 2006). The role of calpain 
in necrotic versus apoptotic cell death is still controversial, however, our 
experiments demonstrated that, in mouse cortical neurons, calpains play a critical 
role in NMDA-mediated excitotoxic apoptosis, but do not contribute to 
excitotoxic injury under conditions associated with ICD and excitotoxic necrosis 
(Chapter III and IV) (D'Orsi et al., 2012).
Pathologic activation of calpain results in the cleavage of a number of neuronal 
substrates that negatively affect neuronal structure and function, leading to 
inhibition of essential neuronal survival mechanisms. Calcium dysregulation is 
necessary to cause delayed calpain activation that potentially contributes to 
delayed cellular damage. Calpain itself may contribute to the sustained calcium 
overload by cleaving and altering the function of its substrates.
The most obvious effect of calpain activity on calcium regulation is the cleavage 
of important calcium channels within the cell. Calpains are able to cleave the 
NCX and the PMCA, that after truncation, both proteins reduces the ability of the 
cell to maintain a low internal calcium concentration and therefore contributes to 
a feed-forward pathway of cytosolic calcium overload (Bevers and Neumar,
2008). In in vitro excitotoxicity and in vivo brain ischemia, calpain activation 
mediates the cleavage of the NCX, which is prevented by calpain inhibitors or 
calpastatin overexpression (Bano et al., 2005). Similar neuroprotection effects 
were observed in the block of PMCA internalisation in hippocampal neurons 
exposed to glutamate excitotoxicity (Pottorf et al., 2006).
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Disruption of neuronal calcium homeostasis is only one mechanism by which 
calpains have been proposed to cause cell death but also the disruption of 
survival signals or activation of death signals through cytosolic, mitochondrial, 
lysosomal, and nuclear substrates remains as potential mechanisms that require 
further evaluation.
Calpains have been shown to cleave AIF, and to induce its release from 
mitochondria and may thereby induce cell death (Cregan et al., 2002, Wang et 
al., 2004, Bano et al., 2005, Polster et al., 2005, Cao et al., 2007). Release of AIF 
in response to excitotoxic stimuli was observed to be suppressed by adenovirus- 
mediated expression of calpastatin (Volbracht et al., 2005, Cao et al., 2007), in 
transgenic mice overexpressing calpastatin (Takano et al., 2005), and following 
//-calpain genetic knockdown in neurons (Cao et al., 2007). Therefore, calpains 
may be function to promote a caspase-indepcndent apoptotic cell death via an 
AIF-mediated mechanism, substituting caspases.
7.9 CaLpain activation in a caspase-independent excitotoxic 
apoptosis
Notably, our study demonstrates that calpain activation occurred downstream of 
mitochondrial engagement during excitotoxic apoptosis. These findings and the 
observation that excitotoxic apoptosis is ¿ox-dependent elicit two related and 
important questions: (i) why does excitotoxic injury not trigger a prominent 
caspase activation, and (ii) why do calpains represent the cell death executioners 
during ¿ax-dependent excitotoxic apoptosis while in other models of ¿ax-
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dependent neuronal apoptosis such as staurosporine exposure, caspases but not 
calpains function as executioners (Lankiewicz et al., 2000). A key factor may be 
the extent of mitochondrial Ca2+ overloading in such paradigms. Following the 
initial NMDA-induced cytosolic Ca2+ increase, neurons not only pump Ca2+ back 
into the extracellular compartment, but also re-establish their cytosolic Ca 
levels through potential-dependent mitochondrial Ca2+ uptake (Nicholls and 
Scott, 1980, Ward et al., 2005). A èax-dependent mitochondrial outer membrane 
permeabilisation (MOMP) will however cause mitochondrial depolarisation due 
to the loss of cyt-c (Goldstein et al., 2000, Luetjens et al., 2000). Mitochondrial 
depolarisation may trigger a Ca2+ release from the mitochondrial matrix, capable 
of activating calpains. It has also been suggested that cyt-c release triggers Ca2+ 
release from the ER, producing a feed-forward mechanism, where ER and 
mitochondria can work together to execute the apoptotic cell death (Boehning et 
al., 2003). Indeed, previous studies have shown that DCD is absent when MOMP 
is blocked (Concannon et a l, 2010).
7.10 Conclusion
Current knowledge of the important role of calpain in a variety of 
neurodegenerative diseases and calpain-associated disorders suggests that 
therapeutic modulation of calpain activity may be of clinical relevance. 
Furthermore, several functional and disease association studies implicates 
calpain inhibition as a potential therapeutic intervention strategy. Therefore, 
elucidation of the signalling cell death pathways that contribute to
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neurodegeneration is also important to provide possible therapies to patients’ 
conditions.
One important concern is that, the use of drugs reducing calpain activity might 
affect the physiological role and function of calpains and eventually cause 
adverse side effects. Therefore, approaches that might involve nonspecific 
calpain inhibition are a potentially unacceptable therapeutic strategy. In contrast, 
approaches that might avoid toxicity include isoform-specific calpain inhibition, 
targeting nondividing cells, or targeting subcellular compartments where 
pathologic calpain activity contributes to neuronal death.
Our study has contributed to elucidate and identify the signalling mechanisms 
involved in excitotoxicity and OGD that have been demonstrated to be 
implicated in ischemic stroke. Using combined biochemical, pharmacological 
and single-cell imaging approaches, we characterised the activation of calpains in 
response to excitotoxic events, demonstrating that calpains play a crucial role in 
6ax-dependent apoptotic cell death but contribute little to the destruction of 
neuron during excitotoxic necrosis. In addition, we identified the temporal 
relationship between calpain activation, MOMP and calcium deregulation, 
establishing that calpains require a functional mitochondrial apoptosis pathway. 
Hence, calpains function downstream the activation of the BH3-only proteins 
and mitochondrial depolarisation and may be activated following the secondary 
delayed calcium deregulation, acting as effectors during the execution stage of 
apoptotic cell-death.
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Calpains Are Downstream Effectors of bax-Dependent 
Excitotoxic Apoptosis
Beatrice D’Orsi,1 Helena Bonner,1 Liam P. Tuffy,1 Heiko Diissmann,1 Ina Woods,1 Michael J. Courtney,2 
Manus W. Ward,1 and Jochen H. M. Prehn1
'Department of Physiology and Medical Physics, Centre for the Study of Neurological Disorders, Royal College of Surgeons in Ireland, Dublin 2, Ireland, and 
2Molecular Signalling Laboratory, Department ofNeurobiology, A. I. Virtanen Institute, University of Eastern Finland, 70210 Kuopio, Finland
Excitotoxicity resulting from excessive Ca2+ influx through glutamate receptors contributes to neuronal injury after stroke, trauma, and 
seizures. Increased cytosolic Ca2+ levels activate a family of calcium-dependent proteases with papain-like activity, the calpains. Here we 
investigated the role of calpain activation during NMDA-induced excitotoxic injury in embryonic (E16-E18) murine cortical neurons 
that (1) underwent excitotoxic necrosis, characterized by immediate deregulation of Ca2+ homeostasis, a persistent depolarization of 
mitochondrial membrane potential ( Ai//m), and insensitivity to bax-gene deletion, (2) underwent excitotoxic apoptosis, characterized by 
recovery of NMDA-induced cytosolic Ca2+ increases, sensitivity to bax gene deletion, and delayed At//m depolarization and Ca2+ dereg­
ulation, or (3) that were tolerant to excitotoxic injury. Interestingly, treatment with the calpain inhibitor calpeptin, overexpression of the 
endogenous calpain inhibitor calpastatin, or gene silencing of calpain protected neurons against excitotoxic apoptosis but did not 
influence excitotoxic necrosis. Calpeptin failed to exert a protective effect in ¿»ax-deficient neurons but protected bid-deficient neurons 
similarly to wild-type cells. To identify when calpains became activated during excitotoxic apoptosis, we monitored calpain activation 
dynamics by time-lapse fluorescence microscopy using a calpain-sensitive Forster resonance energy transfer probe. We observed a 
delayed calpain activation that occurred downstream of mitochondrial engagement and directly preceded neuronal death. In contrast, we 
could not detect significant calpain activity during excitotoxic necrosis or in neurons that were tolerant to excitotoxic injury. Oxygen/ 
glucose deprivation-induced injury in organotypic hippocampal slice cultures confirmed that calpains were specifically activated during 
foflx-dependent apoptosis and in this setting function as downstream cell-death executioners.
Introduction
Overactivation of glutamate receptors ("excitotoxicity”) has been 
implicated in the pathophysiology o f stroke (Zipfel et al., 1999) 
and several chronic neurodegenerative disorders (Rothstein et 
al., 1990; Lipton, 2007; Mattson, 2007). The excessive activation 
of NMD A and AMPA receptors significantly disrupt cellular ion 
homeostasis. As a result, a primarily Ca2+-dependent cell death 
occurs (Choi, 1987). After an intense and sustained period of 
glutamate receptor overactivation, the loss of ion homeostasis is 
frequently irreversible, ATP levels deplete, and excitotoxic necro-
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sis is activated (Tymianski et al., 1993; Ankarcrona et al., 1995; 
Budd and Nicholls, 1996; White and Reynolds, 1996; Vergun et 
al., 1999; Ward et al., 2000). Conversely, transient ionic overload­
ing often results in a less severe disturbance, allowing the cells to 
initially recover and restore their ionic gradients. Nevertheless, 
after the insult, neurons can either build on their initial recovery 
and survive or initiate a cell-death machinery, resulting in exci­
totoxic apoptosis (Ankarcrona et al., 1995; Lankiewicz et al., 
2000; Luetjens et al., 2000). A number of studies addressed the 
differential activation of apoptosis and necrosis, in particular 
during ischemic brain injury (Manabat et al., 2003; Liu et al., 
2004; Wei et al., 2004). Previous studies have shown excitotoxic 
apoptosis to induce the release of pro-apoptotic factors from 
mitochondria, including cytochrome c and apoptosis-inducing 
factor (AIF) (Budd et al., 2000; Lankiewicz et al., 2000; Luetjens et 
al., 2000; Cregan et al., 2002; Wang et al., 2004; W ard et al., 2006). 
The mitochondrial apoptosis pathway is controlled by pro- and 
anti-apoptotic Bcl-2 family proteins and either overexpression of 
anti-apoptotic bcl-2 or bcl-xL, or gene deficiency in the pro- 
apoptotic bax or him genes to prevent excitotoxic apoptosis 
(Xiang et al., 1998; Wang et al., 2004; Dietz et al., 2007; Semenova 
et al., 2007; Concannon et al., 2010). In most cells, the release of 
cytochrome c activates a family of cysteine proteases, the 
caspases, by binding to apoptotic protease-activating factor-1 
(APAF-1) (Liu etal., 1996; Zouetal., 1997). Inneurons,however, 
caspase activation is frequently suboptimal despite the engage­
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ment of the mitochondrial apoptosis pathway (Budd et al., 2000; 
Lankiewicz et al., 2000). This phenomenon maybe attributable to 
high expression levels o f the caspase inhibitor XIAP (X-linked 
inhibitor o f apoptosis protein) (Potts et al., 2003) or reduction in 
protein levels of APAF-1 during neuronal maturation (Wright et 
al., 2007).
Of note, the activation of the Ca2+-activated neutral cysteine 
protease calpain I has also been implicated in excitotoxic neuron 
death (Siman et al., 1989; Brorson et al., 1995; Lankiewicz et al., 
2000). Similar to caspases, calpain 1 cleaves a variety of cytoskcletal 
proteins, enzymes, and transcription factors and may induce mor­
phological alterations that mimic caspase-dependent apoptosis 
(Croall and Demartino, 1991; Wolf et al., 1999). Furthermore, 
calpain has been shown to cleave and inactivate pro-caspase 9, 
pro-caspase-3, and APAF-1 (Chua et al., 2000; Lankiewicz et al., 
2000; Reimertz et al., 2001). Because calpains are activated by 
significant increases in cytosolic C a2'1, calpains may specifically 
play a role in cell demolition during excitotoxic necrosis, but this 
has not yet been experimentally tested. Using a combined bio­
chemical, pharmacological, and single-cell imaging approach, we 
demonstrate here that calpains are required for the execution of 
box-dependent excitotoxic apoptosis but surprisingly play no sig­
nificant role during excitotoxic necrosis.
Materials and Methods
Materials. Fetal calf serum, fetal bovine serum, horse serum, B27 supplement, 
minimal essential medium (MEM), Neurobasal medium, tetramethyirhod- 
amine methyl ester (TMRM), Huo-4 AM, and l,2-6is-(o-ammophenoxy)- 
ethane-N,N,N'JV '-tetraacetic acid, tetraacetoxymethyl ester (BAPTA-AM) 
were from Invitrogen (Bio Sciences). Calpeptin was purchased from ENZO 
Life Sciences and ionomycin from Merck Biosdences. All other chemicals, 
including NMDA and MK-801, came in analytical grade purity from 
Sigma-Aldrich,
Gem-targeted mice. '¡Tie generation and genotyping of bid~' mice lias 
been described previously (Kaufmann et al., 2007). Several pairs of heterozy­
gous breeder pairs of i»a.x-deficient mice were obtained from The Jackson 
laboratory and maintained in house. The genotype o f b o x ' ' '  m ite was 
confirmed by PCR as described by The Jackson laboratory  (http://jaxmice. 
jax.org/protocolsdb/fip =  116:2:863695382966767::NO:2:P2_MASTER_ 
PROTOCOI._ID,P2_JRS_CODE:250,002994). T he bid~'~  mice was 
generated on an inbred C57BL/6 background, using C57BL/6-derived ES 
cells. The bax~/_  mice were originally generated o n  a m ixed C57BL/ 
6X129SV genetic background, using 129SV-derived ES cells bu t had 
been backcrossed for > 12  generations onto  the C57BL/6 background.
D N A  extraction and genotyping. DNA was extracted from  tail snips 
using High Pure PCR Tem plate Preparation Kit (Roche). Genotyping 
was perform ed using three specific prim ers as follows: 5'GGTCTGT- 
GTGGAGAGCAAAC3' (com m on), 5'TCAGGTGCCAGTGGAGAT- 
GAACTC3' [wild-type (W T) allele-specific], and  5'GAGTCATA- 
CTTACTTCCTCCGAC3' (m utant allele-specific) for bid; and 5 'GTT- 
GACCAGAGTGGCGTAGG3' (com m on), 5'GAGCTGATCAGAAC- 
CATCATG3' (W T allele-specific), and 5'CCGCTTCCATTGCTCA- 
GCGG3' (m utant allele-specific) for bax. The sizes o f  the expected PCR 
products are illustrated in Figure 4 A.
Preparation o f mouse neocortical neurons. Prim ary cultures o f cortical 
neurons were prepared from E16 to E18 as described previously (Con- 
cannon et al„ 2010). To isolate the cortical neurons, hysterectomies o f the 
uterus o f pregnant female mice were perform ed using an abdom inal 
injection o f 40 m g/kg pentobarbital (Dolethal) as lethal anesthesia. The 
cerebral cortices were pooled in a dissection m edium  on ice (PBS with 
0.25% glucose and 0.3% bovine serum album in). The tissue was incu­
bated with 0.25% trypsin-EDTA at 37°C for 15 m in. After the incuba­
tion, the trypsinizalion was stopped by the addition  o f m edium  
containing sera. The neurons were then dissociated by gentle pipetting, 
and, after centrifugation (800 X g for 3 m in), the m edium  containing 
trypsin was aspirated. Neocortical neurons were then resuspended in
fresh plating m edium  (MEM containing 5% fetal calf serum , 5% horse 
serum, 100 U /m l penicillin/streptomycin, 0.5 mM L-glutamine, and 0.6% 
D-glucose). Cells were plated at 2 X 105 cells/cm2 on poly-lysine-coated 
plates and incubated at 37°C, 5% C 0 2. The plating m edium  was ex­
changed with 50% feeding m edium  (Neurobasal m edium  em bryonic 
containing 100 U /m l Pen/Strep, 2% B27, and 0.5 mM L-glutam ine) and 
50% plating m edium  with additional cytosine arabinofuranoside (600 
iim). Two days later, the m edium  was again exchanged for com plete 
feeding m edium . All experiments were perform ed on days in vitro (D1V) 
8 -11. All animal w ork was perform ed with ethics approval and under 
licenses granted by the Irish D epartm ent o f Health and Children.
Cell lines. H um an SH-SY5Y neuroblastoma cells were grown in 
DM EM /Ham ’s F-12 (1:1 m ixture) culture m edium  (Lonza) supple­
m ented with 15% fetal calf serum  and 100 U /m l penicillin/streptomycin. 
The m otor neuron-like cell line NSC34 was m aintained in  DMEM 
(Lonza) supplem ented with 10% fetal bovine serum, 2 mM L-glutamine, 
and 100 U /m l penicillin/streptom ycin.
Preparation o f  organotypic hippocampal slice cultures. Organotypic h ip ­
pocampal slices cultures (OHSCs) were prepared and cultured according 
to  the modified procedure (Kristensen et al., 2001). The brain  from  post­
natal day 10 m ouse pups was isolated and transferred to dissection m e­
dium  containing HBSS (Invitrogen), 20 mM HEPES, 100 U /m l penicillin/ 
streptomycin, and 0.65% glucose. Isolated hippocam pi were placed on a 
Mcllwain tissue chopper (Mickle Laboratory Engineering) and cut into 
450-/xm-thick sections. The slices were then transferred into fresh dis­
section m edium  and selected for clear hippocam pal m orphology (intact 
CA regions and dentate gyrus) and placed on porous (0.4 m) m em ­
brane of Millicell inserts (Millipore). The inserts were placed in  six-well 
tissue culture plates w ith 1 ml of culture m edium  consisting of MEM 
supplem ented with 25% horse serum, 4 him L-glutamine, 6 m g/ml 
D-glucose, 2% B27, 50 U /m l penicillin G, and 50 pig/ml streptomycin. 
The slices were m aintained in a humidified incubator with 5% C 0 2 at 
35°C with media changes every second day. All experiments were per­
form ed at DIV 10.
Determination o f neuronal injury: Hoechst andpropidium  iodide stain­
ing o f  nuclear chromatin. Neocortical neurons on 24-well plates were 
stained live with 1 /xg/ml Hoechst 33258 (Sigma) and 5 jam propidium  
iodide (PI) (Sigma) dissolved in  culture m edium. H oechst 33342 stains 
the condensed chrom atin  in  apoptotic cells m ore brightiy than the chro­
m atin in  healthy cells. The intact m em brane o f living cells excludes cat­
ionic dyes, such as PI. PI, a cell-impermeable red fluorescent dye, 
intercalates with nucleic acids in  cells with m em brane leakage. Nuclear 
morphology was assessed using an Eclipse TE 300 inverted microscope 
(Nikon) w ith20X , 0.43 NA phase-contrast objective using the appropri­
ate filter set for Hoechst, PI, and a charge-coupled device camera (SPOT 
RT SE 6; Diagnostic Instrum ents). All experiments were perform ed at 
least three times w ith independent cultures, and, for each tim e point, 
images of nuclei were captured in three subfields containing —300-400 
neurons each and repeated in triplicate. The num ber o f Pi-positive cells 
was expressed as a percentage o f total cells in  the field. Resultant images 
were processed using NIH Image J (Wayne Rasband, National Institutes 
o f Health, Bethesda, MD).
Oxygen-glucose deprivation in OHSCs. Slices were tested for viability 
with PI (5 ixm) before the oxygen-glucose deprivation (OGD) experi­
ments. Healthy slices from W T and bax~!~ mice were transferred to the 
hypoxic chamber (COY Lab Products). The hypoxic chamber had an 
atmosphere com prising 1.5% 0 2, 5% C 0 2, and  85% N 2, and the tem per­
ature was m aintained at 35°C  The slices were transferred to wells con­
taining pre-equilibrated and deoxygenated OGD m edium  (bubbled with 
N2 for 1 h  before use). The OGD m edium  consisted o f the following (in 
mM): 2 CaCl2, 125 NaCl, 25 N aH C 0 3, 2.5 KC1,1.25 N aH 2PO„, 2 M gS04> 
and 10 sucrose, pH  6.8. After 45 m in o f OGD, the slices were transferred 
to  fresh oxygenated culture m edium  and placed in  norm oxic conditions 
(21% 0 2 and 5% C 0 2), and PI uptake was observed over a 24 h period. 
Control slices were free from  OGD. Images were acquired with an Eclipse 
TE 300 inverted m icroscope (N ikon) and a 4 X dry objective w ith Wasabi 
Software version 5.0 (H am am atsu Photonics). The CA1 region was se­
lected from  W T and bax~'~  hippocampal slices after OGD treatment, 
and the mean fluorescent intensity was determ ined. The regional gray-
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level intensity was m easured using the W asabi interactive tool, back­
ground gray-level was corrected, and  the average intensity was plotted for 
nine slices per treatm ent. N euronal injury was expressed as percentage o f 
total injury (OGD perform ed for 4 h  and recovery for 24 h).
After each tim e point, slices were placed in to  a six-well plate w ithout 
media and 90 /a1 o f lysis buffer [2% SDS (w/v), 67.5 mM Tris/Cl, pH  6.8, 
and 10% glycerol] was added to  each insert containing three slices. Slices 
were rem oved by using a pipette and then transferred in to  an Eppendorf 
1 ml tube. The p rotein  was then stored at — 80°C.
SDS-PAGE and Western blotting. Preparation of cell lysates and W est­
ern blotting was perform ed as described previously (Reimertz et al., 
2003). The resulting blots were probed w ith the following: a m ouse 
m onoclonal a -fo d rin  (all-Spectrin) antibody (clone AA6; Millipore) 
diluted 1:1000; a rabbit polyclonal calpain large subunit antibody (Cell 
Signaling Technology) diluted 1:500; a rabbit polyclonal green fluores­
cent protein  (GFP) antibody (peptide 26-39 ; Calbiochem) diluted 
1:1000; and a m ouse m onoclonal /3-actin antibody (clone DM  1A; 
Sigma) diluted 1:5000. Horseradish peroxidase-conjugated secondary 
antibodies diluted 1:10,000 (Pierce) were detected using SuperSignal 
W est Pico Chem ilum inescent Substrate (Pierce) and imaged using a Fu- 
jiFilm LAS-3000 imaging system (FujiFilm).
Plasmids, transfections, and shRNA. Neocortical neurons (DIV 6) and 
NSC34 cells were transfected using Lipofectamine 2000 (Invitrogen), 
whereas SH-SY5Y cells were transfected with TurboFect In Vitro Trans­
fection Reagent (Fermentas). The m em brane-targeted calpain-sensitive 
Forster resonance energy transfer (FRET) probe pSCLPaX, containing 
the calpain-specific spectrin substrate linker, was prepared as follows. 
C om plem entary oligonucleotides 5'GCAG CAGGAGGTGTACGGAG- 
GTAC3' and 5'CTCCGTACACCTCCTGCTGCAGCT3' were annealed 
and ligated into SacI and Kpnl sites between enhanced cyan fluorescent 
protein (ECFP) and Venus in the FRET probe subcloning vector pTK- 
reverse SCAT (Hellwig et al., 2008). This generated a cassette consisting o f a 
coding sequence for the calpain substrate sequence QQEVYG flanked at the 
N terminus by ECFP, a serine tripeptide, and an SacI site (encoding glu- 
tam ate-leucine) and at the C term inus by a Kpnl site (encoding glycine- 
threonine), a flexible serine- glycine-serine tripeptide, and Venus. The 
oligonucleotide sequences im m ediately adjacent to  the overhangs were 
designed to destroy the SacI site during ligation w ith corresponding vec­
tor overhangs and generate a diagnostic PvuII site to facilitate exclusion 
o f constructs with m ultiple concatenated oligonucleotides. The resulting 
pTK-reverse SCLPa vector was digested w ith BsrGI to  generate a BsrGI 
site-flanked DNA fragm ent including calpain substrate m otif and Venus 
coding sequence. This was inserted in-fram e in to  the BsrGI site o f the 
m em brane-targeted ECFP expression vector pECFP-CAAX to generate 
the plasm id pSCLPaX. pECFP-CAAX was generated by replacing the 
coding sequence for EGFP in the plasm id pEGFP-CAAX (Hongisto et 
al., 2008) with the coding sequence for ECFP, using the enzymes Agel 
and BsrGI. For overexpression o f  calpastatin, cells were transfected with 
a vector expressing G FP-calpastatin  (MG209946; OriGene). For inhibi­
tion  of calpain, cells were transfected with a vector expressing either a 
commercial shRNA targeting the large subunit of calpain I  (SHCLNG- 
NM_007600, TRCN0000030664; Sigma) or the large subunit of calpain II 
(SHCLNG-NM_009794, TRCN0000030672; Sigma) or a scramble control 
vector (SHC001; Sigma). A plasmid with an enhanced GFP (pEGFP-Nl; 
Clontech) was used to  allow the identification o f transfected neurons. Cells 
were used for experiments 36 h after transfection.
Real-time live-cell imaging. Prim ary neocortical neurons on W illco 
dishes were coloaded with Fluo-4 AM (3 /am) and TMRM (20 hm) for 30 
m in at 37°C (in the dark) in  experimental buffer containing the following 
(in mM): 120 NaCl, 3.5 KC1, 0.4 KH2P 0 4> 20 HEPES, 5 N aH C 0 3, 1.2 
Na2S 0 4, 1.2 CaCl2, and 15 glucose, pH  7.4. The cells were washed and 
bathed in  2 m l o f experimental buffer containing TM RM , and  a th in  layer 
o f m ineral oil was added to prevent evaporation. N eurons were placed on 
the stage o f an LSM 510 M eta confocal microscope equipped with a 63 X , 
1.3 NA oil-im m ersion objective and a therm ostatically regulated cham ­
ber (Carl Zeiss). After 30 m in equilibration tim e, neurons were exposed 
to  N M DA-induced excitotoxic injury (30 /am NM DA for 5 m in, 100 /am 
NM DA for 5 m in, o r 300 /am NMDA for 60 m in), and glycine (10 /am) 
with MK-801 (5 /am) was added to block NM DA receptor activation as
required. TMRM was excited at 543 nm , and the emission was collected 
with a 560 nm  long-pass filter; Fluo-4 AM was excited at 488 nm , and the 
emission was collected th rough  a 505-550 n m  barrier filter. Images were 
captured every 30 s during NMDA excitation and every 5 m in  during the 
rest o f the experiments. In  separate experiments, neurons, transfected 
with the calpain-sensitive FRET probe and loaded with TMRM (20 dm) 
in experimental buffer, were placed on  the stage o f an LSM 5Live duoscan 
confocal microscope equipped with a 40X, 1.3 NA oil-im m ersion objec­
tive and a therm ostatically regulated chamber set at 37°C (1080; Carl 
Zeiss). After a 30 m in equilibration tim e, drug dissolved in experimental 
buffer was added to the medium . TMRM was excited at 561 nm , and the 
emission was collected by a 575 n m  long-pass filter. CFP was excited at 
405 nm , and emission was collected at 445-505 and 505-555 nm  for 
FRET. Yellow fluorescent protein (YFP) was excited directly using the 
489 n m  laser diode and detected w ith  the same bandpass filter used for 
FRET. Images were captured every 5 m in throughout these experiments. 
All m icroscope settings, including laser intensity and scan time, were 
kept constant for the whole set o f experiments. C ontrol experiments 
under these conditions were also perform ed and  showed that photo tox­
icity had a negligible im pact. The cell-permeable C a2+ chelator 
BAPTA-AM (500 nM) was used for TM RM /Fluo-4 AM and calpain- 
FRET probe experim ents and was added to the m edium  on stage 4 h after 
the NMDA exposure. The donor unquenching control experim ent was 
perform ed in neurons transfected w ith the FRET probe on the LSM 5live 
duoscan using the same m ode o f detection as stated above, except the 
missing delay between consecutive scans. Bleach scans were perform ed 
using the point scanner o f the m icroscope to  scan predefined regions 
only with the 489 n m  diode-pum ped solid-state laser acousto-optic tu n ­
able filter transmission set to 100% and using an 80/20 beam  splitter to 
bleach Venus (see Fig. 6C). All images were processed and analyzed using 
M etaM orph Software version 7.5 (Universal Imaging), and the data were 
presented normalized to  the baseline response.
Statistics. Data are given as means ±  SEM. For statistical comparison, 
one-way ANOVA followed by Tukey’s post hoc test was used, p  values 
<0.05 were considered to be statistically significant.
Results
Treatment with the calpain inhibitor calpeptin reduces 
delayed excitotoxic apoptosis in cortical neurons
To explore the role of calpains in excitotoxic neuronal injury, we 
used three models of NMDA-induced excitotoxicity in primary 
mouse cortical neurons. Cortical neurons were exposed to either 
NMDA (30 or 100 /am ) for 5 min (Fig. 1A) or 300 /am NMDA for 
60 min (Fig. 1 B). Controls were sham exposed to experimental 
buffer. Confocal imaging of individual Ca2+ responses using 
Fluo-4 AM demonstrated that neurons (1) completely and per­
sistently recovered their cytosolic Ca2+ to stable basal levels after 
termination of the NMDA exposure (Fig. 1C), (2) recovered their 
cytosolic Ca2+ levels after the NMDA exposure but showed a 
delayed Ca2+ deregulation (DCD) (Fig. ID ), or (3) failed to 
recover their NMDA-induced increase in intracellular Ca2+ and 
showed an immediate and sustained Ca2+ deregulation (ICD) 
(Fig. IE). We classified neurons according to these C a2+ re­
sponses into three groups designated "tolerant,” “apoptotic/ 
DCD,” and “necrotic/ICD” (Ankarcrona et al., 1995; Ward et al., 
2007). Parallel imaging of mitochondrial membrane potential 
(A'Pm) changes demonstrated that DCD was associated with a late 
mitochondrial depolarization (Fig. 1D), whereas neurons under­
going ICD showed an early and persistent depolarization (Fig. 
1E). In neurons exposed to 100 ¡xm  for 5 min, DCD occurred 
always subsequent to the delayed mitochondrial membrane po­
tential depolarization within a period of 30 ±  2 min. Some neu­
rons characterized by an ICD response still showed nuclear 
pyknosis (data not shown), suggesting that cells with an ICD 
response did not show a homogenously “necrotic” nuclear m or­
phology. Neurons displaying an ICD response after a 60 min
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Figure 1. NMDA receptor overactivation produces distinct types of neuronal responses as evidenced by single-cell imaging: 
tolerance, apoptosis, and necrosis. A, B, Models of excitotoxic NMDA receptor overactivation. The neurons were exposed to 30 ¿am 
NMDA for5min, 100 /am NMDA for5rnm,or 300 /am NMDA for 60min, after which alterationsinAi/>mandintracellularCa2+ were 
monitored in single cells using time-lapse confocal fluorescence microscopy [LSM 510 Meta). C-f, Three neuronal responses were 
readily identifiable (Ward el al., 2007): f ,  DCD/tolerant neuron with recovery of neuronal Ca2 + overloading and extensive hyper­
polarization of 0, excitotoxic apoptosis in which neuronal mitochondria transiently recovered their energetics and a late 
A de po la riza tio n  and DCD occurred hours after ihe initial excitation; E, ICD/necrosis with an acute and ICD associated with a 
rapid collapse of membrane potential. F, Quantification of cellular responsesfor the three injury models (/j =  102, n =  109, n =  
129 for 30 ¡jm/S mln, 100 ¡m! 5 itiin, and 300 jum/60 min treatments, respectively). Data were obtained from at least three 
independent experiments. 6, Quantification of cellularresponses in neurons fro m ix u r '"  mice (n =  61 neurons) and WTcontrols 
(n =  129 neurons) treated with 300 /am NMOA for 60 min. H, NMDA induces dose-dependent excitotoxicity over time. Cortical 
neurons were treated with30/x« NMDA for Smin, 100/iMNMDAfor5min, 300 /a m  NMDA for 60min, or sham conditions for5min 
and allowed to recover as indicated. Cell death was assessed by Hoechst and PI staining. Three subfields containing 300 -  400 
neurons each were captured, and at least three wells were analyzed per time point. Pl-positive nuclei were scored as dead neurons 
and expressed as a percentage of the total population. Data are means ± SEM from n = 3 separate cultures. Ctrl, Control. *p £  
0.05 compared with NMDA-treated control. V  — 0.05 between NMDA treatments (ANOVA, post hoc Tukey's test).
exposure to 300 /am NMDA were insensi­
tive to fewc-gene deletion (Fig. 1G). Neu­
rons undergoing DCD showed chromatin 
condensation primarily in the absence of 
nuclear fragmentation (Fig. 2 A) and may 
therefore be classified as “type II” apopto- 
tic neurons (Leist and Jâàttelâ, 2001).
Quantification of the individual Ca2+ 
responses in relation to the different inten­
sities of NMDA receptor overactivation 
demonstrated that the mild NMDA expo­
sure of 30 /am for 5 min [peak Fluo-4 fluo­
rescence, 1.94 ±  0.13 arbitrary units (AU)] 
primarily produced neuronal tolerance, 
whereas the 5 min exposure to 100 /am 
NMDA (peak Fluo-4 fluorescence, 2.47 
0.14 AU) produced a mix of DCD and 
ICD responses, with DCD responses be­
ing more prominent. In contrast, pro­
longed exposure o f 300 /am NMDA for 60 
min induced primarily ICD (Fig. IP).
Quantification of Pl-positive cells, a marker of 
plasma membrane leakage occurring after 
primary or secondary necrosis, likewise 
indicated that prolonged exposure of 300 
/am NMDA for 60 m in caused significant 
amounts of immediate cell death within 
1 h, whereas cell death induced by a 5 min 
exposure to 30 or 100 /am NMDA showed 
a more delayed profile with a maximal on­
set at 4 h (Fig. 1H).
Because the highest fraction of DCD 
and ICD were detected with 100 /am/ 5 min 
and 300 /am/60 m in NMDA, respectively, 
additional experiments were conducted 
in these two injury models. To explore the 
role of calpains in mediating excitotoxic 
injury, neurons were pretreated with the 
selective calpain inhibitor calpeptin (5-20 
/am) for 2 h and then exposed to NMDA.
W hen neurons were exposed to condi­
tions that favored DCD, calpeptin treat­
m ent exerted a robust dose-dependent 
and long-term neuroprotective effect as 
detected by phase-contrast microscopy,
Hoechst 33258 staining, and quantifica­
tion of PI uptake (Fig. 2A-C). Treatment 
with calpeptin also reduced the accumu­
lation of the calpain-specific, 145 kDa 
spectrin breakdown product that accu­
mulated in NMDA-exposed cultures as 
determ ined by quantitative Western 
blot analysis. Significant increases in 
spectrin cleavage were observed at 4 -8  
h  com pared with the sham -treated cul­
tures and reduced in cultures pretreated 
with calpeptin (Fig. 2D). Surprisingly, 
however, pretrcatm ent with calpeptin failed to show a signif­
icant protection under conditions that favor ICD, as induced 
by the exposure to 300 /am NMDA for 60 m in (Fig. 2£). This 
was confirmed by the analysis of the accum ulation o f the 145 
kDa, calpain-specific spectrin breakdown product that accu­
m ulated only marginally in the neuron cultures (Fig. 2 F).
Gene silencing of ca lp a in  I  and I I  or overexpression of 
calpastatin  confirms the selective requirement for calpain 
activation in  delayed excitotoxic apoptosis
Because pharmacological agents may have off-target effects, we 
next investigated whether the selective requirement of calpains in 
delayed excitotoxic apoptosis could be confirmed using genetic
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to sham conditions or 100 /am NMDA for 5 min in the presence and absence of the calpain inhibitor calpeptin. Images were taken at selected time points (8 and 24 h after treatment). Scale bar, 10 
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neurons in the presence of calpeptin (5 or 20 /am) (AN0VA, post hoc Tukey's test), f ,  f ,  Cortical neurons were treated with 100 /am NMDA for 5 min over 24 h (£) or 300 /am NMDA for 60 min over 4 h 
(f) tn the presence or absence of calpeptin, and the extent of injury was assessed with Hoechst and PI. Data represent means ±  SEM fromn =  3 separate cultures. *p — 0.05 compared with 
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approaches. Gene silencing of the large subunit o f calpain I 
and I I  using two distinct shRNA constructs was validated in 
NSC34 cells after 36 h of transfection when compared with 
cultures transfected with a scramble vector as determ ined by 
W estern blot analysis (Fig. 3A). O f note, transfection with 
either shRNA targeting the large calpain subunit significantly 
reduced cell death in response to 100 jli.m/5 m in NMDA com ­
pared with cells transfected with a scrambled shRNA sequence 
(Fig. 3B). In contrast, immediate cell death in response to 300 
/xm /60 m in NMDA was not reduced by gene silencing of the 
large calpain subunit (Fig. 3C).
Inhibition of calpain activity can also be achieved by overex­
pression o f the endogenous calpain inhibitor calpastatin. Neu­
rons were transfected with a mammalian expression vector for
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Figure 3. Calpain inhibition using RNA interference technology and overexpression of the endogenous calpain inhibitor calpastatin 
attenuate NMDA-induced excitotoxic apoptosis. NSG4 cells were transfected with shRNA plasmids against the large subunit of calpain 
I (shRNA I), calpain II (shRNA II), or scramble shRNA. Reduced expression levels of calpain I and II after shRNA expression compared with 
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calpastatin-GFP or with an EGFP control 
vector. Analysis of GFP-positive neurons 
indicated that transfection of calpastatin- 
GFP significantly reduced excitotoxic cell 
death in response to 100 /xm /5 min 
NMDA (Fig. 3D). Again, immediate cell 
death in response to 300 /lim /60 min 
NMDA was not reduced by calpastatin- 
GFP (Fig. 3E). These results confirmed 
that calpains played a predominant role in 
excitotoxic apoptosis.
The protective activity of calpain 
inhibition requires a functional 
mitochondrial apoptosis pathway
We next explored whether calpain acted on 
Bcl-2 family proteins to promote excito­
toxic apoptosis. One possibility was that cal­
pains activated pro-apoptotic Bcl-2 family 
proteins of the Bcl-2 homology 3 domain- 
only family. Bid represents a prominent 
candidate for such an activity. Bid is in­
volved in the so-called extrinsic apoptosis 
pathway and is proteolytically activated by 
caspase-8 to generate a truncated form 
(tBid) (Lietal., 1998; Luo et al., 1998). It has 
also been suggested that calpain-mediated 
cleavage of Bid generates Bid fragments that, 
similar to tBid, may activate the mitochon­
drial apoptosis pathway (Chen et al., 2001;
Polster et al., 2005). However, cortical neu­
rons from bid-deficient mice were equally 
sensitive to the NMDA-induced delayed 
excitotoxic cell death as WT neurons (Fig.
4A,B). Furthermore, calpeptin also ex­
erted significant neuroprotection in bid- 
deficient neurons, demonstrating that 
calpains were not acting on Bid to p ro­
mote cell death (Fig. 4 B).
In contrast, box-deficient cortical neurons 
were highly resistant to NMDA-induced exci - 
totoxic apoptosis (Fig. 4C). Moreover, cal­
peptin failed to provide a significant 
protection in bax-deficient mice, suggest­
ing that deficiency in bax was dominant over the pro-apoptotic 
activity of calpain and that calpains required a functional m ito­
chondrial apoptosis pathway to mediate excitotoxic apoptosis.
Quantification of the individual C a2+ responses in response 
to a 100 jam /5 min NMDA exposure showed increased neuronal 
tolerance in the b«x-deficient mice compared with the W T con­
trols, as evidenced by decreased DCD responses (Fig. AD). Of 
note, bax gene deletion also led to a significant reduction in ICD 
responses after the exposure to 100 ¡jm /5 min NMDA, suggesting 
that ICD may accompany several cell-death modes or that bax 
gene deletion has an effect on neuronal C a2+ handling.
Calpains are activated during bax-dependent neuronal injury 
induced by OGD
To validate our hypothesis that activation of calpains played a 
predominant role in ¿ax-dependent cell death in a clinically more 
relevant setting, we performed experiments using OHSCs sub­
jected to OGD. OGD is a widely used in vitro model of ischemic 
injury that also produces apoptotic (Kalda et al., 1998) and ne-
crotic (Goldberg and Choi, 1993; Gwag et al., 1995) cell-death 
phenotypes. OHSCs derived from WT and box-deficient mice 
were exposed to OGD for 45 min in the absence or presence of 
calpeptin (20 /xm) and allowed to recover under normoxic con­
ditions over 24 h. As shown in Figure 5B, a 45 min OGD treat­
ment was sufficient to induce CA1 damage in WT OHSCs, 
whereas the neuronal injury in box-deficient slice cultures was 
significantly attenuated. Calpeptin treatment exerted a signifi­
cant neuroprotective effect in WT OGD-treated OHSCs but not 
in the box-deficient slice cultures (Fig. 5 A,B). Western blot anal­
ysis revealed an increased accumulation of the calpain-specific, 
145 kDa spectrin breakdown product in the WT OHSCs but not 
in the box-deficient slice cultures (Fig. 5C).
Calpain activation occurs late during excitotoxic apoptosis
Our experiments demonstrated a functional role of calpains dur­
ing delayed excitotoxic apoptosis but did not provide detailed 
information when during the cell-death signaling cascade cal­
pains became activated. To provide spatiotemporal information
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on calpain activation and its relation to cell death during excito­
toxic injury, we designed a calpain-sensitive FRET probe com­
prising CFP and Venus as FRET donor and acceptor, respectively, 
and an 18 aa linker that incorporated the QQEVYG calpain-
Figure 5. OHSCs isolated from to-deficient mice show reduced calpain activation in re­
sponse to OGD. A, Representative images of OHSCs derived from WT and t a ~ /_  mice. The 
slices were sham exposed or subjected to OGD conditions for 45 min in the absence (control) or 
presence ofcalpeptin (20 /am) and allowed to recover for 24 h. Scale bar, 100 /Am. B, Hippocam­
pal slice cultures from WT and t o _ /_  mice were treated as described in A, and quantification 
of injury was assessed by PI staining 24 h after treatment (n =  5 slice cultures for each condi­
tion). Means ±  SEM are shown. *p £  0.05 compared with OGD-treated WT control (AN0VA, 
post hoc Tukey'stest). C, Whole-cell extracts were prepared from WT and box hippocampal 
slice cultures treated to 45 min OGD and allowed to recover under normoxic conditions for the 
indicated time points. Spectrin cleavage was assessed by Western blotting. JB-Actin served as 
loading control. BP, Breakdown product; FL, full-length.
cleavage site of spectrin. The intact FRET probe was anchored to 
the plasma membrane by a CAAX targeting sequence (for details, 
see Materials and Methods). During calpain activation, FRET 
probe cleavage of the linker peptide results in FRET disruption 
that can be detected by confocal time-lapse microscopy (Fig. 6 A).
To confirm that the FRET probe was reporting calpain cleavage, 
we transfected human neuroblastoma SH-SY5Y cells with the FRET 
probe. After this, cells were exposed to ionomycin and CaCl2, a treat­
ment that results in significant and rapid calpain activation in SH- 
SY5Y cells (Reimertz et al., 2001). Western blot analysis of cytosolic 
extracts demonstrated that endogenous full-length spectrin was
c
C o n tro l 4 h 
w t w t bax -I-
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cleaved with similar kinetics than the intact 
FRET probe (detected using a GFP anti­
body) during addition of ionomycin and 
CaCl2. Moreover, we detected a similar in­
crease in the accumulation of the 145 kDa, 
calpain-spectrin cleavage product and the 
cleaved FRET probe (Fig. 6 B, left). Cleavage 
of the FRET probe was also sensitive to a 
treatment with calpeptin (Fig. 65, right).
To explore the calpain-sensitive FRET 
probe efficiency, we next performed ac­
ceptor photobleaching experiments in 
control neurons. After establishment of a 
baseline, repeated bleaching steps were re­
corded and allowed a clear detection of 
donor unquenching (using similar image 
acquisition settings as in the following 
time-lapse experiments). The unquench­
ing was complete after five consecutive 
bleaching steps as indicated in Figure 6C.
Having established that the FRET 
probe was functional and reported cal­
pain activity, we transfected the probe 
into cortical neurons and exposed them to 
100 jU-M NMDA for 5 min (conditions that 
favor the induction of delayed excitotoxic 
apoptosis) or 300 ¡jlm  NMDA for 60 min 
(conditions that favor ICD; see Fig. 1). Be­
cause ICD and DCD were associated with 
mitochondrial membrane potential depo­
larization (Fig. 1), we detected in parallel 
changes in mitochondrial membrane po­
tential using the membrane-permeant 
cationic fluorescent probe TMRM. Inter­
estingly, in neurons that showed a delayed 
excitotoxic apoptosis, we detected signifi­
cant FRET probe cleavage. However, this 
occurred always subsequent to the de­
layed mitochondrial depolarization (Fig. 
7A), within a period of 42 ±  8 min (Fig. 
7C). This suggested that calpains were 
predominantly activated during the exe­
cution phase of delayed excitotoxic apo­
ptosis. Calpain activity lasted on average 
58 ±  13 min. Onset of cell death, detected 
by the sudden loss of cytosolic CFP fluo­
rescence attributable to plasma mem ­
brane leakage, occurred always after onset 
of the FRET probe cleavage and with an 
average delay of 96 ±  8 m in (Fig. 7C). In 
contrast, cells exposed to 300 /xm NMDA 
for 60 min did not show significant FRET 
probe cleavage either before or during ICD 
(Fig. 75). Analysis o f all cells monitored and 
classified according to their type of response 
(tolerant, DCD, or ICD) revealed that cal­
pain FRET probe cleavage was selectively 
detected in cells that showed DCD (Fig. 7D). 
In contrast, neither tolerant cells nor cells 
undergoing ICD showed a detectable FRET 
probe cleavage.
To investigate whether the DCD was a 
trigger for calpain activation in this system,
Excitation 
405 nm
A
AAX
QQEVYl
(Spoctrin sequence) Emission 
505-550 nm
Excitation 
405 nm
QQI
Emission 
470-500 nm
FRET disruption 
pectrin cleavage.
1176
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
CAAX
iSpectrin FL 
Spectrin BP 
IFRET- probe FL 
FRET- probe CL 
]p-actin 
FRET-probe 
Ionomycin 
OaOl2 
Calpeptin
0.
LL
O
0.
LL
>-
bleached bleached steps
Figure 6. FRET-based single-cell analysis of calpain activity. A, The calpain-sensitive FRET probe consisted of CFP and Venus 
fluorophores linked together by a region containing the talpain-substrata spectrin sequence. The Venus fluorophore is fused to a 
CAAX motif. During cleavage of the spectrin linker, the FRET between CFP and Venus is disrupted. This results in decreased FRET 
fluorescent intensity and increased CFP fluorescent intensity. B, FRET probe expression and cleavage in vitro was validated by 
Western blotting in SH-SY5Y cells using an anti-GFP antibody. After FRET-probe transfection, the cells were treated with ionomycin 
(5 fiM) and CaCI2 (10 mM) for the indicated times in the presence (+ )  or absence ( - )  of calpeptin. /3-Actin was used as loading 
control. BP, Breakdown product; CL, cleavage; FL, full-length. C, The Venus bleaching and correlating CFP unquenching kinetics 
were performed on the LSM 5live duoscan in control neurons transfected with the FRET probe. From the fifth scan onward, each 
scan of a time series was followed by a bleach scan, as indicated by red triangles. On the bottom, corresponding time-frame images 
of the cell are illustrated. Bleached region, used to calculate the average intensity kinetics, is indicated in red and segmented for the 
cell area using the CFP channel. Scale bar, 10
YFP
bleach steps 
CFP
5 10 15
steps number
D'Orsi et al. •  Calpains Mediate Excitotoxic Apoptosis J. Neurosci., February 1,2012 • 32(5):1847-1858 • 1855
TMRM CFP/FRET
B
FR ET-probe 
c leaved (% )
TMRM CFP/FRET
3
<
euocsct)
2o
1.4
1.2
1
0.8
0.6
0.4
0.2
0
300 60’NMDAtreatment
t - o n s e t j  N M D A
■ TMRM 
- CFP/FRET
"05 1 1.5 2
Time (h)
FRET-probe 
cleaved (%)
0%
DCu Toleranc
onset o fA ^ lo s s onset of DCD
onset of 
FRET cleavage
Figure 7. Calpainactivation isselectivelyassociatedwithexcitotoxicapoptosis.yl,^ Cortical neuronsweretransfected with the 
calpain-sensitive FRET probe and after 24 h mounted on the stage of a LSM 5Live duoscan,and neurons were treated with 100 / im  
NMDA for5 min and assayed over24h(>1) or 300 ¿iMNMDAand assayed over4h (8). Fluorescentmeasurements were recorded for 
TMRM, FRET, CFP, and YFP by time-lapse confocal microscope. FRET probe imaging data areexpressed as a ratio of CFP/FRET. TMRM 
was used as a Ai/»m indicator in the nonquenched mode. In neurons that showed a delayed excitotoxic apoptosis (/I), we observed
we treated murine cortical cultures on 
stage with the Ca2+ chelator BAPTA-AM 
(500 nM). BAPTA-AM is a membrane- 
permeable chelator that has been shown to 
be neuroprotective against excitotoxicity 
and is more selective and faster compared 
with other C a2 1 chelators, such as EGTA 
and EDTA (Tymianski et al., 1994). Excito­
toxic injury was induced in cortical neurons 
by an exposure to 100 ¡xm NMDA for 5 min, 
and BAPTA-AM (500 nM) was added 4 h 
after termination of the NMDA exposure. 
Analysis of the onset of At/<m depolarization 
and DCD using TMRM and Fluo-4-based 
confocal fluorescence microscopy showed 
that BAPTA-AM did not produce a consid­
erable delay in the onset of the Ai//m loss (Fig. 
7E) but resulted in a significant delay in 
DCD (Fig. 7F). Furthermore, BAPTA-AM 
produced a robust delay in the onset of FRET 
probe cleavage compared with NMDA- 
exposed control neurons (Fig. 7G).
Discussion
In the present study, we have set o ut to char­
acterize the role of calpains in response to 
transient and prolonged glutamate receptor 
overactivation in mouse neocortical neu-
significant calpain activation (FRET probe cleavage) subse­
quent to delayed A ijim depolarization. In neurons that 
showed an immediate excitotoxic ICD/necrosis (B), no signifi­
cant FRET cleavage was observed. The onset of these events (in 
red and green) and cell death (in black) is indicated by arrows 
(A, B), and representative time-frame Images are illustrated 
(left, pseudocolored CFP/FRET emission ratio; red, TMRM im­
ages). Scale bar, 10 jim . C, Analysis of FRET probe cleavage 
and Its relation to cellular outcome in cells treated with 100 
¡j m  NMDA for 5 min. Data shown represent the mean time 
taken between the onset of FRET probe disruption and onset of 
loss; the mean time taken for complete probe cleavage 
and the mean time taken between onset of FRET probe cleav­
age and onset of cellular collapse. Data were obtained from 18 
separate experiments from 11 independent cultures (n =  22 
neurons). D, Quantification of the number of cells in 100 
NMDA/5 min treated neurons with FRET probe disruption (in 
black, total number of cells; in gray, cells with FRET probe dis­
ruption). Neurons were classified according to their type of 
cellular response (DCD, tolerance, ICD). Data were obtained 
from 18 separate experiments from 11 independent cultures 
(n =  47 neurons), f,  F, Cortical neurons were exposed to 100 
/wM NMDA for 5 min and the Ca2+ chelator BAPTA-AM (500 
nM) was added on stage 4 h after NMDA addition. Alterations In 
A ipm and intracellular Ca2+ were monitored in single cells 
using confocal fluorescence microscopy. Onset of loss (f) 
and onset of DCD (f) was analyzed in neurons in the absence 
(control,/) =  29 neurons) orthe presenceof BAPTA-AM (n =  
19 neurons). *p s  0.05 compared with NMDA-treated con­
trol. G, Cortical neurons transfected with the calpain-sensitive 
FRET probe were treated as described in f  and Fand the onset 
of the FRET probe cleavage was analyzed in transfected neu­
rons in the absence (control, n =  11 neurons) or presence of 
BAPTA-AM (n =  11 neurons). *p <  0.05 compared with 
NMDA-treated control neurons.
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rons. Our data suggest that, surprisingly, calpains do not contribute 
to excitotoxic injury under conditions that are associated with ICD 
and excitotoxic necrosis. Using pharmacological, genetic, and 
single-cell imaging approaches, we demonstrate that calpains rather 
play a critical role in box-dependent, excitotoxic apoptosis and are 
here activated as cell-death effectors during the execution stage.
Our study supports the concept that inhibition of calpain activity 
provides neuroprotection against excitotoxic neuronal injury. One 
of the limitations in our study may be that calpain inhibition slowed 
down cell death rather than arresting it. However, similar neuropro- 
tective effects were observed in hippocampal and cortical neurons 
subjected to excitotoxic and OGD-induced neuronal injury in vitro, 
using the calpain inhibitors calpeptin, MDL-28170, and E-64 (Si- 
man et al., 1989; Brorson et al., 1995; Rami et al., 1997; Lankiewicz et 
al., 2000). Similarly, neuroprotection was also observed using ge­
netic approaches. Knockdown of /u.-calpain (calpain J) in an in vitro 
model of OGD was able to prevent AIF nuclear translocation and 
increased cell survival (Cao et al., 2007). Moreover, calpain inhibi­
tion was neuroprotective in in vivo models of excitotoxic injury (Wu 
et al., 2004), ischemic stroke, and neurodegeneration (Lee et al., 
1991; Rami and Krieglstein, 1993; Bartus et al., 1994; Hong et al., 
1994). It has also been reported that knockdown of calpain II (m- 
calpain) increased survival of primary hippocampal neurons after 
NMDA excitotoxicity (Bevers et al., 2009). Importandy, previous 
studies did not fully address the question under which cell-death 
conditions calpain inhibition is neuroprotective and when in the cell 
death cascade calpains became activated. In this study, we demon­
strate that calpains are specifically involved in box-dependent exci­
totoxic apoptosis. Although treatment with calpeptin failed to show 
any significant protection in neurons undergoing ICD, it provided a 
long-term protection in neurons undergoing DCD/excitotoxic apo­
ptosis. These findings were confirmed using genetic approaches, in­
cluding gene silencing of calpain and overexpression of the 
endogenous inhibitor calpastatin (Fig. 3). Western blot data also 
suggested that, under conditions that favor ICD, calpain-specific 
spectrin proteolysis was not significantly elevated, whereas neurons 
exposed to conditions that favor DCD showed significant calpain 
activalion(Fig.2).Thcsebiochemicaldatawereconfr rmed by single­
cell imaging experiments, in which no significant cleavage o f the 
calpain-sensitive FRET probe was detected in the soma of neurons 
that underwent ICD, whereas neurons undergoing DCD showed a 
full-blown calpain activity (Fig. 7).
These data bring up the question why ICD did not trigger a 
prominent calpain activation on neuronal somata despite the 
very significant increase in cytosolic C a2+, A prolonged gluta­
mate excitation is characterized by a rapid collapse of cellular 
bioenergetics and rapid ATP depletion (Tymianski et al., 1993; 
Ankarcrona et al., 1995; Budd and Nicholls, 1996; Vergun et al., 
1999; Luetjens et al., 2000; Ward et al., 2007). It is possible that 
the activation of calpains requires an energy-dependent process 
and a substantial am ount of ATP to be present. Alternatively, 
ICD-associated membrane rupture and cell death may occur too 
rapidly to allow for a controlled calpain activation. We cannot 
exclude that calpains were still activated locally and in defined 
structures, such as dendrites, or were activated at undetectable 
levels. However, our data demonstrate that any such activity did 
not contribute to cell death in neurons that underwent ICD.
Our experiments also demonstrate that delayed excitotoxic 
apoptosis required a functional, ¿ax-dependent mitochondrial 
apoptosis pathway and that calpains work within this pathway as 
cell-death executioners. Our data did not show a bid requirement 
for excitotoxic apoptosis or for calpain-dependent cell death, be­
cause bid-deficient and WT mice were similarly sensitive to
NMDA-induced apoptosis, and calpain inhibition was equally 
protective in bid-deficient and WT mice (Fig. 4). Polster et al. 
(2005) suggested in isolated mitochondria studies that calpain- 
dependent Bid cleavage triggers the release of pro-apoptotic fac­
tors from mitochondria. In intact neurons, such a mechanism 
may not operate in the setting of excitotoxic apoptosis.
Notably, our study demonstrates that calpain activation oc­
curred downstream of mitochondrial engagement during excito­
toxic apoptosis. These findings and the observation that 
excitotoxic apoptosis is box-dependent elicit two related and im­
portant questions: (1) why does excitotoxic injury not trigger a 
prominent caspase activation, and (2) why do calpains represent 
the cell-death executioners during box-dependent excitotoxic ap­
optosis whereas in other models of box-dependent neuronal ap­
optosis, such as staurosporine exposure, caspases, but not 
calpains, function as executioners (Lankiewicz et al., 2000)? A key 
factor may be the extent of mitochondrial Ca2+ overloading in 
such paradigms. After the initial NMDA-induced cytosolic Ca2+ 
increase, neurons not only pump Ca 2+ back into the extracellular 
compartment but also reestablish their cytosolic C a2+ levels by 
mitochondrial Ca2+ uptake (Nicholls and Scott, 1980; Ward et 
al., 2005). A box-dependent mitochondrial outer membrane per- 
meabilization (MOMP) will, however, cause mitochondrial de­
polarization as a result of the loss of cytochrome c (Goldstein et 
al., 2000; Luetjens et al., 2000). This may trigger a Ca2 1 release 
from the mitochondrial matrix, capable of activating calpains. 
Indeed, previous studies have shown that DCD is absent when 
MOMP is blocked (Concannon et al., 2010). Our calpain-FRET 
imaging data support such a hypothesis: activation of calpains 
occurred downstream of depolarization and with a delay 
similar to that of DCD (Figs. 1-7). Furthermore, delayed appli­
cation of the Ca2H chelator BAPTA-AM after NMDA exposure 
led to significant delay in DCD and calpain activation. However, 
this does not rule out a possible contribution of other factors, 
such as growth factor- and MAPK-dependent calpain activation 
(Zadran et al., 2010). Because other neuronal apoptosis para­
digms do not induce a similar mitochondrial Ca2+ overloading, 
activation of calpains may be less pronounced or absent (Lankie­
wicz et al., 2000). Once activated, calpains inhibit the ability of 
cytochrome c to activate caspases by cleavage of procaspase-3 and 
procaspase-9, as well as APAF-1 (Chua et al., 2000; Lankiewicz et 
al., 2000; Reimertz et al., 2001). As a consequence, a caspase- 
independent excitotoxic apoptosis ensues that is mediated by 
calpains. Calpains cleave a variety of proteins that are required for 
neuronal function, including cytoskeletal proteins and transcrip­
tion factors (Croall and Demartino, 1991). Calpains also process 
and trigger AIF release from mitochondria and may thereby in­
duce cell death (Cregan et al., 2002; Wang et id., 2004; Cao et al., 
2007). Calpains may also further increase neuronal Ca2+ over­
loading by cleavage and inactivation of the N a+/C a2+ ex­
changer (Bano et al., 2005). Indeed, the overexpression of 
calpastatin or of a noncleavable N a +/C a21 exchanger has 
been shown to inhibit DCD during excitotoxic neuronal in­
jury (Bano et al., 2005). Activation o f calpains may therefore 
initiate a self-amplifying C a2+-dependent cell death cascade, 
eventually resulting in the destruction of the neuron.
In conclusion, our study demonstrates that calpains play a 
critical role in box-dependent excitotoxic apoptosis but contrib­
ute little to the destruction of neuron during excitotoxic necrosis. 
This mechanism may be of particular importance for the treat­
ment of neuronal injury associated with submaximal glutamate 
receptor overactivation as evident in the ischemic penumbra or 
during chronic neurodegeneration.
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